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ABSTRACT
The lack of correlation between in vitro and in vivo gene delivery experiments presents a
significant obstacle in the progress of gene therapy studies by preventing the extrapolation of
successful cell culture results into animals. This phenomenon has also been documented in the
specific case of liver where standard hepatocyte culture systems fail to reliably predict the in
vivo performance of gene delivery vectors. This is possibly a consequence of the loss of
differentiated phenotype that these cells undergo when they are dissociated from their in vivo
environment and cultured in vitro. This problem underscores the necessity for better in vitro
models that can mimic the physiological environment and responses of in vivo liver tissue.
This thesis aimed at developing an alternative in vitro gene delivery assay based on the
Tissue-Engineered Liver Microreactor, a culture system designed to facilitate the
morphogenesis of three-dimensional tissue-like structures from isolated liver cells under
continuous perfusion, maintain cell viability and hepatic functionality for long-term culture
periods and enable repeated in situ observation with microscopy. We developed experimental
assays to non-invasively detect and quantify gene delivery efficiency in the 3D environment of
the microreactor culture based on the application of 2-photon microscopy and spectroscopy.
These techniques provide a convenient platform for comparative analysis of different vectors.
Our main objective was to compare the gene delivery efficiency of an adenoviral vector(Ad5-CMV-EGFP) in the microreactor system and 2D hepatocyte monolayer culture.
Quantitative assays were developed based on Real-Time PCR and RT-PCR to measure the
levels of Ad vector uptake and transgene expression. The Ad mass transport in both systems
was mathematically modeled to estimate the Ad uptake constant as a basis for comparison of
delivery efficiency. This parameter was found to be significantly higher in the microreactor
system, suggesting a more efficient mechanism of Ad internalization. Moreover, gene
expression was measured in terms of transgene mRNA levels; the ratio of gene expression
relative to Ad uptake was estimated as the basis for comparison of vector transcription
efficiency. No significant difference was found between the 2 systems. These results provide
some evidence that a more physiological culture system can yield different information(potentially more relevant to the in vivo situation) compared to standard in vitro culture.
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CHAPTER 1
Background and Motivation
1.1 Gene delivery
1.1.1 Introduction
Human gene therapy aims at the treatment of inherited and acquired genetic diseases
by delivering therapeutic genes into somatic cells. Consequently, it involves the identification
and isolation of the appropriate genes, the selection of the target cells and the development of a
technique to deliver the DNA to these cells. The advent of recombinant DNA technology and the
identification of the genetic defects responsible for many disorders have made gene therapy
become a reality and move from feasibility and safety studies in animals to clinical applications
(Crystal, 1995). The first clinical trials began in 1990 and since then 1283 protocols have been
approved for the treatment of a variety of diseases (Figure 1.1). Today about 600 protocols are
underway involving thousands of patients.
However, although simple as a theoretical concept, gene therapy faces significant
obstacles in practice. Clinical trials have demonstrated that gene transfer to humans is indeed
feasible, but there is still no result that can be considered as a major success. Additionally, gene
therapy has suffered major setbacks due to adverse effects on patients. First in 1999, with the
death of 18-year-old Jesse Gelsinger, a participant in a gene therapy trial for ornithine
transcarboxylase deficiency (OTCD); his death was the result of a severe immune response to
an adenovirus vector. Then in 2003, two children successfully treated by gene therapy for X-
linked severe combined immunodeficiency disease (X-SCID) with a retroviral vector, developed
a leukemia-like condition, prompting the FDA to place a temporary halt on all gene therapy trials
using retroviral vectors in blood stem cells.
An important problem that prevents gene therapy from becoming an established
therapeutic strategy is gene delivery, namely the lack of efficient delivery systems and of
sustained transgene expression (Verma and Somia, 1997). Ideally, a gene delivery vector
should be capable of efficiently and stably transferring the gene(s) of interest specifically to the
target cells, without inducing inflammation or host immune responses; moreover it should be
easy to produce and purify (Crystal, 1995). Currently existing vectors can be divided into two
classes: viral (e.g. retroviral, adenoviral) and nonviral vectors (naked DNA, liposomes,
molecular conjugates). Unfortunately, none of these satisfy all of the above mentioned
requirements. Retroviruses cannot transduce non-dividing cells and are mostly used in ex vivo
strategies; moreover the random integration to the host genome involves the risk of insertional
(a)
Indications Addressed by Gene Therapy Clinical Trials
Cancer diseases 67% (n=854)
* Cardiovascular diseases 9.1% (n= 117)
* Monogenic diseases 8.4% (n= 108)
* Infectious diseases 6.5% (n=83)
* Neurological diseases 1.3% (n=17)
* Ocular diseases 0.9% (n=12)
Other diseases 1.6% (n=21)
* Gene marking 3.9% (n=50)
* Healthy volunteers 1.6% (n=21)
The Journal of Gene Medicnme, r" 2007 John Wiley and Sons Lid www wileyco uk/genmed/dcinicl
(b)
Vectors Used in Gene Therapy Clinical Trials
.1· IL
Adenovirus 25% (n=324)
* Retrovirus 23% (n=299)
* Naked/Plasmid DNA 18% (n=234)
* Lipofection 7.9% (n= 101)
* Vaccinia virus 7% (n=90)
* Poxvirus 6.7% (n=86)
* Adeno-associated virus 3.7% (n=47)
* Herpes simplex virus 3.4% (n=43)
* RNA transfer 1.2% (n= 16)
* Others 2.6% (n=33)
O Unknown 3.1% (n=40)
The Journa.l of Gene Medicine, i•' 2007 John Wiley and Sops Ld www wiley co uk/qenmned/clinicl
Figure 1.1. Gene therapy clinical trials since 1989 categorized by: (a) indication and (b)
vector type.
mutagenesis (as was the case in the above mentioned X-SCID trial). Adenoviral vectors,
although very efficient, typically induce strong immune responses (which was the cause of the
fatality in the OTCD trial). Nonviral vectors are less immunogenic and are able to carry genes of
unlimited size but they have very low transfection efficiency compared to viral vectors.
Moreover, there are problems that need to be overcome for all vectors, such as the lack of
target specificity, transgene regulation, and efficient, large-scale production methods (Crystal,
1995).
Therefore, current efforts in gene therapy research focus to a large extent on vector
design, namely the manipulation and modification of already existing systems in order to
improve their properties and circumvent their limitations (mainly through the combination of
features of different vectors), as well as the development of new synthetic systems.
1.1.2 In vitro - in vivo lack of correlation
In order for a new gene delivery system to reach the stage of human trials, extensive
tests have to be performed that provide strong evidence of its potential clinical effectiveness and
demonstrate that it can be used safely with no serious adverse effects. The first step in this
process involves in vitro experiments, typically in monolayer cell cultures. Reporter genes are
used (such as green fluorescent protein, luciferase, 3-galactosidase) to allow the detection and
quantification of gene expression. In this way the in vitro performance of the gene delivery
vector can be determined in terms of its transduction efficiency (percentage of transduced cells)
and the levels of transgene expression. The ability of the vector to provide stable transduction
can also be studied by determining the persistence of gene expression with time.
The intermediate step between in vitro experiments and clinical trials consists of animal
studies, where the in vivo performance of the vector is tested using a reporter gene or the
therapeutic gene of interest. Gene expression can be assayed for example in the former case
by removing and examining tissue sections or by whole animal imaging, or in the latter case, by
measuring the levels of the therapeutic protein in the blood circulation, immunostaining of tissue
sections, DNA, RNA and protein assays, etc.
In this stepwise experimental process, successful results are the necessary condition in
order to proceed to the next stage. However, it is not a sufficient condition to guarantee an
equally successful outcome. There have been several examples in which promising results from
animal studies failed to be reproduced in humans or even the toxicity of the vector could not be
predicted (Crystal, 1995). Likewise, transfection efficiency in vitro and in vivo do not always
correlate, making translation of positive results in cell culture into animals difficult (Luo and
Saltzman, 2000). In general, many parameters could be responsible for the in vitro-in vivo lack
of correlation. Typical in vitro cultures cannot duplicate the complexity of the whole organism;
the interaction of the vector with blood components and the immune system, the dynamic flow
conditions and possible anatomical barriers can affect gene delivery efficiency.
Moreover, the isolation and culture of cells in vitro alter the structural and functional
properties that they exhibit as part of an organized tissue. For example, loss of differentiated
phenotype can affect gene transfer efficiency; well-differentiated airway epithelial cells in vivo
are more difficult to transfect with cationic liposomes than poorly differentiated primary cells in
culture or certain cell lines (Matsui et al., 1997). Similarly, although adenoviral vectors (Ad)
developed for the treatment of cystic fibrosis can deliver very efficiently transgenes to
respiratory epithelial cells grown in culture, experiments in vivo indicated that the murine and
human respiratory epithelium is poorely transduced by Ad (Pickles et al., 1996); a probable
explanation is the absence, from well-differentiated airway epithelial cells, of the specific
receptor and integrins that mediate attachment and internalization of Ad (Pickles et al., 1998).
Since the focus of this thesis is on liver, the following section will describe in more detail
the particular aspects of liver gene therapy.
1.2 Gene Delivery in Liver.
1.2.1 Liver as a target for gene therapy
The liver is an attractive target for gene therapy due to its unique morphological and
functional characteristics. The liver is a highly vascularized organ, with 30 per cent of the
cardiac output flowing through every minute (Guyton, 1981); therefore, intravenously injected
gene delivery vectors can be rapidly delivered to it and the therapeutic proteins that are
subsequently produced and secreted in the blood can be efficiently distributed systemically
(Chiou et al., 1994). Due to its sinusoidal structure and its unusually permeable endothelium
(cell lining with large fenestrations as opposed to a continuous layer) the parenchymal cells
(hepatocytes) are in direct contact with the plasma and its constituents. This structure allows
direct access of large molecules and particles, such as adenoviral vectors, to hepatocytes
(Ledley, 1995).
The liver is also the site of essential metabolic pathways; briefly, its metabolic functions
include carbohydrate, fat and protein metabolism, storage of vitamins, as well as detoxification
or removal of drugs, hormones and other substances (Guyton, 1981). As such, the liver is
involved in many hereditary metabolic diseases (e.g. familial hypercholesterolemia, ao-
antitrypsin deficiency, phenylketonuria), possible candidates for gene therapy. Moreover, it is
responsible for the production and secretion of a large proportion of all plasma proteins, the
major of which is albumin, followed by glycoproteins (e.g. coagulation factors) and lipoproteins.
Of the 70g of proteins per liter of plasma in humans, approximately 55g are produced by
hepatocytes, which, in contrast to other secretory cells, release them immediately (Feldman,
1994). Therefore, the liver is an ideal site for high level expression of therapeutic proteins
(Chiou et al., 1994). An additional feature that makes hepatocytes attractive for gene therapy
applications, is the ability for targeted gene delivery by taking advantage of the presence of a
variety of liver-specific receptors (such as the asialoglycoprotein receptor) or by using
hepatocyte-specific promoters (Ledley, 1995).
1.2.2 In vitro - in vivo lack of correlation in liver gene delivery
Many attempts have been made to deliver genes to the liver using a variety of
approaches, ranging from naked plasmid DNA to sophisticated recombinant viral vectors. There
have been no successful results in humans so far and the design of a method providing efficient
and stable gene transfer and expression in human hepatocytes is still a challenging problem.
The lack of in vitro vs. in vivo and animal vs. human experiment correlation is an important issue
here too. Ferry and Heard (1998) mention some interesting examples. In one case, where DNA
was complexed with polylysine coupled to an asialoglycoprotein moiety for liver-targeted gene
delivery, the system was efficient in vitro and retained its targeting capability in vivo, but in vivo
expression was low and transient. When an adenovirus particle was linked to the receptor-
based DNA carrier to increase transfection efficiency, high expression was observed in primary
hepatocyte cultures but improvements were limited in vivo.
In another case, where retrovirus-mediated gene delivery was combined with the
stimulation of liver regeneration, high levels of efficiency and stability were obtained in rats;
however liver regeneration kinetics differ between rodents and larger mammals leading to poor
results in dogs. Another example that demonstrates the inabilty of in vitro systems to predict
correctly the performance of gene delivery vectors in vivo, involves ecotropic retroviral vectors
which fail to transfect rat hepatocytes in vivo because the ecotropic receptor is not expressed by
hepatocytes in vivo, even though it is expressed under normal culture conditions in vitro (Ledley,
1995). Moreover, in vitro studies aiming at the evaluation of vectors carrying hepatocyte-specific
promoters for liver-targeted gene delivery are likely to be affected by the decrease in the rates
of liver-specific transcription observed in culture systems of primary hepatocytes (Ponder et al.,
1991). Similarly, hepatoma cell lines cannot be used because they fail to reproduce normal
hepatic transcription patterns.
All the above mentioned examples lead to the conclusion that typical in vitro hepatocyte
culture systems provide inadequate and sometimes unreliable information for accurate
predictions of in vivo gene delivery performance. This is possibly a consequence of the changes
in structure and function that these cells undergo when they are dissociated from their in vivo
environment and cultured in 2D monolayers.
In order to further clarify this point, the following section describes in more detail the
characteristic structure of hepatocytes, how it is tightly related to their unique functions, the
effect of in vitro conditions on both, as well as the various in vitro methodologies developed to
study and minimize this effect.
1.3 Primary Hepatocytes Under In Vivo and In Vitro Conditions.
1.3.1 Hepatocytes in vivo.
Hepatocytes are large, cuboidal, epithelial cells (20-30pm diameter), which, in the liver,
are arranged in one cell-thick plates. These plates are separated from each other by specialized
capillaries called the sinusoids. In this configuration, the lateral sides of a hepatocyte establish
contact with the neighboring hepatocytes and form the bile canaliculi, whereas the other sides
face the sinusoids. A narrow space containing extracellular matrix components (space of Disse)
separates the hepatocytes from the endothelial layer that lines the sinusoids (Maher and Bissell,
1993). This arrangement establishes the polarity of hepatocytes by dividing their plasma
membrane into three, morphologically and functionally different regions: the sinusoidal (contact
with blood, e.g. secretion of plasma proteins), the lateral (contact with neighboring hepatocytes
through various kinds of junctions) and the canalicular or apical region (excretion of bile) (Le
Bail et al., 1992; Feldman, 1994) (schematic in Figure 1.2). The maintenance of this architecture
is essential for the hepatocyte's role in xenobiotic metabolism and biliary excretion.
The specialized morphology and function of hepatocytes is a consequence of the
expression of a variety of liver-specific genes, which are regulated by a combination of
transcription factors; the latter are believed to be determined and regulated by extracellular
signals, soluble (hormones) and insoluble (extracellular matrix, cell-cell interactions).
Sinusoids hepatocyte bile canaliculus
ndothelial
all
space of Disse
Figure 1.2 Schematic of liver tissue architecture and hepatocyte microenvironment.
1.3.2 Hepatocytes in vitro.
When hepatocytes are isolated from the liver and maintained under conventional culture
conditions, their recovery and adaptation to the in vitro environment is followed by the rapid loss
of liver-specific functions (protein synthesis, xenobiotic metabolism, cytochrome P-450
induction), the failure to reestablish normal cell polarity and architecture, and the deterioration of
cell viability (Le Cluyse et al., 1996). As a result, the utility of in vitro hepatocyte cultures for
pharmacological and toxicological studies is significantly reduced.
The progress in understanding the factors responsible for the hepatocyte phenotype has
led to the development of various methods that aim at maintaining liver-specific function in vitro
by providing suitable culture conditions. The four parameters that are considered to play an
important role are: the culture medium and extracellular matrix composition, cell-cell interactions
and, cell shape and tissue organization.
The design of alternative, more complex culture systems by manipulation of one or more
of these parameters has led to considerable improvements in cell viability and function. These
approaches range from determining an optimal combination and composition of culture medium
and extracellular matrix, to the more sophisticated co-cultures, sandwich configurations and
spheroidal aggregate cultures. Although the results have been very encouraging, none of these
systems completely restores all liver-specific functions and structure. Moreover, their utility for
various applications might be limited. For example, systems using complex substrata or
sandwich configurations are not amenable to transfection with DNA constructs (Le Cluyse et al.,
1996).
Among the culture systems mentioned above, spheroidal aggregates provide a three-
dimensional cyto-architecture. Landry et al. (1985) first reported that, when rat liver cells are
cultured on a non-adhesive substratum, they tend to aggregate into spheroids, where the
different cell types sort out and reorganize, and extracellular matrix is deposited around each
cell population. Moreover, they showed that these conditions enhance cell viability and allow the
maintenance of some differentiated functions (albumin secretion, tyrosine aminotransferase
induction) for an extended period of time. In addition to this, in spheroid cultures, DNA synthesis
is suppressed even in the presence of growth factors, which suggests that hepatocytes remain
in the Go phase. This indicates the maintenance of differentiated function, given the reciprocal
relationship between differentiation and growth. On the contrary, when the spheroids are
dissociated to form a monolayer, cells enter the G1 phase and proceed through the cell cycle
(Yuasa et al., 1993). Spheroids can also form in spinner flask cultures, a method significantly
more efficient than formation in static dishes and which does not have any adverse effects in
their functional properties (Wu et al., 1996).
The beneficial effect of spheroid culture on hepatocyte function has been attributed to
the three-dimensional structure that approximates in vivo morphology, the production and
deposition by the cells of ECM components, and the establishment of cell-cell interactions. This
hypothesis is re-enforced by experimental evidence. TEM experiments indicate the presence of
tight junctions and microvilli-lined bile canaliculus-like channels (Wu et al., 1996). Moreover,
another study suggests a correlation between cytoskeleton organization and cytochrome P-450
activity, a marker for the level of hepatocyte differentiated function (Hansen et al., 1998).
1.4 The Tissue-Engineered Liver Microreactor: A Promising In Vitro
Assay for Gene Delivery? - Motivation and Overall Objective of
Thesis.
The information presented so far can be summarized into the following main points:
* There is a lack of correlation between in vitro and in vivo gene delivery experiments
which prevents the extrapolation of successful cell culture results into animals and
therefore presents a significant obstacle in the progress of gene therapy studies.
* In the particular case of liver, typical in vitro hepatocyte culture systems provide
inadequate and sometimes unreliable information for accurate predictions of in vivo gene
delivery performance. This is possibly a consequence of the loss of differentiated
phenotype (exhibited by drastic changes in structure and function) that these cells
undergo when they are dissociated from their in vivo environment and cultured in vitro.
* A variety of culture methods have been developed to foster the maintenance of the
hepatocytic phenotype, but still, not all of the important functions of liver can be
replicated at desired levels, prompting continued efforts to develop new methods. The
culture of liver cells in 3D conditions has been shown to promote histotypic
reorganization and maintenance of differentiated functions.
The above statements underscore the necessity for better in vitro models in liver gene
therapy studies, models that can mimic the physiological conditions and responses of in
vivo liver tissue.
This problem provided the motivation for this thesis. We are particularly interested in
developing an alternative in vitro assay for gene delivery to hepatocytes, based on a three-
dimensional tissue-engineered perfusion culture system, the 'liver microreactor'.
The liver microreactor, which was developed in the Griffith lab at MIT, supports the
culture of liver cells in a 3D tissue-like environment that is continuously perfused with medium.
Additionally, the design of this system allows repeated in situ observation with microscopy. It
has been demonstrated that the microreactor facilitates the formation of hepatocellular
aggregates reminiscent of the structures observed in vivo and that this leads to an enhanced
and sustained maintenance of key liver-specific functions (Powers et al, Biotech. Bioeng. 2002
and Tissue Eng. 2002, Sivaraman et al., 2005).
Therefore the liver microreactor provides a promising platform for in vitro studies
of in vivo hepatocyte responses and consequently a promising platform for predicting
the performance of gene delivery vectors in vivo.
With the above statement as our premise we hypothesize that the liver microreactor,
being a more in vivo-like culture, can yield qualitatively and quantitatively different (and possibly
more relevant to the in vivo situation) information regarding the efficiency of gene delivery,
compared to conventional hepatocyte culture.
The overall obiective of this thesis is to test this hypothesis by comparing the
performance of a gene delivery vector in the microreactor system and in standard 2D
hepatocyte culture. For this study a first generation adenoviral vector carrying the gene for
Enhanced Green Fluorescent Protein (EGFP) under the control of a CMV promoter was
selected as the gene delivery vector. The following section describes the properties of Ad and
EGFP as well as the reasons that make them appropriate choices for the experiments in this
thesis.
1.5 Adenovirus as a Gene Delivery Vector.
The adenovirus (Ad) is a DNA virus that infects a wide range of mammalian and avian
hosts and causes respiratory disease in humans. Among the at least 50 different human
adenovirus serotypes that have been identified (Shenk, 1996), type 2 (Ad2) and type 5 (Ad5)
have been most extensively studied and their genome has been completely sequenced;
consequently they are the most widely used as gene delivery vectors (Douglas and Curiel,
1997).
Adenoviruses are icosahedral particles (20 triangular surfaces and 12 vertices), 70-
100nm in diameter and consist of a protein shell (capsid) which surrounds a DNA-containing
core. The capsid is composed of 240 hexons and 12 pentons (corresponding to the vertices).
Pentons and hexons are surrounded by 5 and 6 neighbours respectively. Each penton contains
a base which forms part of the surface of the capsid and a projecting fiber made up of a tail, a
rodlike shaft and a terminal globular structure (knob) (Shenk, 1996; Douglas and Curiel, 1997).
Infection of cells with Ad is a stepwise process. Initially, the virus binds to a specific cell-
surface receptor, the Coxsackievirus and Adenovirus Receptor (CAR) (Bergelson et al., 1997).
It has also been reported that MHC class I can mediate Ad attachment via the fiber (Hong et al.,
1997). Internalization of the Ad is mediated by the interaction of RGD sequences in the penton
base with integrins avP3 and a•vs. After internalization, the Ad is localized within clathrin-coated
vesicles and later in endosomes. Acidification of the endosomes allows the rapid movement to
the cytoplasm. The transport of the virus across the cytoplasm to the nucleus is mediated by
microtubules and is followed by a gradual disassembly of the capsid. When the Ad reaches the
nucleus it attaches to the cytoplasmic side of the nuclear pore complex and releases the DNA
inside the nucleus (Greber et al., 1999; Shenk, 1996; Douglas and Curiel, 1997). The
mechanism of Ad entry in cells is remarkably efficient and has been extensively exploited to
facilitate conjugate-mediated gene delivery (Curiel, 1994; Diebold et al., 1999; Horwitz, 1996).
The Ad genome consists of a single linear, double stranded DNA molecule (-36kb) and
its expression consists of two phases. The early phase involves the early genes El, E2, E3 and
E4 (essential for DNA replication except for E3), whereas the late phase begins after the onset
of DNA replication and involves the expression of Ad structural proteins. The Ad genome can be
manipulated by recombinant technology. Therefore, Ad vectors for gene therapy can be
constructed by substitution of the El region with a transgene. The deletion of the E1A and E1B
early genes is required for safety reasons so that the recombinant Ad vector is replication
deficient. These vectors can be produced in complementary cell lines such as the 293 cells
(Kovesdi et al, 1997). The recombinant adenoviruses are fully competent to infect human cells
without the El region and transcribe the inserted sequences (Horwitz, 1996).
Adenoviral vectors have been extensively studied for their ability to deliver therapeutic
genes in vitro and in vivo (Becker et al. 1994, Ferry and Heard, 1998), and their advantages and
limitations have been identified. Moreover, they represent 25% of approved clinical trial
protocols since 1989 (Figure 1.lb). The major advantages are their ability to deliver genes very
efficiently to a wide variety of both dividing and non-dividing cells, their ability to accommodate
up to -7.5kb foreign DNA (when El and E3 regions are deleted) and the ease of production in
high titers. Moreover, they have been previously used in humans as vaccines without any side
effects (Kovesdi et al., 1997) and their stability in the bloodstream allows administration by
intravenous injection (Douglas and Curiel, 1997).
However, the adenovirus DNA does not integrate into the host genome and remains
inside the cell nucleus in an episomal state resulting in transient transgene expression and the
need for repeated administration. In addition to this, the induction of host cellular and humoral
immune responses leads to the rejection of the transduced cells and precludes the possibility of
readministration of the same vector. Finally, a very important limitation of Ad vectors is the lack
of cell-specific targeting. Several studies are directed towards the identification of the specific
mechanisms responsible for these problems (Muruve et al., 1999; Harvey et al., 1999; Christ et
al., 2000) and the development of various approaches to circumvent them and make Ad vectors
more suitable for gene delivery. Such approaches include the development of "gutless" Ad
vectors (i.e. in which all viral coding sequences have been deleted) to reduce immunogenicity,
and the specific targeting of Ad by genetic or immunological modification of the fiber knob or by
using cell-type-specific promoters (Douglas and Curiel, 1997; Kovesdi et al., 1997; Ferry and
Heard, 1998; Sandig et al., 2000; Pastore et al., 1999; Sandig et al., 1996).
Although Ad vectors are able to infect a variety of cell types in vitro, when administered
systemically in vivo, they accumulate predominantly in the liver. In fact the clearance of Ad5
from the bloodstream and its accumulation in the liver occur within minutes (Alemany et al.
2000). This phenomenon is attributed to the tissue architecture of the liver. The Ad particles
reach the liver via the portal vein and come in contact with the hepatocytes only after passing
through the liver sinusoids, which are lined by fenestrated endothelium. The sinusoidal
fenestrations which have a size of about 100nm allow the access of the Ad particles (average
diameter of 80nm) into the space of Disse and subsequently to the hepatocytes and Kupffer
cells (located on the inside of the sinusoids). Ad is efficiently taken up by both hepatocytes and
Kupffer cells (Alemany et al. 2000; Schiedner et al. 2003).
As mentioned earlier, Ad vectors use a two-step mechanism to infect cells in vitro. The
first step involves the attachment of the Ad fiber knob to the CAR receptor. The second step
involves binding of the penton base RGD motifs to cellular integrins, leading to Ad
internalization. In vivo however, other mechanisms have been found to play a more important
role in the Ad infection of liver cells. It has been shown that when the interactions of Ad with
CAR and integrins are ablated, transduction in the liver is not eliminated (Alemany and Curiel,
2001; Martin et al., 2003; Smith et al., 2002). Moreover, the Ad5 fiber shaft has been found to
bind to heparan sulfate proteoglycans (HSPGs), resulting in liver transduction (Smith et al.,
2003).
Therefore, adenovirus appears to be an interesting vector choice for the
experiments in this study and relevant to the hypothesis we want to examine.
EGFP: Non-invasive reporter of gene expression
The choice of Enhanced Green Fluorescence Protein as a reporter for gene delivery is
based on several properties. EGFP is a stable fluorophore, with excitation and emission spectra
similar to those of fluorescein, therefore it is easy to use in fluorescence microscopy. It can be
followed non-invasively in living cells, allowing the study of dynamic systems, in contrast to
other reporters (chloramphenicol acetyltransferase, alkaline phosphatase, P-galactosidase,
firefly luciferase) which require cell fixation and permeabilization or lack single cell resolution.
Moreover, EGFP can be fused to promoters or proteins and expressed in cells as a reporter for
gene expression or protein localization without any effect on the fluorescence properties or the
protein function (Spector et al., Cells: A laboratory manual). GFP has been used extensively as
a reporter in gene transfer studies in order to obtain quantitative information on transduction
efficiency and levels of expression for different gene delivery vectors (Schaffer et al., 1997;
Muldoon et al., 1997; Schaffer and Lauffenburger, 1998; Protzer et al., 1999) or to monitor gene
expression in time relative to the different steps of the intracellular pathway of the vector
(Leopold et al., 1998; Zelphati et al., 1999; Godbey et al., 1999; Schaffer et al., 2000).
1.6 Thesis Outline.
The main goal of this thesis is to compare adenoviral gene delivery in two in vitro
hepatocyte culture systems, the 3D liver microreactor and 2D cell monolayers. As described in
the previous section, Ad delivery (and in general gene delivery) is a stepwise process including
attachment to the cell membrane, internalization, translocation to the nucleus and gene
expression. The efficiency of any of these steps could potentially be dependent on the
conditions of the culture environment, ultimately resulting in differences in the overall efficiency
of gene delivery between the 2 culture systems. The approach that was followed in this thesis
was to define Ad delivery efficiency in terms of two processes: the Ad vector uptake and the
transgene expression (transcription and translation).
The Ad vector uptake process essentially lumps the steps of cell membrane attachment
and internalization into one. Ad uptake is quantified by measuring the number of Ad genomic
copies present inside the cells. The efficiency of this process is defined in terms of the 'uptake
rate constant', a mathematical model parameter that incorporates the effects of extracellular Ad
mass transfer. This parameter is fitted to the experimental data and becomes the basis of
comparison between the 2 culture systems. This approach is essential due to the fact that in the
liver microreactor the hepatocytes are cultured in a 3-dimensional environment continuously
perfused with medium, whereas the monolayer culture is a 2-dimensional static system;
therefore the differences in extracellular mass transfer need be taken into account.
The transgene expression is what ultimately determines the overall efficiency of gene
delivery. In this thesis, gene expression is quantified in terms of the transgene (EGFP) mRNA
levels. The ratio of mRNA levels over uptake levels is calculated as a measure of the efficiency
of Ad delivery steps that follow the Ad uptake and as the basis of comparison between the 2
systems.
In order to carry out the above approach, mathematical models were developed to
describe the Ad extracellular mass transfer and Ad uptake in the two culture systems. In the
case of the liver microreactor, due to the complexity of the system, experimental methods were
required to provide the necessary information for mathematical modeling of Ad mass transfer; in
particular, a 2-photon microscopy protocol was developed to image the 3D tissue in order to
detect and track Ad delivery via EGFP expression and provide spatial information. Finally,
experimental assays were developed to measure (a) Ad genomic DNA levels (Quantitative
Real-Time PCR) and (b) Ad mRNA levels (Quantitative Real-Time RT-PCR). In addition to this,
a spectrometric assay was developed to track the time course of EGFP expression in the
microreactor and determine the optimum time point to conduct gene expression measurements.
The remainder of this thesis is organized as follows:
CHAPTER 2 (The Tissue-Engineered Liver Microreactor): the liver microreactor system is
presented in detail. The design parameters and fabrication details are described, as well as the
tissue morphogenesis, and functional behavior of the cells. Finally, the specific details related to
the application of the microreactor for gene delivery experiments are presented.
CHAPTER 3 (Materials and Methods): comprises all the experimental procedures and
protocols. The sections about PCR, RT-PCR, Spectrometry and Two-Photon Microscopy
include theoretical background, assay design and optimization details, as well as experimental
data (spectrometry, 2-photon microscopy).
CHAPTER 4 (Quantitative Analysis of Ad Gene Delivery in Hepatocyte Monolayer
Cultures): The first part describes the mathematical model for Ad delivery in monolayer
hepatocyte cultures and presents the experimental results and data analysis. The second part
presents the gene expression results.
CHAPTER 5 (Qantitative Analysis of Ad Gene Delivery in Hepatocyte Microreactor
Cultures): The first part presents the mathematical model development for Ad delivery in
microreactor cultures and the experimental results and data analysis. The second part presents
the gene expression results.
CHAPTER 6 (Discussion and Future Directions): This chapter summarizes the results
obtained in this thesis and discusses the conclusions derived from the experimental data
analysis as well as potential future directions for this research.
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CHAPTER 2
The Tissue-Engineered Liver Microreactor
2.1 Introduction
The liver microreactor was developed in the Griffith lab at the Biotechnology Process
Engineering Center at MIT (Powers et al, Biotechn. Bioeng. 2002, Tissue Eng. 2002). It is a
microfabricated bioreactor designed to: 1) facilitate the morphogenesis of three-dimensional
tissue-like structures from isolated liver cells under continuous perfusion, 2) maintain cell
viability and hepatic functionality for long-term culture periods and 3) enable repeated in situ
observation with microscopy and spectroscopy.
The basic component of this system is the cell scaffold, a thin (230pm) silicon sheet
permeated from top to bottom by a regular array of channels and placed on top of a
microporous filter. The filter is mechanically supported by a second scaffold (schematic shown
in Figure 2.1a). The scaffold assembly is placed between the upper and lower compartments of
a flow-through chamber. Each compartment has a pair of ports to allow the flow of culture
medium. The medium flow is driven by a peristaltic pump into the upper compartment. The
pressure drop between the upper and lower compartments is the driving force for perfusion flow
through the scaffold channels and out of the lower compartment (Figure 2.1b). The chamber is
connected to a medium reservoir and the medium is continuously re-circulated (Figure 2.1c).
The design of the chamber includes an optical window for in situ optical imaging and
spectroscopy during cell culture.
The cells are seeded into the channels of the cell scaffold where they are initially held in
place by the filter. Aided by the adhesive properties of the channel wall surface, the cells attach
to the walls and within 24-48 hours reorganize into 3D tissue structures, as described in more
detail later in this chapter. Each channel represents an individual functional unit of the
microreactor designed to mimic the acinus, the basic functional unit of the liver. All channels are
uniform in size, are exposed to the same culture conditions and contain approximately the same
number of cells. The total number of cells in a microreactor can be adjusted by increasing or
decreasing the number of channels on the scaffold and by scaling up or down the dimensions of
the chamber.
In the following sections of this chapter, the microreactor system is described in detail,
including the scaffold and chamber design and fabrication, the fluid flow and shear stress
properties, the morphogenesis of the tissue structures and the functional behavior of the cells.
Finally, the specific details related to the application of the microreactor for gene delivery
experiments are presented, including an alternative design of the fluidic system, developed to
maintain constant crossflow rates.
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Figure 2.1 Schematic of (a) scaffold, (b) microreactor chamber (cross-section)
and (c) fluid circuit.
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2.2 Microreactor Components and Assembly
Two different microreactor versions were used in this thesis. In the original version
(Figure 2.2a) the chamber is fabricated from stainless steel and features cylindrical upper and
lower compartments; additionally, the scaffold is circular with a diameter of 12.7mm and has
100 channels (10x10 array). The initial experiments of this project were performed with the
original version. Those were preliminary experiments focused mainly on protocol development
and optimization and are not all shown in this thesis. Some, of particular interest are included in
Chapter 3 (sections 3.7 and 3.8). The remainder of the experiments presented in this thesis
including the ones in Chapter 5 (quantitative analysis of gene delivery efficiency), were
performed with the final version of the microreactor (Figure 2.2b). In this case the chamber is
fabricated from polycarbonate and features oblong upper and lower compartments. The silicon
scaffold is also oblong-shaped (12 x 7mm) and has 40 channels (4x10 array). The final version
was designed for better control of fluid flow properties.
(a) (b)
Figure 2.2 Microreactor chamber (a) original version, (b) final version.
The cell scaffold: The scaffolds are fabricated by deep reactive ion etching (DRIE) of double-
side polished 230pm thick <100> boron-doped silicon wafers using standard methods as shown
in Figure 2.3. During step 4 of the DRIE process the microchannel pattern is etched through the
wafer with SF6 followed by passivation in C4F8. As a result the sidewalls of the channels are
covered with a thin layer of fluoropolymer.
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Figure 2.3 Silicon scaffold fabrication by deep reactive ion etching (DRIE). Schematic of the
DRIE process (left) and photos of the channel structure and geometries showing resolution
(right). The upper photos include a photo of the overall scaffold structure (scaffold for the final
version of the microreactor is shown) and a scanning electron micrograph depicting the
texture of the channel walls. The lower micrographs show the resolution of features in two
different channel geometries. The simple channel geometry was used in this thesis. (Figure
adapted from Powers et al., Biotechn.Bioeng., 2002)
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The filter: The microporous filter that is placed between the cell scaffold and the support
scaffold is made from 5pm pore-size Durapore filter (Millipore Corp.) cut to the dimensions of
the cell scaffold.
The support scaffold: In the case of the original version of the microreactor chamber, the
support scaffold is cylindrical with a 12.7mm diameter and a 350.tm thickness. It is fabricated
from 316 stainless steel, using a combination of a wire and die-sinking electro-discharge
machining (EDM) technique to create an array of channels complementary to the cell scaffold.
In the case of the final version of the microreactor chamber, a second silicon scaffold (identical
to the cell scaffold) served as the support scaffold.
The microreactor chamber (original version): The chamber is fabricated by conventional
machining from stainless steel. The upper and lower compartments are cylindrical with an inner
diameter of 7.6mm and both have a glass viewing window. The internal volume of the chamber
is 1.9ml and its total weight including the scaffold assembly and the inlet connectors is 159g.
The microreactor chamber (final version): The chamber is custom-fabricated from
polycarbonate by micromechanical milling and thermal diffusion bonding to create an 8 x 3mm
oblong upper compartment with a 125pm thick optical window. The internal volume of the
chamber is 102pl and its total weight including the scaffold assembly and the connectors (as
shown in Figure 2.2) is 3.5g.
Assembly of the microreactor:
All microreactor components are sterilized by autoclaving except for the polycarbonate
chamber compartments which are sterilized in 70% ethanol. Cell scaffolds are coated with
30pg/ml type I collagen (Vitrogen, Cohesion Technologies) and then rinsed in PBS. The filter is
coated with 1% BSA (bovine serum albumin) in PBS. The scaffold assembly (cell scaffold - filter
- support scaffold) is placed inside the pocket of the upper polycarbonate compartment together
with other components such as gaskets and O-rings (as shown in Figure 2.4) and is secured by
screwing together the two polycarbonate compartments.
The original version of the microreactor is assembled in a similar manner. The scaffold
assembly is secured inside the stainless steel chamber with gaskets and O-rings and the upper
and lower compartments are closed by securing the glass windows.
flow inlet and outlet
silicone gasket connectors
cell scaffold
microporous filter
support scaffold
Figure 2.4 Microreactor assembly (final version). Photo of the complete list of scaffold
assembly components (left) and schematic of the assembly procedure (photograph and
schematic by Dr. Karel Domansky).
The fluidic circuit:
The microrector chamber is connected to a medium reservoir with Silastic tubing (Dow
Corning). The reservoir is made of glass in the case of the original version of the microreactor
system and of polypropylene in the case of the final version. A mini peristaltic pump (Instech
Inc.) is used to circulate the culture medium continuously as shown in the schematic of Figure
2.1. All the components of the fluid circuit are sterilized with autoclaving. The total volume of
medium circulating in the system is 30ml for the original version and 20ml for the final version of
the microreactor.
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2.3 Microreactor Design Parameters. Fluid Flow and Shear Stress
Properties
As mentioned earlier, one of the primary goals of the liver microreactor system is to
enable the formation of structures with tissue-like morphology; that goal guided the selection of
key design parameters. The dimensions of the scaffold channel cross section were selected as
300pm x 300gm, a sufficient length scale for tissue reorganization (Powers and Griffith, 1998).
These dimensions were also empirically determined to support formation of 3D structures and
fluid flow conduits (Powers et al., Biotechn. Bioeng. 2002). The channel depth (230pm) was set
to approximate the size of a hepatic capillary bed, the functional unit of in vivo liver tissue.
Additionally, it ensures sufficient mass transport of oxygen and other nutrients to the cells even
under conditions of zero perfusion flow (diffusion limitations arise at a depth of 150pm). The
medium flow rate into the upper compartment of the chamber was set to 1.0ml/min for the
original microreactor version and 0.5ml/min for the final version. These flow rates were chosen
to minimize changes in oxygen concentration throughout the upper compartment. The crossflow
rate at the start of the culture was measured as -0.7pl/min per channel, a value that ensures
sufficient nutrient supply to the tissue structures via convective transport. Another key
characteristic of the microreactor design is the choice of a filter with low hydraulic permeability
(in comparison to the tissue inside the channels). This means that the filter provides much
higher resistance to the medium flow through the channels than the cell mass, ensuring
homogeneous flow rate and mass transfer throughout the channel array.
Finite element modeling of fluid flow and shear stress distribution for the flow rates
mentioned above showed relatively uniform velocity and shear stress values in the upper
chamber compartment at the surface of the cell scaffold, especially in the case of the final
microreactor version (oblong-shaped flow compartment). Fluid flow inside the scaffold channels
was also mathematically modeled; the maximum shear stress the cells are exposed to is about
0.7dynes/cm2 (0.07Pa), a value that approaches the lower limit of the range of physiological
values for in vivo endothelium (Powers et al., Biotechn. Bioeng. 2002).
2.4 Tissue Morphogenesis in the Liver Microreactor
The morphogenesis of the 3D tissue structures in the microreactor channels is
determined by the adhesive properties of the surface of the channel walls as well as by the
geometry and dimensions of the channels. As mentioned earlier, the silicon scaffold is coated
with type I collagen before the chamber is assembled. Collagen adsorbed on hydrophobic
substrates can be used to control hepatocyte adhesion as well as cell morphology (Powers and
Griffith, 1998; Powers and Griffith-Cima, 1996). Due to the fabrication process of the silicon
scaffolds, the channel walls are coated with a thin layer of fluoropolymer. Hepatocytes were
found to attach and spread on fluoropolymer-covered silicon surfaces coated with collagen I but
not in the absence of collagen. Additionally, hepatocytes did not adhere strongly to silicon
surfaces, with or without adsorbed collagen (Powers et al., Biotechn Bioeng. 2002). Therefore
adsorption of collagen on the silicon scaffolds enhances preferential adhesion of hepatocytes to
the channel walls.
In this thesis, microreactor cultures were established from primary rat hepatocytes pre-
aggregated into spheroids. The process is shown in the schematic of Figure 2.5. Primary
hepatocytes are harvested from rat liver using the 2-step collagenase perfusion procedure; a
hepatocyte enriched fraction is isolated and seeded in spinner flasks. Three days later, the
spheroids that have formed are harvested and seeded into the microreactor channels which
have been coated with collagen (seeding procedure described in detail in Chapter 3). Within 24-
48hrs the spheroids attach to the channel walls, and reorganize to form large structures
throughout the depth of each channel. These tissue structures remain stable for several days
undergoing only minor changes.
Figure 2.6a shows a light micrograph of hepatocyte tissue structures in microreactor
channels 3 days after spheroid seeding. The image is taken by focusing at the top of the silicon
scaffold with a 5X objective lens. The silicon scaffold appears black, the cells are grey and the
areas devoid of cells are bright. A variety of 3D structures are formed. Very often these
structures have a doughnut-like shape with a fluid flow conduit in the middle of the channel; in
other cases there are structures that span the middle of the channel creating more than one
flow conduit as shown in Figure 2.6b. This is a fluorescence micrograph of microreactor
structures stained with Calcein AM (green cytoplasm - live cells) and ethidium homodimer (red
nuclei - dead cells) after 2 weeks of culture which shows that the cells display high viability
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Figure 2.5 Schematic of 3D tissue structure formation in microreactor channels
from hepatocytes isolated from rat liver with collagenase perfusion.
(Powers et al., Tissue Eng. 2002). Viable, healthy cells (colored dark blue) are also observed in
toluidine blue-stained histological sections of tissue structures in the microreactor channels
(Figure 2.6c). Although a hepatocyte-enriched fraction was used to form the spheroids that were
seeded in microreactors, scanning electron micrographs of 3D structures inside the channels
suggested the presence of a heterogeneous cell population at the fluid-tissue interface. Cells
with the cobblestone morphology of vessel endothelium have also been observed (Figure 2.6 d
and e).
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Figure 2.6 Morphological behavior and viability of hepatocytes maintained in microreactors
observed with: (a) light microscopy (3 day culture), (b) fluorescence microscopy (live-dead
assay in 13 day culture), (c) toluidine blue-staining of histological sections, (d) scanning
electron microscopy (2 day culture), (e) SEM (7 day culture).
2.5 Functional Behavior of Cells in the Liver Microreactor
Based on the above results and observations, the culture of hepatocytes in the 3D
perfused environment of the microreactor appears to approximate to a certain extent the
physiological conditions and morphological properties of native in vivo liver tissue. To determine
whether this translates to improved liver-specific functional behavior of the culture, qualitative
observations of cellular features and quantitative measurements of key hepatocyte properties
such as albumin secretion and urea production were performed (Powers et al., Tissue Eng.
2002). Transmission electron micrographs of the tissue structures revealed typical features
observed in vivo, such as tight junctions and desmosomes between adjacent cells, complex bile
canaliculi with microvilli, as well as numerous mitochondria, rough endoplasmic reticulum and
glycogen storage areas. These characteristics are indicative of well maintained metabolic
functions. The rates of albumin secretion (-150pg/cell/day) and urea genesis (-700-
900pg/cell/day) in microreactor cultures were maintained at constant levels for at least two
weeks. Additionally, these levels were one order of magnitude higher than those measured for
static cultures of spheroids prepared from the same cell population. These results offer further
evidence that the microreactor culture environment promotes increased and sustained
functional responses of hepatocytes
More recent studies using a broad spectrum of gene expression, protein expression and
biochemical activity metrics, have shown that in the microreactor cultures the liver-specific
phenotype is maintained at levels closer to those of in vivo liver tissue, compared to standard in
vitro cultures such as 2D collagen gel sandwich cultures. The expression levels of key hepatic
nuclear receptors and transcription factors that regulate the genes responsible for hepatic drug
metabolism (e.g. cytochrome P450 genes) and other liver-specific functions were found to be
better maintained in the liver microreactor. Additionally, the levels of basal and drug-induced
expression of several drug metabolism genes themselves, as well as the biochemical activity of
the corresponding proteins were found to approximate in vivo levels in 7 day-old microreactor
cultures (Sivaraman et al., 2005).
Finally, recent work has shown that the 3D microreactor environment can support the
survival and proliferation of sinusoidal endothelial cells cultured with hepatocytes for 2 weeks,
whereas these cells disappear within a few days in a 2D co-culture system (Hwa et al., 2007).
2.6 Gene Delivery Experiments in the Microreactor.
2.6.1 Experimental variables for gene delivery in the microreactor vs. 2D monolayer
culture.
In standard in vitro gene delivery experiments on adherent cells, the vector is dispersed
in the medium overlaying the cell monolayer. Its uptake by the cells is a process that is
dependent on the relative rates of diffusion and internalization; the parameters that can be
varied to control gene delivery include the initial concentration of the vector and the duration of
exposure (Chapter 4). As described in Chapter 1 the vector that was chosen for the experiments
in this thesis is an adenoviral (Ad) vector expressing EGFP. Preliminary experiments indicated
that a concentration of 4x10 6 pfu/ml (pfu=plaque forming units, a measure for the number of
infectious Ad particles) and a 24h exposure were sufficient for Ad infection of almost 100% of
hepatocytes cultured in confluent monolayers on collagen-coated plates, as determined by the
expression of EGFP with fluorescence microscopy. Therefore these conditions were selected as
the maximum Ad concentration and duration of infection applied in this thesis. The
concentration was varied within a range of one order of magnitude and the infection duration
between 2 and 24 hours.
In the liver microreactor system, the Ad vector is dispersed in the culture medium inside
the reservoir and circulates through the fluidic circuit and into the chamber. The crossflow
transports the vector through the scaffold channels where it interacts with the tissue structures.
Therefore in this case the delivery of the vector to the cells is more likely controlled by
convective transport. These conditions mimic more closely those of in vivo gene delivery where,
after administration into the bloodstream, the vector is transported to the hepatocytes via flow
through the liver sinusoids. For a constant crossflow rate and total volume of circulating
medium, the initial concentration and duration of infection are the parameters that can be varied
to control the levels of Ad delivery. The maximum values of these parameters selected for the
experiments in this thesis were the same as for the 2D monolayer cultures. Preliminary
experiments indicated that these conditions resulted in EGFP expression levels easily
detectable with 2-photon scanning fluorescence microscopy. The concentration was varied
within a range of one order of magnitude and the duration of infection was set at 24h for the
experiments in this thesis.
It needs to be underscored that selecting the same initial Ad concentration and infection
duration in both cases does not correspond to equivalent Ad exposure of the cells because of
the differences in the mechanism of extracellular vector transfer (diffusion vs. convection) and
tissue morphology (2D vs. 3D). These differences will be factored in by means of mathematical
modeling of the Ad mass transfer, before comparing the Ad gene delivery efficiency between
the two in vitro culture systems.
2.6.2 Modification of the microreactor fluidic system design.
As described earlier, a peristaltic pump is used to drive medium flow into the upper
compartment of the microreactor chamber and the pressure drop between the upper and lower
compartments creates perfusion flow (crossflow) through the scaffold channels. The crossflow
rate is controlled by the resistance of the microporous filter between the cell scaffold and the
support scaffold and was measured at -0.7pl/min per channel at the start of the culture.
However, the crossflow rate gradually decreases with time and usually within 24-48 hours
reaches zero. This poses a problem not only in terms of insufficient oxygen and nutrient supply
to the cells deep inside the channels, but also affects the transport of the gene delivery vector.
The crossflow rate is an important parameter that determines the concentration profile and
therefore the rate of cellular uptake of the vector. At zero crossflow rate the transfer of the
vector inside the channels is diffusion limited, whereas at the value mentioned above convective
transport dominates (Pe number is in the order of 103). In order to conduct quantitative
experiments and measure the efficiency of gene delivery in the microreactor cultures the
crossflow rate needs to be maintained at a known constant value.
A second peristaltic pump was connected to the crossflow line to force medium flow
through the channels at a constant rate but did not solve the problem, which indicated crossflow
was stopped due to debris blocking the pores of the filter. When the direction of the flow was
reversed (medium flowing into the lower compartment of the chamber and through the channels
to the upper compartment), the debris was removed from the filter and crossflow was
reestablished. However, due to the continuous recirculation of medium (and debris) in the
system the filter was clogged from the opposite side and crossflow had stopped again within 24
hours. The debris is probably the result of the spheroid reorganization that takes place during
the first 24 hours in the microreactor channels releasing dead cells and cell fragments.
In order to circumvent this problem, the fluidic system operation is modified as follows:
after the spheroids are seeded in the microrector channels, the crossflow rate is controlled by a
peristaltic pump at -0.7il/min per channel (Figure 2.7a). 24 hours later the crossflow direction is
reversed and a Durapore syringe filter (PallGelman) with a 0.45gm pore size is connected to the
crossflow tubing (Figure 2.7b). When the flow is reversed, the debris in the scaffold filter is
removed and released into the medium circulation; however it is prevented from blocking the
scaffold filter again by the presence of the crossflow line filter. Additionally, the tissue structures
inside the cell scaffold have already attached to channel walls and are not affected by the
change in the flow direction. 2 hours after the reversal of the flow, the medium in the reservoir is
replaced to remove the bulk of the released debris. The crossflow filter and the medium in the
reservoir are replaced every 3-4 days.
This modification in the fluidic system allows the unobstructed flow of medium through
the microreactor chamber at constant rates. It also ensures that gene delivery experiments are
conducted under consistent conditions among different microreactor cultures.
2.6.3 Experimental procedure for Ad gene delivery in the microreactor.
As described earlier, the microreactors are seeded with 3-day hepatocyte spheroids
which attach to the scaffold channel walls and reorganize within 24-48h. Day 3 after spheroid
seeding (day 6 after rat liver perfusion) was selected as an appropriate time point for Ad
infection. At that point the tissue has reorganized into stable structures and the albumin and
urea production rates have stabilized (Powers et al., Tissue Eng. 2002). Additionally, conditions
of constant crossflow rate have been established (-~0.7ptl/min/channel). The medium in the
reservoir is then replaced with fresh medium containing the Ad vector, which is allowed to
continuously flow in the system for 24h. During the infection the medium in the reservoir is kept
under well-mixed conditions to ensure uniform concentration of the vector. For that purpose, a
network of Air-Driven Turbine Magnetic Stirrers connected in parallel to an airflow supply line
was installed inside the cell culture incubators. Each medium reservoir is equipped with a stir
bar and positioned on top of a stirrer. The Ad infection is ended by replacing the medium and
the entire fluid circuit (tubing, reservoir and crossflow filter) under sterile conditions (described in
detail in Chapter 3). The cultures are then maintained until the end of the experiment under
normal culture conditions.
(a)
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Figure 2.7 Modification of the microreactor fluidic system design: (a) Operation after
cell seeding (t=O), (b) operation after t=24h and for the remainder of the culture.
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CHAPTER 3
Materials and Methods
3.1. Cell Culture
3.1.1 Rat Liver Perfusion and Hepatocyte Isolation
Hepatocytes were harvested from 150-230g male Fisher rats with a modification of
Seglen's two-step collagenase perfusion procedure (Seglen, 1976) as described in Powers et
al., 2002. Briefly, the liver was initially perfused with Ca2+-free buffer through a catheter inserted
in the inferior vena cava at a flow rate of 25 mI/min for 6-7 min (until the blood was cleared from
the liver and the liver had acquired a light caramel color); then the liver was perfused with
collagenase solution at a flow rate of 15 ml/min for approximately 11 min (until the tissue had
disintegrated enough to allow for the isolation of hepatocytes without compromising cell
viability). The liver was then removed and gently shaken in a DMEM/Albumin/Penicillin-
Streptomycin (DAPS) solution to break up the tissue and free the cells. The resulting cell
suspension was filtered through a 100[im mesh filter to remove tissue debris and processed to
isolate a hepatocyte-rich fraction. In particular, the cells were centrifuged twice at 50g for 3 min
at 40C to remove debris, dead cells and non-parenchymal cells. To further increase the
percentage of live hepatocytes in the preparation, the cells were subjected to a centrifugation in
an isodensity Percoll solution followed by a washing step in DAPS solution and a 2 nd
centrifugation. The resulting pellet was resuspended in Hepatocyte Growth Medium (HGM)
(chemically defined medium as described by Block et al. 1996, but without hepatocyte growth
factor and with modifications as described below). Hepatocyte viability was assessed with the
trypan blue exclusion method and only cells from perfusions yielding greater than 85% viability
were used for cell culture experiments.
3.1.2 Composition of Hepatocyte Growth Medium (HGM) and DAPS Solution
HGM consists of DMEM supplemented with L-proline (0.03 g/L), L-ornithine (0.1 g/L),
niacinimide (0.305 g/L), glucose (2.25 g/L), galactose (2 g/L), bovine serum albumin (2 g/L),
Hepes (10 mM), ZnCl2 (0.0544 mg/L), ZnSO 4 7H20 (0.075 mg/L), CuSO 45H20 (0.02 mg/L),
MnSO4 (0.025 mg/L), penicillin-streptomycin (100 U/ml), L-glutamine (1 mM), insulin (5 mg/L),
transferrin (5 mg/L), sodium selenite (5 gg/L), dexamethasone (0.1 gM) and epidermal growth
factor (20 ng/ml). The above composition of HGM includes corrections of mistakes in Block et
al, as determined by personal communication with the Michalopoulos lab. The mixed HGM
solution was sterilized by filtration through a 0.22 lpm low protein-binding Nalgene PES filter unit
and stored at 40C. The epidermal growth factor (EGF) was added to HGM right before use. The
DAPS solution used during the hepatocyte isolation procedure consists of DMEM, albumin and
penicillin-streptomycin at the same concentrations as HGM and was also sterilized by filtration
before use. DMEM and glutamine were purchased from GIBCO/BRL, the insulin-transferrin-
sodium selenite mixture from Roche, EGF from BD Biosciences and the rest of the components
from Sigma.
3.1.3 Monolayer Hepatocyte Culture
Non plasma-treated bacteriological polystyrene 12-well plates were coated with collagen
I (Vitrogen) via adsorption from a 3 gg/ml solution in PBS (GIBCO/BRL) at room temperature for
one hour. Hepatocytes were plated at a density of 3x105 cells per well, cultured in HGM and
maintained in a humidified 8.5% CO2 atmosphere at 370C inside an incubator.
Measurement of Cellular Surface Area, A
The average surface area (A) of a primary rat hepatocyte in the monolayer culture
system described above was determined from phase contrast photomicrographs. Images were
acquired with a Zeiss Axiocam HRc video camera attached to a Zeiss Axiovert 100 Microscope
with a 10X objective lens and were processed with the Openlab v3 software on a Macintosh G4
computer. Cells were imaged 24 hours after plating. Images were acquired from two 12-well
plates and four different wells (two per plate). A total of 11 regions of interest (ROI) were
outlined in the acquired images and the surface area of each region was measured with the
software; a hemocytometer grid was used for calibration. The number of hepatocytes in each
region was counted manually. A total of 775 cells were counted and the average cellular surface
area was determined to be approximately:
A = 1.7x10- cm2 /ce ll
The hepatocyte surface area measurements were required for the calculations with the
mathematical model for adenoviral vector mass transfer and cellular uptake in monolayer
cultures, as described in Chapter 4.
3.1.4 Tissue-Engineered Liver Microreactor Culture
Assembly and Preparation of Microreactors
All microreactor components except for the polycarbonate chamber were sterilized by
autoclaving. The two chamber parts were sterilized by soaking in 70% ethanol for 15 min and
then washed in PBS. The silicon scaffolds were coated with collagen I (Vitrogen) via adsorption
from a 30 pg/ml solution in PBS at room temperature for one hour (in a 6cm tissue culture plate
with a volume of 10ml of collagen solution). The crossflow filters were soaked in a PBS-BSA
(1%) solution (sterilized by filtration) to render them protein resistant and prevent adsorption of
nutrients from the medium during the liver tissue culture. The microreactor chambers were
assembled and connected to the fluid flow circuit and the medium reservoir under sterile
conditions as described in Chapter 2. The microreactor systems were then operated in the
absence of cells to establish continuous medium flow and neutralize the surfaces of the system.
The medium in the reservoir was replaced with fresh HGM immediately before the hepatocyte
seeding. The total volume of medium flowing in the microreactor system was 20 ml.
Hepatocyte Spheroid Cultures
Hepatocyte spheroids were formed in suspension using methods similar to Wu et al,
1996. After rat liver perfusion and hepatocyte isolation the cells were seeded in 250ml spinner
flasks (BellCo Glass, Inc.) at a density of 3x107 hepatocytes suspended in 100ml HGM per flask
and were cultured under continuous stirring conditions for three days to form spheroids. The
spinner flask cultures were maintained on a spinner table (BellCo Glass, Inc.) at a speed of 85
rpm in a humidified 8.5% CO2 atmosphere at 370C. On day 3 after hepatocyte isolation, the
spheroid suspension was filtered through a 300pm mesh nylon filter (SEFAR America) to
remove the spheroids that were larger than the microreactor channel dimensions (300x300pm
cross section and 230lpm depth). The flow-through suspension was then filtered through a
100pm mesh nylon filter (SEFAR America) to remove small cell clumps, dead cells and debris;
the spheroids collected on the filter were re-suspended in 25ml rinse medium (DAPS) and
centrifuged at 40g for 3min. The spheroid pellet was then re-suspended in 25-30ml HGM before
seeding into the microreactors. The quality (size: majority of spheroids between 100-200gm;
shape: tightly formed aggregates without dead cells protruding) and cell viability of the
spheroids was qualitatively determined by observation under the microscope with the addition of
Trypan Blue. The quality of the spheroid culture is important for establishing healthy
microreactor cultures.
Microreactor seeding and culture maintenance
Each microreactor was seeded with hepatocyte spheroids under sterile conditions. The
spheroid suspension was loaded into a 1 ml syringe. The medium flow in the system was
stopped and the syringe was connected to the upper outlet of the microreactor chamber. The
spheroid suspension was slowly injected into the reactor chamber; the tubing leading to the
upper inlet of the reactor chamber was clamped to force fluid flow only through the silicon
scaffold channels and out of the lower outlet of the chamber. This led to the spheroids settling
inside the scaffold channels (the presence of the crossflow filter prevents them from flowing
through). When the channels were filled with spheroids, the syringe was removed. HGM was
pumped into the upper inlet at 0.4 ml/min and collected in a waste container for 2 min to clear
spheroids from the top surface of the silicon scaffold. Then the upper inlet tubing was
reconnected to the chamber and the medium flow was reestablished in the system as shown in
Figure 2.7a. The microreactor cultures were maintained in a humidified 8.5% CO2 atmosphere
at 370C.
At 24 hours after cell seeding (day 4 after hepatocyte isolation), the direction of the
medium flow in the crossflow line of each microreactor was reversed (medium now flowing from
the reservoir into the lower part of the chamber, through the scaffold channels to the upper part
of the chamber) and a syringe filter was introduced in the crossflow line tubing (as shown in
Figure 2.7b). The medium in the reservoir was also replaced. As explained in detail in Chapter
2, this procedure ensures the unobstructed flow of medium through the scaffold (and therefore
through the tissue culture). At that time the spheroids had already attached to the collagen-
coated scaffold channel walls and therefore were not dislodged by the change in the direction of
fluid flow. Two hours later, the medium in the reservoir was replaced again to ensure the
removal of debris that was released from the chamber filter due to the reversal of the direction
of crossflow.
The syringe filter in the crossflow line (whose purpose was to prevent debris from
reaching and clogging the chamber filter and consequently obstructing the flow) was replaced
every three days as well as the medium in the reservoir. However, in the case of Ad gene
delivery experiments, the medium was also replaced at the beginning and at the end of Ad
infection.
3.2. Adenoviral Gene Delivery
3.2.1 Adenovirus vector
The vector used in this thesis for gene delivery experiments was an El-, E3-deleted first
generation human adenovirus 5 vector, which contained an expression cassette consisting of
the cytomegalovirus (CMV) immediate/early promoter and enhancer, an artificial splice site
(SV40 intron), the transgene and the polyadenylation site from SV40. The transgene encoded
the enhanced green fluorescent protein (EGFP). This vector, labeled as H5.010OCMVEGFP, was
purchased from the Vector Core of the Institute for Human Gene Therapy at the University of
Pennsylvania, School of Medicine. The genomic and infectious titers of the vector were
measured by the supplier as 4.7x10 12 particles/ml and 2.8x1011 pfu/ml (pfu: plaque forming
units) respectively, establishing a particle over pfu ratio equal to 17. The Ad preparation was
tested for the presence of RCA (replication competent adenovirus) and was found negative.
This vector preparation was used for the experiments described in this thesis unless mentioned
otherwise. The vector was aliquoted in adenovirus storage buffer (10% glycerol in PBS) and
stored at -800C. Before each gene delivery experiment the Ad was diluted in HGM to give the
required concentrations.
Another Ad vector, labeled H5.01OCMVLacZ (expressing 0-galactosidase), was used as
a control in a microreactor experiment (see Chapter 5) as well as in the experiments testing the
specificity of the primers/probe set designed for the TaqMan PCR assay (see section 3.4). This
vector is identical to H5.010CMVEGFP apart from the transgene sequence. The genomic and
infectious titers were 5x10 12 particles/mi and 1.67x1011 pfu/ml respectively (particle over pfu
ratio = 30). This vector was also purchased from the Vector Core at UPenn.
The construction of the above-mentioned vectors and the protocols for propagation,
purification and genomic and infectious titer quantification are described in detail by Davis et al.
(1998, 2001). However, since the methods applied for the quantification of the Ad titers have a
significant effect on the quantitative analysis of gene delivery in both hepatocyte monolayer and
microreactor systems (as it will be discussed in Chapter 4), a few details are mentioned here.
The genomic titer (concentration of total Ad particles) was quantified by optical absorbance at
260 nm. The infectious titer (concentration of infectious Ad particles) was determined with the
plaque assay on 293 cells, which support the replication of first generation adenoviral vectors
(Graham et al. 1977). In this assay, detection of one Ad particle involves infection of a 293 cell
(cultured in a monolayer) by one Ad particle suspended in the medium, followed by viral
replication and spread of infection to nearby cells sufficient to form a visible plaque.
According to the protocol followed by our vector suppliers, 293 cells were seeded in 6-
well plates and incubated with dilutions of the Ad preparation (1 ml of Ad solution per well) for
three to four hours. After removing the Ad-containing medium the cells were overlaid with agar.
A second agar overlay was applied on day 7 and when plaques became visible (day 12) a third
agar overlay mixed with Neutral Red was added. The plaques were counted in the wells
corresponding to the Ad dilution that resulted in the formation of 10-90 plaques per well. The
infectious titer (pfu/ml) was calculated by multiplying the average number of plaques with the
dilution factor.
3.2.2 Adenoviral Vector Infection in Monolayer Hepatocyte Cultures
Primary hepatocytes were harvested from male Fisher rats, isolated from non-
parenchymal cells with successive centrifugation steps and seeded on collagen-coated 12-well
plates at a density of 3x10 5 cells per well as described in section 3.1. The hepatocyte
monolayers were cultured in HGM for 24 hours. Then (t = 0) the medium in each well was
replaced with 750pl HGM containing AdEGFP at three different concentrations: 4x10 5 , 2x10 6
and 4x10 6 pfu/ml. These Ad concentrations are based on the infectious titer of the original Ad
preparation as measured by the vector supplier and correspond to MOI values of 1, 5 and 10
respectively. (MOI = multiplicity of infection = pfu/cell = [concentration] x [HGM volume] / [cell
number])
At different time points (t = 2, 4, 8, 12 and 24 hr), the Ad infection was terminated by
removing the Ad-containing supernatant and washing twice with PBS (carefully so as not to
disturb the cell monolayer). The hepatocytes were then either harvested immediately for DNA
extraction (data set 1), or cultured in HGM until t=48hr. In the second case the cells were
subsequently harvested for DNA extraction (data set 2), counterstained with Hoechst and
Ethidium Homodimer for fluorescence imaging of EGFP expression (data set 3), or harvested in
Trizol reagent for RNA extraction (data set 4). Triplicate wells were prepared for each initial Ad
concentration, time point condition and data set. Additionally, negative controls (no Ad added to
the medium) were prepared in each case.
Nuclear Counterstaining of Monolayer Hepatocyte Cultures Infected with AdEGFP Vector
At time t=48hr after the beginning of the Ad infection, the hepatocyte monolayers were
incubated with ethidium homodimer-1 (Molecular Probes) at a concentration of 4gM in HGM for
10 minutes, followed by an incubation with Hoechst 33342 (Molecular Probes) at a
concentration of 20pg/ml in HGM for 20 minutes. Both ethidium homodimer and Hoechst are
nucleic acid stains. Ethidium homodimer enters cells with damaged plasma membranes and
upon binding to the DNA emits bright red fluorescence in dead cells (ex/em -495nm/-635nm),
while it is excluded by the intact membrane of living cells. Hoechst is cell-permeant and upon
binding to the DNA emits bright blue fluorescence (ex/em -350nm/-461nm). Therefore, the live
and dead cells on the hepatocyte monolayers can be distinguished by visualizing their
respective blue- or red-labeled nuclei with a fluorescence microscope.
Imaging of Transqene (EGFP) Expression in Monolayer Hepatocyte Cultures and Quantification
of AdEGFP Gene Delivery Efficiency and Cell Viability.
After staining, the hepatocyte monolayers were imaged with a Zeiss Axiovert 100
microscope equipped with Zeiss Achrostigmat dry lenses (5X with NA=0.12, 10X with NA=0.25
and 20X with NA=0.30; NA: numerical aperture) and a mercury-arc lamp (ebq 100). EGFP was
detected with a FTIC filter set, Hoechst with a DAPI filter set and ethidium homodimer with a
rhodamine filter set. The images were captured with a Zeiss Axiocam HRc camera and
processed with the OpenLab v3 Software on a Macintosh G4 computer. The green, blue and
red layers of each image were combined in a three-color overlay; an example is shown in Figure
3.2.1. As mentioned in a previous section, triplicate wells were prepared for each initial Ad
concentration and infection time point condition. Images were acquired for 5-6 different regions
of each 'Ad concentration & time point' combination (for example MOI=10 & 24hr infection,
MOI=10 & 12hr infection, etc...).
The total number of cells was determined by counting manually the number of blue
nuclei (stained with Hoechst) and the number of dead cells by counting the red nuclei (stained
with ethidium homodimer) on each image. Cell viability was calculated as the % ratio of the live
cell number over the total cell number. The number of EGFP-expressing (green) cells was also
counted manually. Control cultures (no Ad infection) did not display any visible levels of green
fluorescence; therefore any cell on the acquired images of Ad infected monolayers that
displayed green fluorescence detectable by eye was scored as an EGFP positive cell. The
efficiency of Ad gene delivery was calculated as the % ratio of EGFP-expressing cells over the
total number of live cells. The sums of cell counts for all images corresponding to each 'Ad
concentration & time point' combination were used for the viability and efficiency calculations.
The results are presented in Chapter 4.
Figure 3.2.1. Fluorescence micrograph of rat hepatocyte monolayer infected with Ad5-
CMV-EGFP at MOI=5* for 24 hours. The cells were stained with Hoechst 33342 and
Ethidium Homodimer 1 and imaged 24 hours after the end of the Ad infection with a Zeiss
Axiovert 100 microscope and a 10X dry objective lens. EGFP was detected with a FTIC
filter set, Hoechst with a DAPI filter set and Ethidium Homodimer with a Rhodamine filter
set. The images were captured with a Zeiss Axiocam HRc camera and processed with the
OpenLab v3 Software on a Macintosh G4 computer. An overlay of the green, blue and red
images is shown here.
*corresponds to the infectious Ad titer provided by the vector supplier.
3.2.3 Adenoviral Vector Infection in Liver Microreactor Cultures.
On day 6 after the hepatocyte isolation, the medium inside the microreactor reservoir
was replaced with fresh HGM containing the Ad5-CMV-EGFP vector. Three different Ad
concentrations were used: 4x105, 2x106 and 4x106 pfu/ml. These Ad concentration values refer
to the entire medium volume in the microreactor system and are based on the infectious titer of
the original Ad preparation as measured by the vector supplier. Typically in each experiment
duplicate microreactors were prepared for each Ad concentration as well as control
microreactors with no Ad added. The Ad vector circulated in the microreactor system for 24
hours. During the infection, the medium in the reservoir was kept under well-mixed conditions to
ensure uniform concentration of the vector. For that purpose, a network of air-driven turbine
magnetic stirrers connected in parallel to an airflow supply line was installed inside the cell
culture incubators. Each medium reservoir was equipped with a stir bar and positioned on top of
a stirrer.
At the end of the Ad infection (t=24h) the microreactor chamber was disconnected from
the rest of the system and connected to a new set of tubing and reservoir components with
fresh HGM. The Ad particles inside the chamber were washed out by flowing fresh medium
through the upper and lower inlets and collecting the first 2 ml flowing out of the upper outlet,
before connecting the upper outlet tubing. Additionally, two hours after the removal of Ad, the
medium in the reservoir was replaced again.
The liver microreactor cultures were then maintained until approximately t=70h after the
beginning of Ad infection (day 9 after hepatocyte isolation) unless specified otherwise. At that
time the silicon scaffolds containing the hepatocyte tissue were removed from the microreactor
chambers and were stored either at -200C for DNA extraction or at -800C in Trizol reagent for
RNA extraction.
3.3. DNA Extraction and Quantification
3.3.1 DNA Extraction and Purification
Hepatocyte Monolayer Cultures
Hepatocytes were harvested with a cell scraper in 200 pl PBS per well (after the culture
medium was removed). The DNA was extracted with the High Pure PCR Template Preparation
Kit (Roche). During this process the cells are lysed by incubation with Proteinase K and a buffer
containing a chaotropic salt, which inactivates nucleases. The samples are subsequently flown
through filter tubes pre-packed with special glass fibers. DNA binds to the glass fibers and after
a series of wash-and-spin steps in a microcentrifuge to remove PCR inhibitory contaminants
and other cellular impurities, it is eluted with a low salt buffer. The resulting DNA solutions were
stored at -200C until DNA quantification and real-time PCR analysis.
Liver Microreactor Cultures
The cells were harvested from the silicon scaffolds in 200 pl of Tissue Lysis Buffer with
repetitive pipeting to break up the tissue structures. The DNA was extracted with the High Pure
PCR Template Preparation Kit as described in the previous paragraph. The resulting DNA
solutions were stored at -200C until DNA quantification and real-time PCR analysis.
3.3.2 Quantification of Total DNA Content in Hepatocyte Culture Samples
After DNA extraction and purification the samples (hepatocyte monolayer cultures and
tissue-engineered microreactors) were assayed for total DNA content with the RediPlateTM 96
PicoGreen@ dsDNA Microplate Assay (Molecular Probes). This assay is based on the ability of
the nucleic acid stain PicoGreen to selectively bind to dsDNA and subsequently emit bright
green fluorescence. The stain is predispensed in the wells of a 96-well microplate and is
dissolved in TE buffer before the addition of the DNA samples; fluorescence is measured in a
fluorescence microplate reader using excitation at 485 nm and detection at 530 nm. The
fluorescence of the sample of interest is compared to that of a standard curve of DNA. The
assay has a linear range of 1-100 ng DNA in a 200 jpl assay volume according to the
manufacturer.
The RediPlate PicoGreen assay was applied to all DNA samples that were also assayed
for AdEGFP genomic copy number with quantitative real-time PCR. A standard curve was
prepared for each microplate. The standard curve was derived from a series of dilutions of calf
thymus DNA (Sigma) in TE buffer ranging from 0.2 to 10 gg/ml (2 to 100 ng in a 200 pl assay
volume). All standards were assayed in triplicates. The slopes of the standard curves were
comparable within a narrow range among microplates from the same production batch -the
coefficient of variation was less than 10% (Figure 3.3.1). Among microplates from different
batches the coefficient of variation for the standard curve slopes was less than 14%. All
hepatocyte samples were assayed in triplicate and the total DNA content was determined from
the standard curve by interpolation. The mean values were used for further calculations
(normalization of real-time PCR data). The assay was repeated for samples for which the
coefficient of variation exceeded 10%.
3.3.3 Cellular DNA Content Measurements for Rat Hepatocytes
To determine the DNA content of a rat hepatocyte (for data normalization purposes),
samples of hepatocytes were needed containing known numbers of cells. After each rat liver
perfusion and hepatocyte isolation though, the cell viability and concentration of the resulting
hepatocyte suspension can be determined with the trypan blue exclusion method in a
hemocytometer as described in section 3.1. Therefore, triplicate samples of varying cell
numbers (from 104 to 4x105) were prepared from the resulting hepatocyte suspension of three
different rat perfusions. DNA was extracted with the High Pure PCR Template Preparation Kit
and quantified with the RediPlate 96 PicoGreen dsDNA Microplate Assay as described in the
previous paragraphs. Figure 3.3.2 shows a plot of DNA content (jg DNA) as a function of
hepatocyte number. Each data point corresponds to the mean value of 9 samples (3 samples x
3 rat perfusions) and the error bars represent the standard deviation. A straight line was fitted to
the data with linear regression (Excel) and the slope represents the cellular DNA content. As
shown in the plot, each rat hepatocyte contains 7.73x10 -6 jg DNA. This number was used to
convert the normalized PCR data (Ad copies per gg DNA) to Ad copies per cell, as required by
the mathematical model presented in Chapter 4.
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Figure 3.3.1. Dynamic range, sensitivity and reproducibility of RediPlate 96 PicoGreen
dsDNA assay. Calf thymus DNA dilutions ranging from 0.2 to 10 gg/ml were assayed in
triplicates. Fluorescence was measured with a microplate reader. The fluorescence
signals were plotted against the DNA concentration after subtracting background
fluorescence. Four different experiments are shown. The symbols represent the mean
data values and the error bars the standard deviation. The lines represent the standard
curves (linear regression with Excel).
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Figure 3.3.2. Rat hepatocyte DNA content measurements. Samples of varying cell
numbers were prepared after rat liver perfusion and hepatocyte isolation. DNA was
extracted and quantified with the Rediplate 96 PicoGreen dsDNA Microplate Assay
(standard curves were derived from a series of calf thymus DNA dilutions).
Fluorescence was measured with a microplate reader and the DNA content of each
sample was determined from the standard curve by interpolation. The DNA content is
plotted here as a function of cell number. The data points represent the mean values of
9 samples (3 samples x 3 rat perfusions) and the error bars the standard deviation. The
straight line corresponds to the linear regression with Excel.
3.4. Quantitative real time TaqMan® PCR
3.4.1 Introduction
Quantitative real-time PCR has been applied extensively in the field gene therapy in the
last 10 years to assess the transfer of gene delivery vectors and track their distribution in vivo as
well as to accurately determine viral vector titers (Heid et al. 1996, Becker et al. 1999, Hackett
et al. 2000, Ma et al. 2001, Senoo et al. 2000). The advantages of this quantitative method
include a large dynamic range (up to 7 orders of magnitude), reproducibility, accuracy and
sensitivity, as well as high sample throughput.
The TaqMan PCR assay is based on the use of a dual-labeled fluorogenic probe that
hybridizes to the target DNA sequence between the forward and reverse primer sites. The
probe contains a fluorescent dye at the 5' end (FAM, 6-carboxyfluorescein), which serves as a
reporter and another at the 3' end (TAMRA, 6-carboxy-tetramethyl-rhodamine) that serves as a
quencher. When the probe is intact, the emission spectrum of FAM is absorbed by TAMRA
(fluorescence energy transfer phenomenon) due to the proximity of the two dyes. During PCR,
the primers and probe anneal to the target DNA sequence (if it is present in the sample) and the
polymerization (primer elongation) step begins. As the primer upstream of the probe is
extended, the 5' to 3' nucleolytic activity of the AmpliTaq Gold DNA polymerase cleaves the
probe, thus separating the two dyes and increasing the fluorescence emission of the reporter
(Figure 3.4.1) while polymerization of the strand proceeds. This process occurs in every PCR
cycle and therefore the accumulation of the PCR product can be detected by monitoring the
increase in emission intensity (Heid et al. 1996, Applied Biosystems 2000, 2002).
The PCR reaction takes place in a 96-well plate placed inside a Sequence Detection
System (the ABI Prism 7700 system was used in this study). Light from an argon ion laser is
distributed to the 96 wells through a multiplexed array of optical fibers and excites the
fluorescent dyes in each well for 25 msec. The resulting emissions (500-660 nm) are collected
every 7 sec by the optical fibers and directed to a spectrograph with a CCD camera (Figure
3.4.2). The fluorescent signals are subsequently analyzed and the data processed with the
Sequence Detection Software (Applied Biosystems 2000). A value ARn is calculated which
represents the normalized fluorescence emission intensity of the reporter (i.e. divided by the
fluorescence emission intensity of a passive reference dye) at any given time during the PCR
reaction, Rn÷, minus the normalized emission intensity of the reporter before the PCR reaction,
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Figure 3.4.1. Schematic of real-time TaqMan PCR method.
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Figure 3.4.2. Schematic of fluorescence detection system
Rn- (ARn = Rn' - Rn). An amplification plot is created where ARn is plotted as a function of time
represented by cycle number (Figure 3.4.3a). The initial PCR cycles where the fluorescent
signal is below the detection limit, define the baseline of the amplification graph. When sufficient
PCR product has accumulated, the signal can be detected above the baseline as it continues to
increase proportionally to the increase in PCR product. Eventually the reaction will reach a
plateau due to the insufficient quantities of DNA polymerase and other reagents. A fixed
threshold is assigned arbitrarily based on the baseline data variation. Then, the cycle number
where the plot crosses the threshold value is defined as the threshold cycle CT. The value of CT
can be used to determine the quantity of the DNA template in a sample of interest and is
inversely related to the number of template copies. The lower the CT value is, the greater the
initial quantity of DNA template is because it takes fewer PCR cycles to reach the threshold
level of fluorescence. By plotting the CT values vs. the initial template quantities for a series of
dilutions of the DNA template, a standard curve can be constructed. Given the CT of an
unknown sample, its initial quantity can be determined from the standard curve by interpolation
(Figure 3.4.3b).
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Figure 3.4.3. (a) Example of an amplification plot generated by the Sequence Detection
Softvýare from the fluorescence emission data collected during each PCR cycle. (b)
Example of a standard curve plot for the q uantification of an unknown sample.
3.4.2 TaqMan PCR Assay Design and Optimization for Quantification of Adenoviral
Vector Gene Delivery
Primer and probe design
The TaqMan primers and fluorogenic probe for the quantification of Ad vector levels
(H5.010 CMV EGFP) were designed with the Primer Expresso software (Applied Biosystems)
using the default values for the design parameters. The Ad sequence was provided by the
vector supplier (Vector Core, UPenn). Although the search for a primer/probe set was confined
to the sequence that encodes for the EGFP gene, the entire Ad vector genome sequence was
imported in Primer Expresso in order to test for possible non-specific hybridization to Ad DNA
regions other than EGFP, which could result in mispriming and would compromise the efficiency
I .I
of the PCR reaction. The results of the software search were examined according to specific
guidelines that take into account the nucleotide composition and the melting temperatures of the
oligonucleotide sequences in order to ensure optimum performance of the assay (Applied
Biosystems 2001). Eventually, the TaqMan primers 5'-GGGCACAAGCTGGAGTACAAC-3'
(forward) and 5'-GTGGCGGATCTTGAAGTTCAC-3' (reverse) and the fluorogenic probe FAM-
5'-CCGACAAGCAGAAGAACGGCATCA-3'-TAMRA were selected. These primers amplify a
96 bp DNA fragment on the EGFP gene.
PCR reaqents and amplification reaction conditions
The amplification reactions were performed with reagents from Applied Biosystems
according to the manufacturer's directions. A 50p1 reaction contained 25pC of 2X TaqMan
Universal PCR Master Mix, 5l of forward primer (300nM*), 5pl of reverse primer (300nM*), 5l
of probe (250nM) and 10gL1 of the DNA sample. The TaqMan Universal PCR Master Mix
contains TaqMan buffer A (1X), MgCI 2 (5mM), dUTP (400gM), dATP, dCTP, dGTP (200lpM
each), AmpliTaq Gold DNA polymerase (0.025U/il), AmpErase UNG (0.01U/gl) and glycerol
(8%). The concentrations in parentheses refer to the final concentation of each reagent in the
50•l PCR reaction mixture. Thermocycling was performed in an ABI Prism 7700 Sequence
Detection System. The samples were subjected to 500C for 2 min (UNG enzyme incubation to
degrade carryover contamination) and 950C for 10 min (AmpliTaq Gold enzyme activation) and
then to 45 cycles of 950C for 15 sec (denaturing step) and 600C for 1 min (annealing/extension
step) with continuous monitoring of fluorescence emission. The data were processed with the
SDS software (Applied Biosystems).
*Note: primer concentrations determined after optimization.
Primer concentration optimization
The optimal concentrations of forward and reverse primer were identified experimentally
by independently varying the concentration levels from 50nM to 900nM (Table 3.1) and running
amplification reactions with a fixed amount of target DNA template. Optimal PCR performance is
achieved by selecting the primer concentrations that provide the lowest CT and highest ARn (PE
Biosystems 1999).
The adenoviral vector that has been used throughout this thesis for gene delivery to
hepatocyte cultures served as the target DNA template for this optimization experiment. The Ad
was pre-treated with proteinase K to prevent any interference of the viral capsid components
with the activity of the DNA polymerase or its accessibility to the Ad DNA (Ma et al. 2001). The
Ad was incubated with proteinase K at 370C for 30min. This was followed by a 20min incubation
at 950C to inactivate the proteinase K. The amount of template used was 2.6x108 Ad genome
copies (10ng DNA) per PCR reaction (Note: the initial Ad genome concentration was
determined with OD 260 spectrophotometer measurements by the vector supplier). The
concentration of the TaqMan probe was set to 250nM as recommended by the manufacturer. All
primer combination reactions were run in triplicates as well as the No Template Control (NTC).
Table 3.1. Primer optimization matrix.
Reverse Forward Primer (nM)
Primer (nM)
50 300 900
50 50/50 300/50 900/50
300 50/300 300/300 900/300
900 50/900 300/900 900/900
Table 3.2 shows the results for all nine primer concentration combinations. The
combination of 50nM forward and reverse primer gave both the lowest ARn and highest CT
values. All other primer combinations that contained a 50nM concentration of either the forward
or the reverse primer resulted in reduced ARn and slightly increased CT values. Finally, all
primer combinations that contained at least 300nM forward and reverse primer gave both the
highest ARn and the lowest CT values; therefore any of these combinations will provide optimal
PCR performance. A concentration of 300nM for both primers was selected for all subsequent
PCR experiments for the quantification of Ad vector gene delivery in hepatocyte cultures.
Table 3.2. Primer concentration optimization results
Forward/Reverse standard standard
ARn* mean CT mean
primer (nM) deviation deviation
. 0.00 45
NTC -0.05 -0.02 0.02 45 45.00 0.00
-0.01 45
0.06 18.41
50/50 0.05 0.06 0.00 18.67 18.45 0.21
0.06 18.26
0.38 17.21
50/300 0.36 0.36 0.03 17.32 17.50 0.42
0.33 17.98
0.32 17.09
300/50 0.38 0.37 0.05 16.71 16.80 0.26
0.42 16.60
0.50 16.62
50/900 0.44 0.47 0.03 16.93 16.81 0.16
0.45 16.87
0.43 16.27
900/50 0.48 0.44 0.03 16.16 16.27 0.11
0.41 16.38
1.32 15.92
300/300 1.20 1.23 0.08 15.97 15.88 0.11
1.16 15.76
300/900 1.25 1.28 0.04 15.62 15.61 0.011.31 15.60
1.13 15.68
900/300 1.17 1.17 0.03 15.84 15.75 0.08
1.20 15.74
1.28 15.22
900/900 1.42 1.32 0.09 15.27 15.26 0.03
1.24 15.28
*ARn values correspond to the final measurements of PCR run (45 th cycle).
** NTC: no template control
Sensitivity and dynamic range of the PCR assay
In theory, a single copy of a target DNA sequence can be detected with the real time
TaqMan PCR method under optimal conditions. However, several parameters such as the
primer and probe concentrations or the nature and purity of the DNA template can affect the
sensitivity of the assay. To determine the detection limit and the dynamic range with the above-
mentioned primers/probe set, the Ad-EGFP vector was used as the PCR template. After
treatment with proteinase K, a series of 10-fold dilutions of the vector were prepared and PCR
was performed in triplicates. As shown in the amplification plot in Figure 3.4.4, as few as 10 Ad
copies could be detected with the assay (Note: the assay could detect 2 Ad copies per reaction
in 4 out of 6 replicates). The linear range for quantification was between 10 and 108 Ad copies
per PCR reaction - 7 orders of magnitude wide (Figure 3.4.5). The coefficient of variation of CT
values was less than 2%.
The ability of the assay to distinguish differences of 2-fold and 50% in Ad vector levels
among samples was also tested. Figure 3.4.6a presents a [CT] vs. [template quantity] plot for
the above mentioned serial dilutions (the fitted standard curve is also shown) as well as
samples containing 2x10 2, 3x10 2, ..., 2x105 , 3x10 5 Ad copies (red square symbols). All data
points represent the mean values of triplicate PCR reactions and the error bars the ± standard
deviation. Figure 3.4.6b shows a log-log plot of the template quantity of the samples determined
by interpolation using the standard curve versus the expected template quantity. The CT values
are also shown in the table in figure 3.4.6c. The results indicate that the assay is capable of
distinguishing 2-fold differences (between 103 - 2x1 03, 104 - 2x104, 105 - 2x105 Ad copies; not so
sensitive between 100-200 copies) as well as 50% differences (between 200 - 300, 2x103
3x1 03, 2x10 4 - 3x1 04, 2x105 - 3x10 5 copies).
Specificity of PCR assay
The specificity of the primers/probe set was confirmed by performing PCR with a
different adenoviral vector as a template, a vector carrying the gene for P-galactosidase (vector
H5.010CMVLacZ, Vector Core, UPenn) instead of EGFP. The two vectors are identical except
for the transgene that they deliver. PCR reactions were carried out in triplicates for samples
containing 2x107 copies of Ad-LacZ with or without Ad-EGFP at ratios of 1:1 and 1:10 . The
results are summarized in Table 3.3. Two of the replicates containing only Ad-LacZ template
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Figure 3.4.4. Amplification plot generated by the ABI Prism 7700 Sequence Detection
System for a series Ad-EGFP vector dilutions. Curves 1 to 9 correspond to 108, 107,
106, 105, 104, 103, 102, 10 and 0 (no template control) Ad copies respectively. Triplicate
samples are shown. The horizontal line at ARn = 0.07 represents the threshold.
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Figure 3.4.5. Dynamic range of TaqMan PCR assay for Ad-EGFP vector. Cycle
number CT is plotted against the initial Ad template quantity. All points represent the
mean of triplicate PCR reactions ± the standard deviation. The standard curve is shown
as a solid line.
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failed to amplify; the third replicate had a CT value above 42 cycles, which corresponds to a
template copy number outside the linear range for quantification (see standard curve inset).
Additionally, the presence of 2x107 copies of Ad-LacZ had a negligible effect (less than 1.3-fold
difference in measured concentration) on the amplification of 2x10 3 and 2x107 copies of Ad-
EGFP.
As mentioned earlier, this TaqMan assay was developed to quantify Ad gene delivery in
hepatocyte cultures (i.e. detect Ad in a background of genomic DNA). In order to ensure that the
standard standardSample Cr  mean deviation Copy # mean deviation
45.00 0.13
Ad-pgal 42.27 44.09 1.58 0.83 0.36 0.41
(2x07 copies)
45.00 0.13
31.13 1.60E +03
Ad-pgal/Ad-EGFP 31.11 31.14 0.03 1.82E+03 1.79E+03 37.56
1:10-4
31.17 1.75E+03
17.07 2.92E +07
Ad-pgal/Ad-EGFP 17.35 17.27 0.17 2.41E+07 2.56E+07 3.11E+06
1:1
17.38 2.36E+07
excess genomic DNA would not interfere with the quantification of the vector, a control
experiment was performed where DNA extracted from primary rat hepatocytes was mixed with
Ad-EGFP vector of known quantities and amplified with TaqMan PCR'. Figure 3.4.7 shows a
plot of the standard curve (10 to 108 copy number range) as well as the CT values for the
samples containing Ad in the presence of cellular DNA (red squares). The results indicate that
the presence of 25ng of hepatocyte genomic DNA per reaction had a negligible effect over a
range of 102 to 10' Ad copies and therefore did not affect the efficiency of the PCR assay.
Reproducibility of PCR assay
In all further PCR experiments, serial dilutions of the Ad-EGFP vector (ranging from 102
to 10' Ad copies) were included as standards for the detection and quantification of Ad DNA in
hepatocyte cultures. In these experiments the slopes of the standard curves were comparable
within a very narrow range; the average slope value was -3.44 and the coefficient of variation
was less than 1% (12 PCR runs included). All triplicate amplifications resulted in very similar CT
values with coefficient of variation that did not exceed 1%. All hepatocyte culture samples were
assayed in triplicate and the Ad copy number was determined from the standard curve by
interpolation. The mean Ad copy number values were calculated and the assay was repeated
for samples for which the coefficient of variation exceeded 10%.
In conclusion, the above-mentioned experiments established the specificity, sensitivity
(10 copies, 2-fold and 50% difference), dynamic range (6-7 log decades), precision (<2% CV of
CT values) and reproducibility of the designed TaqMan PCR assay as well as the ability to
detect the Ad-EGFP vector in the context of rat hepatocyte DNA. These attributes make this
method a valuable means for the quantitative analysis of the main experiments in this thesis,
which aim at the comparison of Ad gene delivery in two different types of hepatocyte culture. In
addition to this, the primers/probe set designed here is specific to the EGFP gene not the Ad
vector; therefore this assay could be directly applied to the quantification of gene delivery with
different types of vectors.
Note: primary hepatocytes were harvested from a male Fisher rat and DNA was extracted with
the High Pure PCR Template Preparation Kit (Roche). The DNA content was quantified with the
Rediplate 96 PicoGreen dsDNA Microplate assay (for details refer to section 3.3).
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Figure 3.4.7. Specificity of PCR assay. Amplification of Ad-EGFP in the presence of
hepatocyte genomic DNA (25 ng/reaction).
3.5 RNA Extraction and Total RNA Quantification
3.5.1 RNA Extraction and Purification
Hepatocyte Monolayer Cultures
The hepatocytes were lysed and homogenized directly in the culture plates with 1 ml
Trizol Reagent (Invitrogen) per well after the HGM medium had been removed. The
homogenized samples were stored in microcentrifuge tubes at -800C until further processing to
isolate the RNA. The RNA isolation process involved the addition of chloroform to each sample
followed by centrifugation to separate the solution in three phases: an upper aqueous phase
(RNA), an interphase (DNA) and a lower organic phase (protein). The aqueous phase was
transferred to a fresh tube. The detailed instructions of the Trizol Reagent protocol were
followed for the execution of the above-mentioned steps. The RNA samples were then purified
with the RNeasy Mini Kit (Qiagen). During this process each sample is mixed with an equal
volume of 70% ethanol and applied to an RNeasy mini column. The RNA binds to the silica-gel
membrane in the column, is washed from contaminants with a special buffer and eventually is
eluted with 301l RNase-free water. These bind, wash and elution steps are performed by
centrifugation. The purified RNA samples were stored at -800C until total RNA quantification
and real-time RT-PCR analysis. Before performing these assays all samples were treated with
RNase-free DNase I (Invitrogen) according to the manufacturer's protocol.
The interphase that formed during the Trizol-chloroform centrifugation of each sample
was also transferred into a fresh tube for the purification of the DNA.
Liver Microreactor Cultures
The silicon scaffolds containing the hepatocyte tissue were removed from the
microreactor chambers and were placed in microcentrifuge tubes in 1 ml Trizol Reagent. The
cells were mechanically lysed with a syringe and a 24-gauge needle to ensure that the
hepatocyte tissue inside the scaffold channels was thoroughly homogenized. The silicon
scaffolds were then removed and the RNA was isolated and purified as described in the
previous paragraph.
3.5.2 DNase Treatment of RNA Samples
All RNA samples were treated with RNase-free DNase I (Invitrogen) to eliminate any
potential contamination with DNA, which might interfere with the quantification of total RNA. 1pl
RNA sample (2pl for liver microreactor samples) was mixed with 1lI 10X DNase I Reaction
Buffer, 1ip DNase I (1U/pl), and DEPC-treated water to a total volume of 101. The mixture was
incubated for 15 min at room temperature. Then the DNase I was inactivated with 1 1l of 25 mM
EDTA solution and incubation at 650C for 10 min. Each sample was diluted with 39j1 TE buffer
to a total volume of 50l before total RNA quantification.
3.5.3 Quantification of Total RNA Content in Hepatocyte Culture Samples
After RNA isolation and purification followed by treatment with DNase I, the samples
(hepatocyte monolayer cultures and tissue-engineered microreactors) were assayed for total
RNA content with the RediPlateTM 96 RiboGreen@ RNA Quantitation Kit (Molecular Probes).
This assay is based on the ability of the nucleic acid stain RiboGreen to bind to RNA and
subsequently emit bright green fluorescence. The stain is predispensed in the wells of a 96-well
microplate and is dissolved in TE buffer before the addition of the RNA samples; fluorescence is
measured in a fluorescence microplate reader using excitation at 485 nm and detection at 530
nm. The fluorescence of the sample of interest is compared to that of a standard curve of RNA.
The kit contains rRNA standards from E. coli. The assay has a linear range of 3-200 ng in a 200
pl assay volume according to the manufacturer. This method for RNA concentration
quantification was chosen over the more commonly used measurements of absorbance at 260
nm, because of its advantages of higher sensitivity, accuracy and dynamic range, as well as the
ability for processing multiple samples at the same time.
The RediPlate RiboGreen assay was applied to all RNA samples that were also assayed
for EGFP mRNA levels with quantitative real-time RT-PCR. A standard curve was prepared for
each microplate. In order to ensure accurate RNA quantification of the rat hepatocyte samples
with this assay, the standard curve derived with the E. coli rRNA standards provided in the kit
was compared to a standard curve derived from a series of dilutions of Rat Total RNA (Ambion)
treated with DNase I ranging from 0.01 to 1ig/ml (2 to 200 ng in a 200 pi assay volume). All
standards were assayed in triplicates. There was no significant difference between the E. coli
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Figure 3.5.1. RediPlate 96 RiboGreen RNA Quantitation assay. Comparison of
standard curves prepared with E.coli rRNA (included in the Rediplate kit) and Rat total
RNA dilutions. Fluorescence was measured with a microplate reader. The fluorescence
signals are plotted against the RNA concentration. All standards were assayed in
triplicates. The symbols represent the mean values and the error bars the standard
deviation.
and the Rat RNA standard curves (Figure 3.5.1). Therefore all subsequent plates were run with
the standards included in the kit.
The slopes of the standard curves among different microplates were comparable within
a narrow range - the coefficient of variation was less than 3% (n=6). All hepatocyte samples
were assayed in triplicate and the total RNA content was determined from the standard curve by
interpolation. The mean values were used for further calculations (to determine the volume of
each sample needed for the reverse transcription reaction).
__
3.5.4 Cellular RNA Content Measurements for Rat Hepatocytes
To determine the RNA content of a rat hepatocyte (for data normalization purposes),
samples of hepatocytes were needed containing known numbers of cells. After each rat liver
perfusion and hepatocyte isolation though, the cell viability and concentration of the resulting
hepatocyte suspension can be determined with the trypan blue exclusion method in a
hemocytometer as described in section 3.1. Therefore, triplicate samples of varying cell
numbers (from 104 to 4x10 s) were prepared from the resulting hepatocyte suspension of a rat
perfusion. RNA was extracted as described in Section 3.5.1 and quantified with the RediPlate
96 RiboGreen RNA Quantitation Kit as described in Section 3.5.3. Figure 3.5.2 shows a plot of
RNA content (jg RNA) as a function of hepatocyte number. Each data point corresponds to the
mean value of 3 samples and the error bars represent the standard deviation. A straight line
was fitted to the data with linear regression (Excel) and the slope represents the cellular RNA
content. As shown in the plot, each rat hepatocyte contains 4.8x10 -5 jg RNA. This number was
used to convert the normalized RT-PCR data (EGFP RNA copies per gg RNA) to EGFP mRNA
copies per cell.
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Figure 3.5.2. Rat hepatocyte RNA content measurements. Samples of varying cell
numbers were prepared after rat liver perfusion and hepatocyte isolation. RNA was
extracted and quantified with the Rediplate 96 RiboGreen RNA Quantitation Kit.
Fluorescence was measured with a microplate reader and the RNA content of each
sample was determined from the standard curve by interpolation. The RNA content is
plotted here as a function of cell number. The data points represent the mean values of
3 samples and the error bars the standard deviation. The straight line corresponds to
the linear regression with Excel.
3.6 Quantitative real-time RT-PCR
3.6.1 Introduction
Real-time PCR is the method of choice for gene quantification because of its significant
advantages, as presented in Section 3.4 of this chapter. With the addition of a reverse
transcription (RT) step before the PCR reaction, it has also become one of the most widely used
methods for detecting and quantifying gene expression and comparing mRNA levels in different
sample populations. There are several factors that make the quantification of RNA with RT-PCR
significantly more complex than the quantification of genomic DNA. These include the inherent
variability of RNA extracted from biological samples and its instability and most importantly the
efficiency of the RT reaction. Due to the exponential nature of PCR, even minor experimental
variations can lead to large changes in the final amplified product; therefore every step must be
carefully designed and controlled. The additional step of reverse transcription, during which the
RNA is converted into a cDNA template, is critical for the overall sensitivity, accuracy and
reproducibility of the assay. The amount of produced cDNA must accurately represent the
amount of input RNA. The efficiency of the RT reaction depends on the enzyme, the type of
primers that prime the cDNA synthesis as well as the abundance of template (Bustin et al.,
2005; Wong and Medrano, 2005; Bustin, 2002; Huggett et al., 2005).
In order to minimize these errors and correct for sample-to-sample variation, it is
essential to apply a normalization strategy. An endogenous cellular RNA is amplified
simultaneously with the target RNA and is used as a reference against which the target RNA
values are normalized. The choice of the reference gene is a challenging issue itself and
depends on the experimental system studied. Ideally, that gene should be expressed at
constant levels independently of the experimental treatment.
In this thesis, real-time RT-PCR was applied for the quantification of EGFP expression
after AdEGFP infection in rat hepatocyte monolayer and microreactor cultures. These in vitro
systems were established from relatively homogeneous hepatocyte populations isolated from
rat livers; therefore the variability among biological samples should not be a significant issue,
although there could be differences between monolayer and microreactor cultures. Ribosomal
RNA (18S rRNA) was selected for normalization since it has been shown to be a reliable control
in rat liver compared to housekeeping genes such as P-actin and GAPDH (Sivaraman et al.,
2005; Bustin, 2000). Other reports also suggest the use of rRNA as the most reliable strategy
for accurate RNA quantification (Bustin, 2002; Bustin et al, 2005). Normalization against total
RNA concentration is another option provided that total RNA levels can be accurately
rrmeasured.
It is possible to obtain absolute quantification of the target RNA. However, the
preparation of standard curves from in vitro transcribed RNA requires a lot of effort and presents
many problems. DNA standards can also be used; there is no control for the efficiency of the
reverse transcription though (Applied Biosystems: User Bulletin #2, Relative Quantitation of
Gene Expression, 2001). Another option is relative quantification, where RNA quantity is
expressed relative to a basis sample (calibrator). The calibrator becomes the lx sample and all
other samples are expressed as an n-fold difference relative to the calibrator. In that case the
results can be analyzed with the Comparative CT (2-ACT) Method (Livak and Schmittgen, 2001).
According to this method, the amount of target RNA, normalized to an endogenous reference
and relative to a calibrator is given by the equation:
amount of target = 2-CT
AACT = ACT,q - ACT,cb
where ACT.q is the difference in threshold cycles between target (EGFP) and reference (18S) for
any sample and ACT,cb is the difference in threshold cycles between target (EGFP) and
reference (18S) for the calibrator sample. The comparative CT method is applicable only if the
amplification efficiency of the target and the reference genes are approximately equal; therefore
a validation experiment is required before using this method. This experiment is presented in
the data analysis section.
The RT and PCR reactions were performed in a two-step assay following protocols and
using reagents established by Applied Biosystems. The TaqMan PCR amplifications were
performed with the ABI Prism 7700 Sequence Detection System. Random hexamers were used
as the primer for the RT reaction in order to produce cDNA templates for both the target mRNA
and the reference rRNA.
The general procedure for the real-time RT-PCR experiments consisted of the following
steps: (a) RNA isolation and characterization, (b) DNase treatment, (c) reverse transcription, (d)
PCR and (e) data normalization and analysis. These steps are described in detail in the
following section.
3.6.2 Quantitative real-time RT-PCR Assay Design for Quantification of EGFP mRNA
Levels after Ad Vector Gene Delivery
L(a) Template preparation (RNA isolation and characterization)
RNA was isolated from hepatocyte monolayer and microreactor cultures with Trizol
Reagent (Invitrogen) and purified with the RNeasy mini kit (Qiagen). In the final step of this
procedure the RNA was eluted with 301l RNase-free water. The total RNA content of each
sample was measured with the RediPlateTM 96 RiboGreen@ RNA Quantitation Kit (Molecular
Probes). These procedures are described in detail in Section 3.5.
(b) DNase Treatment
Before the reverse transcription reaction all RNA samples were treated with RNase-free
DNase I (Invitrogen) to eliminate any potential contamination with DNA, which would lead to
inaccurate quantification of mRNA levels. Monolayer cultures: the RNA samples were initially
diluted 4 times; then 400 ng RNA were mixed with 1i1l 10X DNase I Reaction Buffer, 1 il DNase
I (1U/gl), and DEPC-treated water to a total volume of 10 al. Microreactor cultures: 200 ng RNA
were mixed with 1.5pal 10X DNase I Reaction Buffer, 1.5al DNase I (1U/pl), and DEPC-treated
water to a total volume of 15gl. The mixtures were incubated at room temperature for 15 min.
Then the DNase I was inactivated with 1 1l of 25 mM EDTA solution (1.5al for microreactor
samples) and incubation at 650C for 10 min.
(c) Reverse Transcription (cDNA synthesis)
The reverse transcription reactions were performed with reagents from Applied
Biosystems according to the manufacturer's directions. Monolayer cultures (400ncq RNA): each
RT reaction had a total volume of 40g1 and was prepared by mixing the 11 l RNA sample
(volume after DNase treatment) with a 29.l RT mix. The RT mix contained 4g1 of 10X RT buffer,
8.8•1 MgCI2 (5.5mM), 8jl dNTPs mixture (500gM each), 21l Random Hexamers (2.5 gM), 0.8gl
RNase Inhibitor (0.4 U/gl), 2.5pl MultiScribe Reverse Transcriptase (3.125U/[Ll) and 2.9il
RNase-free water. The concentrations in parentheses refer to the final concentration of each
reagent in the 40il RT reaction mixture. Microreactor cultures (200nq RNA): each RT reaction
had a total volume of 501il and was prepared by mixing the 16.5[l RNA sample (volume after
DNase treatment) with a 33.5gl RT mix. The RT mix contained 5jil of 10X RT buffer, 11 l MgCl 2,
10g1l dNTPs mixture, 2 .5p1 Random Hexamers, 1i1 RNase Inhibitor, 3.125gl MultiScribe
Reverse Transcriptase and 0.875gl RNase-free water. The final reagent concentrations were
the same as in the monolayer culture samples. Since 18S rRNA was selected as the
endogenous reference for normalization, a higher concentration of MultiScribe reverse
transcriptase was applied (Applied Biosystems: TaqMan@ Gold RT-PCR Kit, Protocol, 2002).
The reactions were incubated at 250C for 10 min (hexamer incubation), then at 370C for
60 min (reverse transcription) and at 950C for 5 min (reverse transcriptase inactivation). After
thermal cycling all cDNA samples were stored at -200C.
RT reactions without reverse transcriptase (minus RT controls) were also prepared for
each sample. The minus RT controls can account for any residual DNA contamination, since
any PCR amplification in these samples would be attributed to genomic DNA templates.
(d) Real-Time PCR Data Acquisition
The amplification reactions for the EGFP cDNA template were performed with the same
set of primers and TaqMan probe (FAM/TAMRA) as described in Section 3.4.2. The 18S cDNA
template was detected and amplified with a pre-designed set of primers and TaqMan probe
provided by Applied Biosystems (Eukaryotic 18S rRNA Endogenous control, Pre-Developed
TaqMan Assay Reagents). The amplicon generated is 187 bp in length and the primer and
probe sequences are conserved among several eukaryotic organisms including rat. The
TaqMan probe contains the VICTM dye as the reporter and TAMRA as the quencher.
The two templates were amplified in separate reactions and each sample was assayed
in triplicate. In the case of the EGFP template, the 50•1 PCR reaction contained 2511 of 2X
TaqMan Universal PCR Master Mix, 5gl of forward primer (300nM), 5al of reverse primer
(300nM), 5gl of probe (250nM) and 10gl of the cDNA sample. In the case of the 18S template,
the 501 PCR reaction contained 25pl of TaqMan Universal PCR Master Mix (2X), 2.5gl of the
primer and probe mix, 12.5gl RNase-free water and 101l of the cDNA sample. cDNA samples
were diluted before PCR (100x for monolayer samples and 40x for microreactor samples). The
quantity of cDNA sample added in each PCR reaction corresponds to 1 ng total RNA (except
when specified otherwise).
Thermocycling was performed in an ABI Prism 7700 Sequence Detection System. The
samples were subjected to 500C for 2 min (UNG enzyme incubation to degrade carryover
contamination) and 950C for 10 min (AmpliTaq Gold enzyme activation) and then to 45 cycles of
950C for 15 sec (denaturing step) and 600C for 1 min (annealing/extension step) with continuous
monitoring of fluorescence emission. The data were processed with the SDS software (Applied
Biosystems). The theoretical and experimental details of real-time TaqMan PCR are described
in detail in Section 3.4.
(e) Data Normalization and Analysis
Comparative CT Method:
Before using the Comparative CT Method for RT-PCR data analysis, a validation
experiment was performed to ensure that the amplification efficiencies of the EGFP and 18S
templates were similar. Serial dilutions of a cDNA sample were assayed in triplicate for the
EGFP and 18S templates with real-time PCR and the difference in threshold cycles ACT was
calculated (the sample was isolated from a hepatocyte monolayer culture that had been infected
with AdEGFP at a concentration of 6.4x107 i.p./ml for 24 hr). The results are shown in Table 3.3
below:
Table 3.3: Validation experiment for Comparative CT Method.
Input Amount EGFP 18S ACT
ng Total RNA Average CT Average CT EGFP - 18S
1 30.55±0.03 19.35±0.13 11.20±0.14
0.5 31.88±0.17 20.38±0.07 11.50±0.18
0.1 34.18±0.13 22.86±0.21 11.31±0.25
0.05 34.96±0.22 23.79±0.13 11.18±0.25
0.01 37.62±0.26 26.27±0.07 11.35±0.27
Fiigure 3.6.1 shows a plot of ACT versus the log (input amount of RNA). If the absolute value of
the slope in the plot is <0.1 then the 2-ACT method can be used for the relative quantification of
EGFP mRNA levels in the experiments of this thesis. The slope in figure 3.6.1 was determined
from linear regression with Excel and is equal to 0.0113, which is below the required limit.
Table 3.4 illustrates how the relative EGFP mRNA levels are calculated with the
Comparative CT Method. This example shows the results for three hepatocyte monolayer
cultures infected with AdEGFP for 24 hr at three different concentrations: Co (sample A), Co/2
(sample B) and Co/10 (sample C), where Co=6.4x107 i.p./ml. The CT values for the EGFP and
18S templates are used to calculate ACT, AACT and 2-ACT (the amount of EGFP mRNA
normalized to 18S and relative to the calibrator). The calibrator in this case is the sample
exposed to the highest Ad concentration Co (sample A).
Table 3.4: Relative Quantification with the Comparative CT Method.
These results indicate that sample B contains 8.3x less EGFP mRNA than sample A and
sample C contains 115x less EGFP mRNA than A.
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Figure 3.6.1. Relative amplification efficiency of 18S and EGFP templates. Serial
dilutions of a cDNA sample (ranging from 0.01 to 1 ng input amount of total RNA) were
assayed with real-time TaqMan PCR for the EGFP and 18S templates. This figure
shows a plot of the difference in threshold cycles ACT versus the log input amount of
total RNA. The data points represent the difference of the average CT values and the
error bars the standard deviation of the difference. The straight line corresponds to the
linear regression with Excel. The cDNA sample was prepared from a hepatocyte
monolayer culture that had been infected with AdEGFP at a concentration of 6.4x107
i.p./ml for 24 hr.
Simplified Comparative CT Method (2-AcT Method):
As described previously, the total RNA content of all experimental samples studied was
quantified with the RiboGreen assay. Then, the PCR amplification reactions were set up using
cDNA derived from the same amount of input RNA. This way the PCR results were already
normalized to an external measurement (total RNA). In this case it is possible to apply a
simplified version of the Comparative CT Method (Livak and Schmittgen, 2001), where the
amount of target RNA relative to a calibrator is given by the equation:
amount of target = 2-aC'T
AC'T = CT,q - CT,cb
where CT,q is the threshold cycle of the target (EGFP) for any sample and CT,cb is the threshold
cycle of the target (EGFP) for the calibrator sample. Table 3.5 shows the application of this
simplified method to the example presented in Table 3.4:
Table 3.5: Relative Quantification with the Simplified Comparative CT Method.
These results indicate that sample B contains 7.4x less EGFP mRNA than sample A and
sample C contains 94x less
in Table 3.4.
EGFP mRNA than A, values that are comparable to those derived
Sample EGFP ACT EGFP(initial Ad conc.) Average CT CT - CT,A Rel. to ARel. to A
1.00A (Co) 30.67±0.13 0.00±0.13 1.09(0.91-1.09)
0.135B (Co/2) 33.56±0.03 2.89±0.03 (0.132-0.137)
1.06x10-2C (Co/10) 37.22±0.04 6.55±0.04 (1.03-1.10)x10-2
Absolute Quantification of EGFP mRNA:
The levels of EGFP expression can also be quantified in terms of the number of cDNA
copies with a standard curve prepared from a series of dilutions of the Ad vector, as described
in Section 3.4. Again, since the PCR amplification reactions were set up using cDNA derived
from the same amount of input RNA the results are already normalized against total RNA
concentration. Table 3.6 shows the results for the example presented in Table 3.4:
Table 3.6: Absolute Quantification with Standard Curve Method.
According to the results sample B contains 7.3x less EGFP mRNA than sample A and sample C
contains 90x less EGFP mRNA than A. These values are very similar to the ones derived with
the Simplified Comparative CT Method.
In conclusion, all three methods for the analysis of RT-PCR data produce comparable
results for the experiments in this thesis, the simplified Comparative CT Method being perhaps
the easiest to apply.
Sample EGFP Average copy #
(initial Ad conc.) Average CT per ng RNA
A (Co) 30.67±0.13 910.0±82.0
B (Co/2) 33.56±0.03 124.5±2.4
C (Co/10) 37.22±0.04 10.1±0.3
3.7 Miniaturized Spectrometer System for Detection and
Quantification of EGFP Expression in Microreactor Cultures
3. 7.1 Introduction
The design of the microreactor chamber allows the passage of light through the silicon
scaffold channels as described in Chapter 2. Based on this characteristic, a fiber optic
spectrometer system was built by Dr Karel Domansky to measure EGFP expression in
rnicroreactor cultures infected with an Ad gene delivery vector, by directing light of the
appropriate wavelength into the microreactor chamber and detecting the emission of green
fluorescence (Figure 3.7.1a) (Domansky et al., 2004). As illustrated in the schematic (Figure
3.7.1b), light from an LS-1 Tungsten Halogen Source (Ocean Optics) passes through a
bandpass excitation filter (470/40nm), and travels via an optical fiber to the lower part of the
microreactor chamber and through the hepatocyte tissue inside the silicon scaffold channels.
The light exiting the upper part of the microreactor chamber is directed with the help of a
collimator through a longpass emission filter (495nm) which filters out the excitation light, and is
transmitted through an optical fiber to a USB2000 Fiber Optic Spectrometer (Ocean Optics).
The spectrometer is a linear CCD-array detector responsive from 200 to 1100nm and is directly
connected to a computer equipped with the OOIBase32 Spectrometer Operating Software
(Ocean Optics). The software collects and processes the spectral data and displays them in
real-time. In the experiments that will be presented in this thesis, the dark signal (background
noise recorded by blocking the path of the excitation light immediately after the light source) was
subtracted from the EGFP spectrum for every measurement. Integration time was set to 30sec
and the displayed data were the average of two spectra.
This setup provides a non-invasive way to detect EGFP expression in the microreactor
cultures and to follow the changes in expression with time by monitoring the emitted spectra at
various times after infection with the Ad gene delivery vector, as presented in the following
section. The spectrometer measurements were performed without disrupting the continuous
medium flow in the microreactor system and typically lasted only a few minutes.
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Figure 3.7.1 (a) Miniaturized Fiber Optic Spectrometer System (photograph by Karel
Domansky). (b) Schematic of the spectrometer setup for EGFP detection in the
microreactor cultures.
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3.7.2 Detection of EGFP expression with the Spectrometer
All the spectrometer data presented in Chapter 5 were obtained with the instrument
shown in Figure 3.7.1. However, the first experiments to evaluate and optimize this technique
were performed with the older version of the microreactor culture system (stainless steel
clhamber, Figure 2.2a). The original configuration of the fiber optic spectrometer adapted to that
system is shown in Figure 3.7.2.
The example in Figure 3.7.3 illustrates the application of the spectrometer system for the
detection of EGFP. One microreactor culture (graph a) was infected with the AdEGFP vector at
a concentration of 4x106 pfu/ml for 24 hours. The second (graph b) was not infected with Ad so
as to serve as a control sample. The emission spectra were recorded for both microreactors
immediately before the Ad infection (t=0O) and at different times afterwards. As shown in Figure
3.7.3, the intensity of the spectrum increased with time in the infected microreactor, whereas it
remained practically unchanged in the control.
3.7.3 Monitoring the time course of EGFP expression in microreactor cultures with
spectrometer measurements
The increasing spectrum intensity levels reflect the increasing levels of produced EGFP
protein as a result of Ad gene delivery in the hepatocyte cultures. Therefore, these
measurements provide the means for tracking the changes in EGFP expression with time. The
intensity values at 509nm (wavelength corresponding to the EGFP emission spectrum
maximum) were used as a measure of EGFP expression. For each microreactor the intensity
value at time t=O (It=o) was subtracted from the value measured at any time t (It). Intensity was
plotted as a function of time t.
Figure 3.7.4 shows results of spectrometer measurements performed in five experiments
(5 different rat liver perfusions). The time course of EGFP expression is plotted for several
microreactor cultures infected with AdEGFP at a concentration of 4x106 pfu/ml for 24h. Control
cultures were prepared in every experiment; since all controls showed no change in spectrum
intensity with time only one sample is included in the plot (pink triangles). Additionally, one
Figure 3.7.2 Original configuration of the Miniaturized Fiber Optic Spectrometer System
adapted to the older version of the microreactor culture system (stainless steel
chamber). Photograph by Karel Domansky.
microreactor culture was infected with an Ad vector carrying the gene for 3-galactosidase (Adp-
gal) at the same conditions as the AdEGFP vector. No change in intensity was observed after
infection (black triangles). Consequently, the increase in intensity observed in the cultures
infected with AdEGFP was solely the result of EGFP expression and not of any other effect
caused by the interaction of the Ad particles with the hepatocyte tissue. Based on the results
presented in this plot, EGFP expression increases rapidly after Ad infection and reaches
maximum levels around 50-70h after the beginning of Ad infection, then slowly decreases with
time. EGFP expression was followed until t= 1 days in some microreactor cultures.
The experiments presented in Figures 3.7.3 and 3.7.4, were performed with the original
version of the microreactor system (stainless steel chamber). Similar results were obtained for
the polycarbonate microreactors.
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Figure 3.7.3 Detection of EGFP expression in hepatocyte microreactor cultures with
the miniaturized spectrometer system. The graphs show the EGFP emission spectra
recorded at different times after the beginning of Ad infection (t=O): (a) microreactor
culture infected with AdEGFP at a concentration of 4x10 6 pfu/ml for 24h, (b) control
microreactor culture (not infected with Ad).
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Figure 3.7.4 Time course of EGFP expression in hepatocyte microreactor cultures after
infection with an Ad gene delivery vector. Microreactor cultures were infected with AdEGFP
at a concentration of 4x106 pfu/ml for 24 hours. EGFP expression was detected with the
spectrophotometer. The EGFP emission spectra were recorded at different times after the
beginning of the Ad infection (t=O). The intensity (It) at 509nm (EGFP emission maximum)
was selected as a means for quantifying the levels of EGFP expression. This graph shows
the intensity change (It-it=o) at 509nm plotted against the time t after the beginning of the Ad
infection. Results from five experiments (different rat liver perfusions) are presented. Two
controls are included: one microreactor culture infected with Adf3-gal (black triangles) and
one not infected at all (pink triangles).
Note: the data presented as yellow and pink triangles correspond to the microreactor cultures
shown in Figure 3.7.3 (a) and (b) respectively.
3.7.4 Quantification of EGFP expression with spectrometer measurements
It is not possible to quantitatively compare the EGFP intensity levels among the samples
shown in Figure 3.7.4 because these values are not normalized to the total number of cells
present in each microreactor. The difference in intensity values could be a result of the cell
number variability. However, if the hepatocytes are harvested at the end of each experiment
and the total DNA is extracted and quantified, then quantitative information about gene delivery
efficiency can be extracted from spectrometer measurements. The change in the EGFP
expression levels as a function of Ad concentration can then be measured and compared to the
change in EGFP mRNA levels as well as to the change in the cellular uptake of Ad particles.
This approach was followed in the microreactor experiments presented in Chapter 5. In these
experiments hepatocyte DNA was extracted and quantified as described in Section 3.3.
3.8 Two-Photon Laser Scanning Fluorescence Microscopy in
Microreactor Cultures
3.8. 1 Introduction
The basic characteristic of the microreactor is that it allows the culture of hepatocytes in
a 3D tissue environment. Therefore, a non invasive, in situ imaging method with three-
dimensional resolution was needed to detect AdEGFP delivery to the tissue structures inside
the microreactor channels. Two-photon excitation microscopy can satisfy these requirements.
Two-photon excitation first appeared as a theoretical concept in the 1930s and was
proved experimentally three decades later (Masters and So, 2004); however, it was introduced
in laser scanning microscopy for biological and other applications relatively recently (Denk et al.,
1990). Two-photon excitation is the result of the simultaneous absorption of two photons in a
single (quantitized) event. In conventional fluorescence microscopy a fluorophore molecule is
excited by the absorption of a single photon of a particular wavelength (e.g. 350nm) and returns
to the ground state by emitting a single photon of lower wavelength. In two-photon microscopy,
the same fluorophore is excited by the simultaneous absorption of two photons of longer
wavelength (700nm), each of which by itself does not have sufficient energy to cause the
transition to the excited state (Sheppard and Shotton, 1997); the resulting emission however is
the same (Figure 3.8.1a). Since two photons have to be absorbed the rate of absorption and
consequently of the resulting fluorescence emission depends on the square of the excitation
intensity. This property is responsible for the several advantages of two-photon microscopy.
The extremely high laser powers required for two-photon excitation events to happen
can be achieved with mode-locked (or pulsed) lasers, where, although the average laser power
is low, the power at the peak of the pulse is very high. Moreover, as the laser beam focuses on
the sample, the density of the photons increases and at the focal point it becomes high enough
to generate two-photon excitation (Figure 3.8.1b). Consequently, fluorescent emissions result
only from the focal point. Since there are no out-of-focus emissions, there is no need for a
confocal aperture to obtain 3D resolution, in contrast to confocal microscopy (in fact 3D
resolution is identical to that of an ideal confocal microscope) and, photobleaching and
photodamage of the sample are minimized. Furthermore, attenuation of the excitation beam by
out-of-focus absorption does not occur, allowing increased depth penetration in the sample
(Piston, 1999; Denk et al., 1995). This is also enhanced by the fact that high wavelength light is
used (red or near infrared).
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In this thesis, two-photon laser scanning fluorescence microscopy was applied for the
detection of EGFP expression in hepatocyte microreactor cultures after AdEGFP infection. A
protocol was developed for quantitative assessment of gene delivery efficiency, cell viability and
the spatial distribution of Ad-infected hepatocytes.
3.8.2 Two-photon imaging in Hepatocyte Microreactor Cultures: Detection of EGFP
expression; spatial distribution and temporal variations.
Experimental procedures
The application of 2-photon microscopy for the detection of Ad gene delivery in
hepatocyte microreactor cultures was initially demonstrated with the original configuration of the
microreactor system (stainless steel chamber, Figure 2.2a). Microreactors seeded with day 3
spheroids were infected with an adenovirus vector carrying the gene for EGFP driven by the
CMV promoter. The Ad vector used in the experiments described in this section was provided
by Dr Jack Wands (Liver Research Center, Brown University).The Ad was introduced inside the
microreactor reservoir on day 3 after seeding at a concentration of 4xl Opfu/ml. (Note: this value
is based on the infectious titer of the original Ad preparation as measured by the vector
supplier.) The virus circulated for 24 h and was subsequently washed from the system.
Two-photon imaging: The expression of EGFP in hepatocytes cultured inside the microreactor
channels was detected with a two-photon laser scanning fluorescence microscope built by Dr
Peter So's lab (Department of Mechanical Engineering, MIT). Two-photon imaging involved the
acquisition of a stack of xy planes, each plane corresponding to different depth or z distance
from the surface of the silicon scaffold advancing in increments of 1ppm (as illustrated in the
schematic part of Figure 3.8.2). Images were obtained using a mode-locked Titanium-Sapphire
tunable femto second laser (Coherent Inc.) with 150 fsec pulse width with a 76 MHz repetition
rate. The power of incident light was regulated with a Glan-Thompson polarizer and was
typically measured to be 65 mW before entering the Axiovert 5100 TV microscope optics (Carl
Zeiss Inc.). An excitation wavelength of 840nm was typically used to maximize the adsorption
cross section for EGFP. A galvanometer-driven x-y scanner (Cambridge Technology) provided
raster scanning of the sample to generate a two-dimensional image within a focal plane at a
speed of 6-10 s per frame. A piezoelectronic driver (Physik Instruments) was used to precisely
control the distance between the objective lens and the sample for depth profiling. The
maximum imaging depth was defined by the working distance of the microscope objective. The
original version of the microreactor chamber was designed to have a 0.980 mm distance
between the silicon scaffold surface and the lens to enable imaging of the hepatocyte tissue
deep inside the channels. Images were taken using a 20X Achroplan water immersion objective
lens (Carl Zeiss Inc.) with a numerical aperture of 0.5 and a working distance of 2 mm.
Chromatic selection of green fluorescent light was achieved with a dichroic filter set using a
bandpass filter centered at 525 ± 25 nm. EGFP emission was detected with a single photon
counting system using a R5600-P photomultiplier tube (Hamamatsu). A 100 MHz single photon
counting discriminator (F100T, Advanced Research Instruments) converted single photon bursts
into TTL pulses, which were counted via computer.
A control experiment was performed to calibrate the extent of spectral loss of intensity as
a function of sample depth due to light scattering. Green fluorescent beads were embedded in a
matrix of agarose (10%) and lipid (5%) to simulate optical conditions found within a cell mass
and imaged under the above mentioned conditions. Approximately 50% of intensity was lost
within a depth of 60 pm (Powers et al, 2002).
Detection of EGFP expression and spatial distribution
Figure 3.8.2 shows 2-photon imaging data from two microreactor cultures, one infected
with AdEGFP and a control. The samples were imaged approximately 70 hours after the
beginning of Ad infection. Each of the four columns of panels contains sequential images (xy
planes) corresponding to a microreactor channel; each plane is 10pm deeper than the one
above it. Only part of a channel cross section can be seen in each panel. The yellow lines
outline the channel boundaries. The first three columns correspond to three different channels in
the microreactor that was infected with Ad. The last column corresponds to one channel inside
the control microreactor culture. The bright colored areas represent EGFP-expressing cells.
Fluorescence emission due to EGFP expression was clearly detected throughout the depth of
the tissue imaged (100pm) and was significantly higher than the hepatocyte auto-fluorescence
levels displayed in the control culture. These data demonstrate the accessibility of the 3D
hepatocyte tissue structures to in situ fluorescence microscopy and therefore the possibility to
obtain spatial information about EGFP expression under defined Ad delivery conditions.
Temporal variations in EGFP expression
Figure 3.8.3a shows two-photon imaging data from a microreactor culture infected with
Ad. In this experiment EGFP expression was monitored in specific channels at three different
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time points after Ad infection (t = 21, 64, 93h). The data presented in this figure correspond to a
single channel. The same three sequential planes (10pm apart) are shown for each time point.
Total EGFP expression in that microreactor was also followed with time with spectrometer
measurements. Figure 3.8.3b shows the EGFP spectrum intensity change (It-lt=O) at 509nm
plotted as a function of time after the beginning of Ad infection. The green circles mark the time
points when two-photon imaging was also performed. As described in section 3.7 EGFP
expression increases rapidly 24-70h after Ad infection reaching a maximum which gradually
declines after a few days. This trend is captured in the two-photon data as an increase in
brightness from the early to the later time points. These results demonstrate the ability to obtain
temporal information about gene expression with two-photon microscopy.
Additionally, two-photon imaging data also reveal morphological structures of the
hepatocyte tissue inside the microreactor channels. In channels 1 and 2 of Figure 3.8.2 the
tissue cross section consists of several layers of hepatocytes spanning a distance from the
walls to the middle of the channel; the gaps observed inside the tissue mass (especially for
channel 2) might be conduits for medium flow. In channel 3 the tissue cross section is thinner
and the cells spread along the wall. Note that only part of a channel cross section can be seen
in each panel. In Figure 3.8.3 the hepatocytes span the middle of the channel diagonally and
also spread along the wall.
3.8.3 Two-photon imaging of EGFP expression in Hepatocyte Microreactor Cultures:
Quantification of Ad gene delivery efficiency in terms of % EGFP-expressing cells.
The results presented in the previous section offer qualitative information about Ad gene
delivery in the microreactor system. However, as mentioned earlier, one of the goals in this
thesis was to develop quantitative methods to analyze the barriers to gene delivery in 3D
hepatocyte tissue. For that purpose, a two-photon imaging protocol was developed to (a)
measure the efficiency of Ad gene delivery by quantifying the percentage of hepatocytes
expressing EGFP, (b) determine the effect of Ad delivery to cell viability by quantifying the
percentage of dead hepatocytes and (c) determine the distribution of Ad-infected cells
throughout the depth of the tissue inside the silicon scaffold channels. To detect and quantify
the total number of cells (EGFP and non-EGFP expressing) as well as the number of dead cells
with two-photon microscopy, the microreactor cultures were incubated with two nucleic acid
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Figure 3.0.3 (a) Two-p hoton imaging of a single channel in a hepatocyte microreactor at different
times (21, 64 and 93h) after Ad infection (4x10 6 pfu/ml for 24h). Three sequential xy planes (at
40, 50 and 60pm depth from the silicon scaffold surface) are shown for each time point. Only part
of a channel cross section can be seen in each panel. The yellow lines outline the channel
boundaries. The bright colored areas correspond to EGFP-expressing cells. (b) Time course of
total EGFP expression in the above-mentioned microreactor (2 controls included). The green
circles mark the time points when two-photon imaging was also performed.
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stains: Ethidium Homodimer 1, which stains the nuclei of dead cells fluorescent red and
Hoechst 33342, which stains the nuclei of living cells fluorescent blue.
Experimental procedures
These experiments were carried out with the polycarbonate chamber version of the
microreactor system. Microreactor cultures were infected with AdEGFP (vector described in
section 3.2) for 24h at concentrations ranging from 4x105 to 4x106pfu/ml. (Note: these values
are based on the infectious titer of the original Ad preparation as measured by the vector
supplier.)
Nuclear counterstaining: The microreactor cultures were stained with ethidium homodimer 1
and Hoechst approximately 70h after the beginning of the Ad infection, in preparation for
imaging with two-photon fluorescence scanning microscopy. Initially, the medium in the
reservoir was replaced with fresh HGM containing ethidium homodimer-1 at a concentration of
6pM; the solution was left to flow through the system for 30 minutes. The medium was then
replaced with HGM containing Hoechst 33342 at a concentration of 15gg/ml which ran through
the microreactor system for 60 minutes. Longer times are required for counterstaining of the
microreactor cultures in comparison to the monolayer cultures to ensure efficient penetration of
the dyes through the three-dimensional tissue structures located inside the microreactor
channels.
Two-photon imaging: The samples were imaged with the two-photon laser scanning
fluorescence microscope system at the Center for Biological Imaging of the University of
Pittsburgh. Images were obtained using a mode-locked titanium-sapphire ultrafast tunable laser
system (Coherent Mira Model 900-F; Coherent, Inc., Santa Clara, CA). The power of incident
light was typically -450mW outside the laser cavity and was regulated with a custom-built input
power attenuator (neutral density attenuator filter) before entering the Olympus IX70 inverted
microscope optics (Olympus America, Inc.). An excitation wavelength of 820nm was selected to
adequately detect all fluorophores of interest, Hoechst, EGFP and Ethidium Homodimer 1. The
system also comprised Olympus Fluoview confocal scanning electronics and external
photomultiplier detection systems. Scanning speed was set at 16 s per frame. xy image planes
were acquired at 2 pm z-axis intervals. A piezoelectronic driver was used to precisely control the
distance between the objective lens and the sample for depth profiling. Images were taken
using a 20X Olympus LMPlan IR objective lens (Olympus America, Inc.) with a numerical
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aperture of 0.4. Each microreactor channel was scanned twice; the first time for EGFP and
Ethidium Homodimer detection with a dichroic filter set (Chroma Technology Corp.) comprising
a HQ535/50m filter (green emission), a 565dclp dichroic mirror and a HQ610/75m filter (red
emission); the second time for Hoechst detection with a dichroic filter set using a bandpass filter
centered at 450 ± 25 nm (blue emission).
Environmental Control System (ECS): When cell cultures are removed from the controlled
environment of the incubator they are inevitably exposed to non optimal conditions. The
temperature decreases and the pH increases to non physiological levels within 10min; exposure
to these conditions for prolonged periods of time can be detrimental to the culture. During the
two-photon microscopy experiments at least three channels were imaged in each microreactor.
Each channel was scanned twice and the thickness of the imaged tissue was typically 100 m.
Given the scanning speed (16s per frame) and the distance between consecutive frames (2pm),
the duration of imaging for each microreactor was at least 90min.
In order to maintain the culture conditions at physiological levels (T-370C, pH-7.4)
during imaging, the microreactors were connected to a portable environmental control system
(ECS, shown in Figure 3.8.4a). The ECS was built by Dr. Karel Domansky and is designed to
maintain the temperature and pH of the microreactor culture by controlling the temperature and
pH of the medium flowing into the chamber (Domansky et al., 2004). A portion of the tubing
connected to the upper inlet of the chamber is enclosed in a cartridge equipped with heating
panels. A temperature sensor measures the temperature of the medium exiting the microreactor
chamber, Toutlet. These measurements are transmitted to a controller/heater device and
compared to a setpoint value (Tsetpoint). Tsetpoint is the value of the temperature of the medium
exiting the chamber when the temperature inside the chamber (T) is at 370C. The difference
between Tsetpoint and Toutlet is used to control the rate of heat transfer to the medium flowing
through the cartridge. The pH was controlled by continuous flow of a mixture of air and 8.5%
CO02 through the cartridge. (Note: only the portion of the tubing enclosed in the cartridge is gas
permeable.) Calibration experiments were performed to determine Tsetpoint using a microreactor
chamber equipped with a temperature sensor. The change in temperature T inside the chamber
as a function of time after the microreactor was removed from the incubator and connected to
the ECS is shown in Figure 3.8.4b. The change in medium pH with time was also measured
with an inline pH probe connected at the chamber outlet and is shown in Figure 3.8.4c. The
temperature and pH stabilized at 370C and 7.55 respectively after approximately 15-20min. The
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cartridge and the microreactor chamber were attached on a Plexiglas sheet and mounted on a
stainless steel platform designed to fit the microscope stage.
Two-photon image processing and analysis with the MetaMorph software
The raw data of each two-photon scan consisted of a stack of xy-planes (z-stack). Each
plane (image) was processed as follows: The three wavelength components (Hoechst, EGFP
and Ethidium Homodimer) were initially separated and subjected to a low pass filter to smooth
out noise and other areas containing high spatial frequency data. The green component was
subtracted from the red component to eliminate the effect of EGFP bleed-through to the
Ethidium Homodimer channel. The three processed components (blue, green and red-green z-
stacks) were combined to create an overlay z-stack. As mentioned earlier, each microreactor
channel was scanned twice; the EGFP and Ethidium Homodimer components were acquired
with the first scan and Hoechst with the second. Whenever the images of the 2 scans were
slightly displaced the color alignment feature of the software was applied.
The 3D reconstruction module of the MetaMorph software was used to create a 3D
model from each processed z-stack. The 3D model consists of a series of angled top views of
the microreactor channel which, when viewed in quick succession, enhance the visualization of
the details of the 3D tissue architecture. The view at a 00 angle is equivalent to the projection of
all the xy-planes of the z-stack on a single plane.
Figure 3.8.5 shows two-photon imaging data from microreactor cultures infected with
AdEGFP at a concentration of 4x1 06pfu/ml for 24h. The cultures were stained with Hoechst and
Ethidium Homodimer and imaged -70h after the beginning of the Ad infection. The data were
processed as described above. Three-color overlay images from three microreactor channels
are presented. The first four rows of panels consist of four xy-planes (at 10Opm distance from
each other) selected from each channel. In the last row, each panel shows the projection, on a
single plane, of all xy-planes of the respective channel (00 angle view of the 3D reconstructed
model). The white squares outline the channel boundaries. The blue- and red-stained nuclei
correspond to live and dead cells respectively and the green fluorescent areas to EGFP-
expressing cells.
Quantification of gene delivery efficiency and cell viability: To quantify the percentage of
EGFP-expressing cells (gene delivery efficiency) and live cells (cell viability) in each imaged
channel (z-stack), the total number of live cells was determined by counting the Hoechst-stained
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Figure 3.8.4 (a) Environmental Control System (ECS) (photograph by Dr. Karel
Domansky). (b) Plot of the temperature T inside the microreactor chamber as a function
of time after the microreactor was removed from the incubator and connected to the
ECS. (c) Plot of the medium pH at the microreactor chamber outlet as a function of time
after the microreactor was removed from the incubator and connected to the ECS.
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Figure 3.8.5 Two-photon imaging of hepatocyte tissue in microreactor cultures infected with
AdEGFP and stained with Hoechst and Ethidium Hornodimer 1. Microreactor cultures were
infected with AdEGFP at a concentration of 4x 100pfulml for 24h. The cultures were stained
with 15pg/ml Hoechst (blue) and 6pM Ethidium Homodimer (red) and imaged with 2-photon
laser scanning fluorescence microscopy -70h after the beginning of the Ad infection. This
figure shows processed data from three microreactor channels. The white squares outline the
channel boundaries. The blue- and red-stained nuclei correspond to live and dead cells
respectively and the green fluorescent areas to EGFP-expressing cells. The first four rows of
panels consist of consecutive xy-planes (10 pm apart) in each channel. In the last row, each
panel shows the projection, on a single plane, of all xy-planes that are part of the z-stack of the
respective channel.
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nuclei, the number of dead cells by counting the Ethidium Homodimer-stained nuclei and the Ad
infected cells by counting the number of green fluorescent cells. Cell counting was performed
manually with the help of the 'object counting' function provided in the MetaMorph software. To
facilitate this procedure single-plane projections of the z-stacks were used. To avoid
underestimating the cell count due to overlap, each z-stack was divided to sub-stacks; the xy-
planes of each sub-stack were projected to a single plane and the counts of all sub-stacks were
combined in the end.
The data in Figure 3.8.6 were obtained from the same experiment as those in Figure
3.8.5. Separate single-plane projections of the blue, green and red z-stacks as well as of their
overlays are shown for three microreactor channels. The separated color images were used to
facilitate counting of the live, dead and EGFP-expressing cells. Quantitative results are
presented in Chapter 5.
Spatial distribution of EGFP-expressing and dead cells inside microreactor channels: To
determine whether there was variation in the distribution of EGFP-expressing cells and dead
cells as a function of the depth z inside the microreactor channels, each z-stack (corresponding
to a 100pm tissue sample) was divided into two sub-stacks (A: 0-50pm and B: 50-100pm). The
percentage of EGFP-expressing cells as well as that of dead cells was quantified separately for
each sub-stack. Average values from several microreactor channels were determined for A and
B and were compared. The results are presented in Chapter 5.
Figure 3.8.6 (on the following page). Two-photon imaging in microreactor cultures for
quantification of gene delivery efficiency. Microreactor cultures were infected with AdEGFP at a
concentration of 4x106pfu/ml for 24h. The cultures were stained with 15p~g/ml Hoechst and 6pM
Ethidium Homodimer and imaged with 2-photon laser scanning fluorescence microscopy -70h after
the beginning of the Ad infection. This figure shows processed data from three microreactor
channels. The z-stacks for the blue, green and red components of each channel and their overlay
were projected on single planes to produce the reconstructed top views of the imaged channels
presented here. The grey squares outline the channel boundaries. The blue- and red-stained nuclei
correspond to live and dead cells respectively and the green fluorescent areas to EGFP-expressing
cells.
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CHAPTER 4
Quantitative Analysis of Ad Gene Delivery in
Hepatocyte Monolayer Cultures
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4.1 Introduction
This chapter presents the quantitative analysis of adenoviral vector gene delivery to
hepatocyte monolayer cultures. It is divided into two parts. The first part addresses the
extracellular mass transfer and cellular uptake of the AdEGFP vector. A mathematical model is
developed to describe these processes and the Ad uptake rate constant ku is determined by
fitting to experimental results using the model.
The second part examines the events following the Ad internalization, namely the
transgene (EGFP) expression (DNA transcription and mRNA translation). Protein expression is
detected with fluorescence microscopy and the gene delivery efficiency is quantified in terms of
the percentage of Ad-infected cells. The mRNA levels of the transgene are measured with
quantitative real-time RT-PCR.
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4.2 Extracellular Mass Transfer and Cellular Uptake of AdEGFP Vector
4.2.1 Mathematical Model description
In vitro Ad gene delivery experiments are typically performed by overlaying the vector-
containing medium on top of a cell monolayer adhering to the surface of a tissue culture plate.
The Ad particles immediately above the cells are taken out of the medium by adsorption to the
cell surface and internalization, creating a concentration gradient in the vertical (x) direction.
Additionally, the gravitational force acting on the viral particles causes them to sediment.
Therefore, the Ad particles suspended in the medium are subject to three processes: diffusion,
sedimentation and uptake by the cells (Figure 4.1a). The application of the conservation
equation for Ad particles in the medium (control volume) and at the interfaces where x=O and
x=L (Figure 4.1b) leads to the derivation of the following governing equation and boundary
conditions that describe Ad mass transfer in this system (detailed derivation in Appendix 4.1):
ac aC a2C
= u, + D (1)at ax ax
ac
u,C + D = kuC at x = 0 (2)
ax
ac
u,C + D = 0 at x = L (3)
ax
Additionally, the initial Ad concentration in the cell culture medium is uniform, therefore the initial
condition is:
C = CO  at t = 0 (4)
C is the concentration of infectious adenovirus in the medium (Ad particles/cm3), t is time (s), us
is the sedimentation velocity (cm/s), D is the diffusion coefficient of Ad in the medium (cm2/s), ku
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(a) Schematic of Ad gene delivery in tissue culture well,
(b) governing equation and boundary conditions for Ad mass transfer
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Figure 4.2: Revised governing equation and boundary conditions for Ad mass transfer
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is the Ad uptake rate constant (cm/s) and L is the depth of the liquid film above the cell
monolayer (cm). Co is the initial Ad concentration. A list of the mathematical model parameters
including their values is presented in Table 4.1. Table 4.2 contains a list of the variables.
The cell monolayer is considered uniform and any edge effects at the walls of the tissue
culture plate are assumed negligible, therefore the problem is one-dimensional.
The first term on the right hand side of Equation 1 describes the process of
sedimentation, which is included in the conservation equation as a convective flux. The
sedimentation velocity, us, represents the velocity of an Ad particle when the gravitational force
is balanced by the forces due to buoyancy and drag, and can be expressed as:
u, = s -g = 7.4x 10-8cm /s
where s is the Ad sedimentation coefficient and g the gravitational acceleration. In the
experiments described in this chapter s can be assumed constant and independent of
concentration given that the Ad solution is very dilute (volume fraction of Ad particles in medium
< 3.5x10-8 ).
The second term on the right hand side of Equation 1 describes the process of diffusion.
The Ad particles are assumed to be spherical with a diameter of 100nm (March et al, 1995) and
therefore their diffusion coefficient in cell culture medium can be evaluated with the Stokes-
Einstein equation (Deen 1998):
D = T =6.5 x 10-8cm 2 / S
where K is Boltzmann's constant, T is the medium temperature, p is the medium viscosity and r
is the Ad radius.
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Table 4.1: Parameters in mathematical model for Ad mass transfer in monolayer hepatocyte
cultures.
Parameter Symbol Value Reference
gravitational 981 cm/s 2
acceleration
Ad sedimentation Nyberg-Hoffman et al.,
s 750 S*coefficient Nature Medicine 3 (7), 1997
sedimentation
velocity Us 7.4 x 10-8 cm/s Us = s gvelocity
Boltzmann's -16  -2  -1
c 1.38 x 1016 cm2 g S2 K 1constant
culture medium T 310K -temperature
culture medium assumed equal to the viscosity
viscosity 0.007 g.cm s1  of water at 370C
Ad particle radius r 50 nm see section 1.5
Ad diffusionAd diffusion calculated with Stokes-coefficient in cell D 6.5 x 10.8 cm2/s Einstein equation (Deen 1998)Einstein equation (Deen 1998)culture medium
calculated from surface aread epth of cell cultur L 0.2 cm (3.8cm2) and medium volume
(0.75cm3) per culture well
determined by measuring the
surface area per cell A 1.7 x 10-5 cm2  average cellular area on
in monolayer culture phase-contrast microscope
images of hepatocyte cultures
Ad uptake rate determined by fitting
constant ku cm/s experimental data to
mathematical model
initial Ad determined by fitting
concentration in Co Ad particles/mi experimental data to
medium** mathematical model
* 1S (Svedberg) = 10-13s
** refers to infectious Ad particles
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Table 4.2: Variables in mathematical model for Ad mass transfer
cultures.
in monolayer hepatocyte
Variable Symbol
Ad concentration in medium (particles/ml)* C
time after start of Ad infection (s) t
distance from cell monolayer surface (cm) x
number of Ad particles taken up by cell monolayer NAd
Number of cells per culture plate well n
* refers to infectious Ad particles
Equation 2 states that the Ad flux at the cell monolayer surface (x=0) should be equal to
the Ad uptake rate by the cells. The uptake rate is assumed to follow first order kinetics and ku is
the rate constant. Equation 3 is a no flux boundary condition at the surface of the medium (x=L).
The mean displacement of an Ad particle by diffusion for time t can be calculated with
the following equation (Einstein, 1956):
X(t)= 2Dt
Given that the maximal time period for Ad exposure in the experiments described in this thesis
is 24 hours, the maximum mean displacement will be:
S= 0.1cm
which is half the depth L of the Ad containing medium (0.2 cm). Therefore it can be reasonably
assumed that the Ad concentration at x=L will not change significantly during the infection
process and the second boundary condition (Equation 3) can be replaced with:
C = Co at x = oo (3a)
(semi-infinite domain, Figure 4.2). This change allows for an analytical closed form solution of
the mathematical model to be obtained using the method of the Laplace transform.
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The total number of Ad particles taken up by the cells in a tissue culture plate well during
the time of exposure to Ad, NAd, can be derived as the integral with time of the Ad flux at the x=O
boundary:
T T
NAd = JnA(flux)x=odt = nAJkCx=0dt (5)
0 0
where n is the number of cells per well, A is the cellular area and z is the duration of the Ad
infection. (Note: the flux at x=O is equal to the Ad uptake rate as shown in Equation 2)
The derivation of the analytical solution for the system of equations 1, 2, 3a and 4 is
described in detail in Appendix 4.2. The total number of Ad particles taken up into the cells per
well at a given time is given by the following equation:
NAd = nACO0 { t+ Dtexp
D 2ku -u
2 kuku 
- Us)
I 2k -ust erfc "2 s[- 1 (6)
If the contribution of sedimentation is assumed negligible compared to that of diffusion (us = 0),
the above equation is reduced to:
NAd = nAC 0 2 + - exp k erfc ku  - 1 (7)
Equation 7 can also be derived from the analytical solution of the system of equations (1), (2),
(3a) and (4) without the sedimentation terms (Appendix 4.3).
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In order to roughly determine the relative significance of Ad sedimentation compared to
diffusion, a "Peclet" number can be calculated:
Pe = UsX(t)
D
where X(t)= is the mean displacement by diffusion for time t. The values for the Pe number
range from 0.03 (t=2h) to 0.1 (t=24h) Indicating that for short durations of Ad infection the rate of
diffusion is much faster than the rate of sedimentation.
Figure 4.3a shows the predictions of the 2 mathematical models (equation 6 - diffusion/
sedimentation and equation 7 - diffusion) for the uptake of Ad particles by the cell monolayer.
NAd, normalized to the monolayer surface area (nA) and the initial Ad concentration in the cell
culture medium (Co), is plotted as a function of the duration of Ad infection (t) for varying values
of the uptake rate constant ku ranging from 5x10-8 to 5x10 s- cm/s. As expected, the number of
Ad particles taken up by the cell monolayer increases with increasing ku values and increasing
time of exposure to the Ad vector. Another observation is that the contribution of the
sedimentation term to the mathematical model predictions appears insignificant as expected
from the estimations of the Pe number; therefore it will not be included in the analysis that
follows. For values of ku even further below 5x10 8 cm/s the NAd curve tends to overlap with the
one for ku=0. As the uptake rate constant increases above the value of 5x10-5 cm/s the curves
tend to overlap. At that point the uptake rate is very fast relative to diffusion and the Ad vector
transfer process is entirely controlled by diffusion. Under these conditions equation 2 can be
replaced with the fast-reaction boundary condition, C=0 at x=0 and therefore the uptake rate
constant does not enter the mathematical model. The solution of the model in that case is as
follows (Appendix 4.4):
NAd = 2nAC0(- (8)
Figure 4.3b shows a plot similar to the one in Figure 4.3a for Ad uptake predictions with the
diffusion model for varying ku values (Equation 7) as well as for the fast-reaction boundary
condition (Equation 8).
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The Ad concentration profile in the medium (diffusion model) is given by the following
equation:
C(x, t) = CO erf + exp (x + kut) erfc + ku  (9)
Figure 4.4 shows the predicted Ad vector concentration profiles in cell culture medium for
different ku values. At 2 hours after the beginning of Ad infection a distinct concentration
gradient has already formed for uptake rate constant values higher than 5x10-8 cm/s and
becomes more pronounced as the ku value increases. This indicates that under these conditions
the uptake process is faster than diffusion, which is consistent with the fact that viral infection in
standard culture systems is generally diffusion limited. The concentration at the top of the
medium (x=L=0.2 cm) is not affected significantly by the cellular uptake throughout a 24hr
exposure to Ad.
4.2.2 Experimental Approach to Evaluate the Uptake Rate Constant ku.
The mathematical model describes the Ad vector mass transfer and uptake processes in
a standard 2D hepatocyte culture system was developed for the purpose of determining a
characteristic parameter that quantifies the efficiency of Ad gene delivery. That parameter is the
uptake rate constant, ku, and it represents the ability of the target cells to bind and internalize
the Ad vector. An equivalent parameter will be estimated in Chapter 5 for the case of the 3D
tissue-engineered liver microreactor system. The ultimate goal of this comparative analysis will
be to illustrate in a quantitative way the effect of a more organotypic in vitro hepatocyte culture
on the efficiency of Ad gene delivery.
The experimental approach that was designed in order to determine the unknown rate
constant ku, consisted of measurements of the number of Ad particles (NAd) taken up by
hepatocyte monolayer cultures exposed to varying initial Ad concentrations (Co) for varying
amounts of time (t). Then the unknown parameter was evaluated by curve-fitting the
experimental results with the analytical solution derived from the mathematical model (equation
7).
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The experimental procedures were described in detail in Chapter 3 (Materials and
Methods). Briefly, monolayer cultures of primary rat hepatocytes were established on collagen-
coated 12-well plates at a density of 3x105 cells per well and incubated in HGM for 24 hours.
Then (t = 0) the medium in each well was replaced with 750pl HGM containing Ad5-CMV-EGFP
at three different concentrations: 4x105, 2x106 and 4x106 infectious particles (i.p.) /ml. These Ad
concentrations are based on the infectious titer of the original Ad preparation as measured by
the vector supplier and correspond to MOI values of 1, 5 and 10 respectively. At specified time
points (t = 2, 4, 8, 12 and 24h), the Ad infection was terminated. The hepatocytes were then
either harvested immediately for DNA extraction (data set 1) or cultured in HGM until t=48hr
when they were harvested for DNA extraction (data set 2). Triplicate wells were prepared for
each initial Ad concentration, time point condition and data set. DNA was extracted from each
sample and quantified with the RediPlate 96 PicoGreen Microplate Assay. The number of Ad
particles internalized by the cell monolayer in each sample, NAd, was determined by quantifying
the number of Ad genomic copies with quantitative real-time TaqMan PCR. The PCR results
were normalized to the DNA content for each sample.
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Figure 4.3. Mathematical model predictions for the uptake of Ad particles by the cell
monolayer, N. (normalized to the cell monolayer surface area, nA, and the initial Ad
concentration in the cell culture medium, C0) as a function of the duration of Ad infection
for varying values of the uptake rate constant kI. (a) Effect of sedimentation on Ad
uptake. The black curves correspond to the diffusion/sedimentation model. The red
curves correspond to the diffusion model. (b) Diffusion model with fast-reaction
boundary condition (black curve) and with flux=(uptake rate) boundary condition for
varying rate constant values.
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Figure 4.4. Adenoviral vector concentration profiles in cell culture medium after 2, 12
and 24 hours of hepatocyte monolayer exposure to Ad, as predicted by the diffusion-
uptake mathematical model (equation 8) for varying uptake rate constant (K) values.
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4.2.3 Experimental Results and Analysis
Adenoviral vector uptake in monolayer hepatocyte cultures
Incubation of the hepatocyte cultures with Ad5-CMV-EGFP led to the internalization of
the vector and the transfer of the viral genome into the cell nucleus and subsequently the
expression of EGFP. Figure 4.5 shows results from two experiments (different rat perfusions).
The normalized Ad uptake (NAd/n) is plotted as a function of the time the cell monolayers were
exposed to the Ad vector and for three different initial Ad concentrations spanning one order of
magnitude, Co, Co/2, C/10. Co is equal to 4x10 6 i.p./ml (or pfu/ml) according to the infectious
titer as measured by the vector supplier. The closed symbols correspond to data set 1 (DNA
harvested immediately after termination of Ad infection). The open symbols correspond to data
set 2 (DNA harvested at t = 48 hr). All data points represent the mean values of two
experiments performed in triplicate and the error bars represent the standard deviation.
As expected, the average number of Ad particles taken up by the cells increased with
increasing time of exposure and increasing concentration of Ad in the medium, and appeared to
approach a plateau at longer times. From the comparison of the two data sets we concluded
that the number of intracellular Ad genome copies did not change significantly between the
termination of infection and t = 48 hr when transgene (EGFP) expression reached maximum
levels. Consequently, there was no significant degradation of the internalized vector genome
over this time. This information was important to have for the experimental analysis in the
microreactor cultures (Chapter 5), where the cells were harvested at the time of maximum
EGFP expression for DNA and RNA extraction, as well as for the analysis of EGFP expression
data and their normalization to the Ad vector uptake results.
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Figure 4.5. Experimental results for adenoviral vector uptake in monolayer hepatocyte
cultures. Primary rat hepatocytes were seeded on collagen-coated 12-well plates at a
density of 3x105 cells per well, cultured for 24hr in HGM, then incubated with Ad5-CMV-
EGFP at three concentrations (Co, Co/2 and C/1 0) for varying amounts of time (ranging
from 2hr to 24hr). Two sets of triplicate samples were prepared for each condition. In
the first set, the cells were harvested immediately after the end of Ad infection. In the
second set the cells were cultured in HGM until t = 48hr and subsequently harvested.
DNA was extracted from all samples. Total DNA content was measured with the
Rediplate 96 PicoGreen DNA Quantification Kit. The number of Ad genome copies was
quantified with real-time TaqMan PCR. This graph shows the number of Ad copies
normalized to cell number and plotted against time of infection. All data points represent
the mean values of two experiments (different rat liver perfusions) performed in
triplicate + the standard deviation of the mean. Closed symbols correspond to samples
where cells were harvested immediately after termination of Ad infection. Open symbols
correspond to samples where the cells were harvested at t=48hr.
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Initial Ad concentration, Co: real infectious Ad titer vs. plaaue assay measurements
Another important observation arising from the results in Figure 4.5 was that the Ad
uptake per cell greatly exceeded the maximum expected values (MOI). For example, according
to the infectious titer of the Ad preparation measured by the vector supplier, Co = 4x106 i.p./ml.
The total medium volume per well was 750Ll, therefore the total number of infectious Ad
particles per well was equal to 3x106; given that there were 3x105 cells per well, the maximum
expected number of internalized Ad particles per cell (NAdn) was 10 (MOI=10). However, after
24 hours of exposure to Ad of initial concentration equal to Co, NAdn was almost an order of
magnitude higher (Figure 4.5).
This discrepancy is the result of the methods used to determine the infectious titer of Ad
preparations. Whereas the internalized Ad particles were measured in this thesis with
quantitative real-time PCR, a very sensitive and accurate method, the Ad infectious titer was
quantified with the plaque-forming assay. As described in Section 3.2, this method measures
the number of plaques formed after the infection of 293 cells with dilutions of the Ad preparation.
Although it is the predominant technique used in Ad production laboratories, the plaque assay
can significantly underestimate the actual infectious particle concentration, depending on the
conditions under which it is performed, such as the total volume of the Ad-containing medium
above the 293 cell monolayers as well as the duration of the infection. As shown in the
mathematical model developed in this chapter, the process of Ad delivery is diffusion limited. If
the plaque-assay experiments do not allow sufficient time for the Ad vectors to diffuse through
the liquid film and reach the monolayer surface, then the concentration of infectious viral
particles will inevitably be underestimated. The inability of this assay to accurately measure
infectious titers has been documented in literature and alternative approaches have been
proposed (Mittereder et al., 1996, Nyberg-Hoffman et al., 1997; Shabram and Aguilar-Cordova,
2000); however it still remains the prevalent method for this type of measurements.
According to the plaque assay protocol that was followed by our vector suppliers, the
293 cells were cultured in 6-well plates (surface area per well = 9.5 cm2). The volume of the Ad-
containing medium solution was 1 ml per well; therefore the depth of the liquid film above the
cells was equal to 0.105 cm. Since the duration of the infection was 3 to 4 hours, the mean
displacement of an Ad particle by diffusion would be:
. = 2 = 0.037 to 0.043 cm
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which is much smaller than the depth of the liquid film. This means that the Ad vectors at a
distance greater than 0.037 or 0.043 cm (i.e. the majority of the vectors) did not have sufficient
tiime to reach the cell monolayer and interact with it.
Estimation of parameters k, and Co with nonlinear least squares curve fitting.
It is obvious from Equation 7 that an accurate knowledge of the initial Ad concentration
Co is essential in order to reliably determine the value of the uptake rate constant with nonlinear
least squares curve fitting. Since this was not the case in our experiments as explained in the
previous section, Co was also considered as an unknown parameter in the analysis of the
experimental data. Both ku and Co were fitted to the data with equation 7. For that purpose the
optimization toolbox of the software package MatLab was applied and specifically the function
Isqcurvefit, which solves nonlinear curve-fitting (data-fitting) problems in the least squares
sense. The medium-scale Levenberg-Marquardt algorithm was chosen with a termination
tolerance on the vector x = [Co, ku] set to TolX = 10-9 and the default settings for all other
optimization parameters. Data set 1 was used (NAgn versus t). Since NAdn is linearly
proportional to the initial concentration Co (Equation 7), the data for initial concentrations Co/2
and Co/10 were multiplied by a factor of 2 and 10 respectively and the unknown parameters
were fitted to all the data together. The algorithm converged to the parameter values: Co =
6.4x10 7 i.pJml and ku = 9x10" cm/s with the value of the squared 2-norm of the residual
(resnorm) equal to 451. The computed values of Co and ku are also shown in Figure 4.6, where
data set 1 (symbols) and the mathematical model correlation (solid lines) were plotted.
According to these results, the initial Ad concentration was more than an order of
magnitude higher than the one calculated from the infectious titer measurements with the
plaque assay (4x10 6 i.p./ml). In fact, this value is much closer to the total Ad particle
concentration (6.8x107 p./ml) as calculated from the genomic titer of the Ad preparation. The
genomic titer is typically measured with optical absorbance at 260 nm (OD260) and one
absorbance unit is equivalent to approximately 1012 Ad vector particles; this is a widely accepted
method for quantifying total particle concentration. Therefore, according to our results the
majority of Ad particles in the vector preparation were infectious. Similar observations were
made when an alternative approach that circumvents the diffusion limitations of the plaque
assay was applied for titer measurements (Nyberg-Hoffman et al., 1997; Shabram and Aguilar-
Cordova, 2000).
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Figure 4.6. Mathematical model correlation to the experimental results for adenoviral
vector uptake in monolayer hepatocyte cultures. The diffusion/uptake model (Equation
7) was used to fit the initial Ad concentration in the cell culture medium, Co, and the Ad
uptake rate constant, ku, to the experimental data described in Figure 4.5. (Note: the
data corresponding to the samples where cells were harvested immediately after
termination of Ad infection were used). The graph shows the number of Ad copies
normalized to cell number and plotted against time of infection. All data points represent
the mean values of two experiments (different rat liver perfusions) performed in
triplicate ± the standard deviation of the mean. The solid lines represent the
mathematical model correlation performed with a nonlinear least squares method
implemented in MATLAB's Optimization Toolbox.
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A minimum boundary on the concentration Co can be estimated by fitting this parameter
to the data with the fast-reaction boundary condition mathematical model (Equation 8) for all
starting concentrations used experimentally. In this case, the experimental results for NAd/n
(data set 1) were plotted against the square root of time t (Figure 4.7); a straight line was fitted
to each of the three data series (Co, Co/2, Co/10) with linear least squares regression (Excel)
and Co was determined from the slopes. The average value was calculated as Co = 5.6 (± 0.3) x
107 i.p./ml. For this value the squared 2-norm of the residuals was calculated as resnorm = 572,
which is higher compared to the value obtained with the diffusion model correlation.
Consequently the diffusion model provides a better fit for the experimental data. Therefore the
initial Ad concentration Co is bound by this value and the genomic titer:
5.6x107 i.p./ml < Co < 6.8x107 i.p./ml
The lowest possible value for the uptake rate constant ku can be calculated by assuming
the initial concentration Co is equal to the maximum possible value i.e. the genomic titer and
fitting ku to the data . In that case ku=5.6 xl0-6cm/s and value of the squared 2-norm of the
residuals was calculated as resnorm = 410. Therefore:
k, > 5.6xlO cmIs
The values that were determined by fitting both parameters to the data are within these
boundaries.
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Figure 4.7. Fast-reaction boundary condition model correlation to the experimental
results for adenoviral vector uptake in monolayer hepatocyte cultures. Equation 8
(shown above) was used to fit the initial Ad concentration in the cell culture medium, Co,
to the experimental data described in Figure 4.5. (Note: the data corresponding to the
samples where cells were harvested immediately after termination of Ad infection were
used). The graph shows the number of Ad copies normalized to cell number and plotted
against the square root of time. All data points represent the mean values of two
experiments (different rat liver perfusions) performed in triplicate ± the standard
deviation of the mean. The solid lines represent the mathematical model correlation
performed with linear least squares regression in Excel. Co was estimated from the
slope for each data series (Co, Co/2, Co/1 0) and an average value was calculated.
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4.3 Transgene (EGFP) Expression
As previously described, there are many steps involved in the process of gene delivery.
In the first part of this chapter, the attention was focused on the extracellular transfer and the
cellular uptake of the Ad vector. Understanding the mechanisms that control these steps is an
essential part of gene therapy research. However, the efficiency of gene delivery is ultimately
determined by the end result, the successful production of the desired protein. In the second
part of this chapter, the focus moves on to the detection and quantification of EGFP expression
on monolayer hepatocyte cultures infected with the AdEGFP vector. Two different types of
measurements are presented. The first involves the detection of EGFP protein with
fluorescence microscopy and the quantification of gene delivery efficiency in terms of the
percentage of EGFP-expressing cells; the second involves the application of Real-Time RT-
PCR to measure the mRNA levels of EGFP. The EGFP expression measurements were made
48 hours after the Ad infection, when the EGFP expression reaches maximum levels in the
hepatocyte monolayer cultures.
4.3.1 Quantification of AdEGFP Gene Delivery Efficiency and Cell Viability with
Fluorescence Microscopy.
The experimental procedures for the hepatocyte monolayer culture and the Ad infection
were presented in section 4.1.2 and were described in detail in Chapter 3 (Materials and
Methods). Triplicate wells were prepared for each initial Ad concentration (Co, Co/2 and Co/10,
where Co = 6.4x10 7 i.p./ml as determined in section 4.1.3) and time point condition (t = 2, 4, 12
and 24 hours). After the Ad infection, the hepatocytes were cultured in HGM until t=48hr when
they were counterstained with Ethidium Homodimer-1 and Hoechst 33342 for fluorescence
imaging. 5-6 different regions were chosen for imaging in each triplicate well group. For each
region separate images were acquired with a FITC filter for EGFP (green), a DAPI filter for
Hoechst (blue) and a Rhodamine filter for Ethidium Homodimer (red). The three images were
combined in a three-color overlay. (More details about the staining and imaging procedures are
presented in Chapter 3.)
Figure 4.8 shows six fluorescence micrographs of hepatocyte monolayers infected with
the Ad vector. Each panel is an overlay of the green, blue and red images of a specific region
134
24hr 4hr
Co
Col2
Coll0
Figure 4.8. Fluorescence micrographs of hepatocyte monolayers infected with Ad5-CMV-
EGFP. The cells were stained with Hoechst 33342 and Ethidium Homodimer 1 and
imaged at t=48hr with a 10X dry objective lens. Panels A, B and C correspond to a 24hr
Ad infection at concentrations of Co, Co/2 and CO/10 respectively. Panels D, E and F
correspond to a 4hr Ad infection at concentrations of Co, Co/2 and Co/10 respectively.
Each panel shows an overlay of the green, blue and red images captured. (Co = 6.4 x 107
i.p/ml)
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on a cell culture well. The images were captured with a 10X dry objective lens. Panels A, B and
C correspond to a 24 hr infection at concentrations of Co, Co/2 and Cd/10 respectively. Panels
D, E and F correspond to a 4 hr infection at concentrations of Co, Co/2 and C/1 0 respectively.
The observation of these images leads to the following conclusions: as the initial concentration
of Ad in the medium decreases, the percentage of hepatocytes that express EGFP and the
levels of EGFP expression in these cells decrease as well; secondly, as the duration of the Ad
infection decreases so does EGFP expression. These qualitative observations are in agreement
with the results for the cellular uptake of the Ad vector presented in the first part of this chapter.
Quantitative information for the Ad gene delivery efficiency was obtained from the
fluorescence micrographs in terms of the percentage of the hepatocytes expressing EGFP. For
that purpose, the number of live cells on each imaged region was determined by counting
manually the number of blue nuclei (Hoechst), the number of dead cells was determined by
counting the number of red nuclei (Ethidium Homodimer) and the number of EGFP-expressing
cells was determined by counting the number of green fluorescent cells. Then the gene delivery
efficiency was calculated as follows:
# of EGFP' cellsgene delivery efficiency = 100%# of live cells
In Figure 4.9A, gene delivery efficiency (% EGFP-expressing cells) is plotted as a
function of the time the hepatocyte monolayers were exposed to the Ad vector and for three
different initial Ad concentrations. Each data point represents the mean value of 5-6 imaged
regions + the standard deviation of the mean. The number of hepatocytes with detectable levels
of EGFP expression (under the conditions of image acquisition applied in this experiment)
increased with time of infection and Ad concentration. At the highest Ad concentration (Co) the
percentage of cells with detectable levels of EGFP approached 100%, even for relatively short
duration of infection such as 4 hours. However, it must be emphasized that there was a
significant difference in the fluorescence intensity (i.e. levels of EGFP) between the time points
of 24 and 4 hours, as demonstrated in Panels A and D of Figure 4.8, a difference which could
reflect the different number of Ad vectors internalized by the cell monolayer (see Figure 4.6).
Additionally, the percentage of dead cells on the monolayer cultures was calculated as a
measure of the toxicity of the Ad infection and is presented in Figure 4.9B. The viability fell to
80% in the case of the highest Ad concentration and longer times of infection. However, it must
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Figure 4.9. Quantification of Ad gene delivery efficiency and cell viability in monolayer
hepatocyte cultures with fluorescence imaging. The cells were incubated with Ad5-
CMV-EGFP at three concentrations (Co, Co/2 and Co/10) for varying amounts of time
(ranging from t=2hr to 24hr). Triplicate samples were prepared for each condition. After
the end of Ad infection the cells were cultured in HGM until t = 48hr and subsequently
counterstained with Hoechst 33342 and Ethidium Homodimer-1 for fluorescence
imaging. Images were acquired from 5-6 different regions in each triplicate group. The
number of live cells was determined by the count of Hoechst-stained nuclei, the number
of dead cells by the count of Ethidium-stained nuclei and the number of EGFP-
expressing cells by the count of green fluorescent cells. Graph A shows the % EGFP-
expressing cells plotted against time of infection. Graph B shows the % dead cells on
the hepatocyte monolayers plotted against time of infection. All data points represent
the mean values of the imaged regions + the standard deviation of the mean. (Co = 6.4
x 107 I.p./ml)
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be noted that these numbers do not take into account the number of cells that might have died
and detached from the monolayers before the time of the fluorescence imaging.
4.3.2 Quantification of EGFP mRNA Levels with Real-Time TaqMan RT-PCR.
The same procedures for Ad infection in monolayer cultures as described earlier were
followed in these experiments as well. Triplicate wells were prepared for each initial Ad
concentration (Co, Co/2 and Co/10, where Co = 6.4x10 7 i.p./ml as determined in section 4.1.3)
and time point condition (t = 2, 4, 8, 12 and 24 hours). After the Ad infection, the hepatocytes
were cultured in HGM until t=48hr when they were harvested in Trizol reagent for RNA
extraction (data set 4). RNA was isolated and purified, and the total RNA content of each
sample was measured. The same amount of RNA (400 ng) was used for all reverse
transcription reactions. The quantity of cDNA sample amplified in each PCR reaction
corresponded to 1 ng input total RNA. For each sample the target gene (EGFP), as well as an
endogenous reference gene (18S rRNA) were amplified with quantitative real-time TaqMan
PCR. The results were analyzed with the Comparative CT Method, which calculates the EGFP
rnRNA levels normalized to 18S and relative to a calibrator. One of the three cultures infected
with Ad for 24 hr at concentration Co was selected as the calibrator sample. Additionally, the
data were analyzed with the Standard Curve method to determine the number of EGFP cDNA
copies present in each sample; in this case EGFP expression was normalized to the amount of
total RNA. All experimental procedures and data analysis methods are described in detail in
Chapter 3 (sections 3.5 and 3.6).
Control hepatocyte monolayer samples that were not infected with Ad showed no PCR
amplification as expected. The minus RT controls for Ad-infected samples (in which the reverse
transcriptase is omitted from the RT reaction) also tested negative; consequently there were no
DNA contaminants present in the RNA template samples.
Figure 4.10 shows the normalized EGFP mRNA levels relative to the calibrator (2 -AACT)
calculated with the Comparative CT Method. EGFP expression is plotted on a logarithmic scale
against the time the hepatocyte monolayers were exposed to the Ad vector, and for the three
different Ad concentrations. Each data point represents the mean value of three samples. The
error bars correspond to the standard deviation of the mean. The results indicate that there is
some variability among samples subjected to the same Ad infection conditions reflected in the
error bars on the plot. However, the real-time RT-PCR assay could clearly detect the effect of
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Figure 4.10. Quantification of EGFP mRNA levels after AdEGFP vector infection in
monolayer hepatocyte cultures with real-time RT-PCR. Primary rat hepatocytes were
seeded on collagen-coated 12-well plates at a density of 3x105 cells per well, cultured for
24hr in HGM, then incubated with Ad5-CMV-EGFP at three concentrations (Co, Co/2 and
Co/10, where Co=6.4x10 7 i.p./ml) for varying amounts of time t (ranging from 2hr to 24hr).
Triplicate samples were prepared for each condition. The cells were harvested at t = 48hr
for RNA extraction. Total RNA content was measured with the Rediplate 96 RiboGreen
RNA Quantification Kit. 400ng RNA were used for cDNA synthesis by reverse
transcription. EGFP mRNA and 18S rRNA (endogenous reference) were amplified with
real-time TaqMan PCR in separate reactions (1ng input total RNA per reaction). The PCR
data were analyzed with the Comparative CT Method. This graph shows the EGFP mRNA
levels normalized against the 18S levels and relative to a calibrator sample (2 -AcT)
plotted against time of infection. The calibrator sample was one of the 3 cultures infected
with Ad for 24hr at concentration Co. All data points represent the mean values of three
samples and the error bars correspond to the standard deviation of the mean.
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tlhe increasing Ad concentration on the levels of EGFP expression, which was observed
qualitatively with fluorescence imaging of the monolayer cultures (Figure 4.8). The increase in
mRNA levels with Ad concentration is also in agreement with the trend observed for the Ad
vector uptake measurements (Figure 4.6).
Similar results were obtained with the Standard Curve method (Figure 4.11). EGFP
expression normalized against total RNA (cDNA copies/ng RNA) is plotted here on a linear
scale versus the duration of Ad infection. Monolayer cultures infected with the highest Ad
concentration Co show a trend of increasing levels of EGFP expression with time of infection as
expected from the fluorescence microscopy and Ad vector uptake data. However, the data for
the Ad concentration of Co/2 show an unexpected decrease in mRNA levels at the 24hr time
point, a result that is probably due to an experimental error and is not supported by the
fluorescence and Ad uptake data. The mRNA expression at the lowest Ad concentration, Cl/10,
does not show any significant trend with infection time; however, at that level of expression the
cDNA copies before PCR amplification are in the order of 50, which is close to the sensitivity
limit of the assay.
The ratio of mRNA levels divided by the intracellular Ad levels can be calculated as a
measure of transgene expression efficiency relative to Ad uptake, a quantity that will be a basis
for comparison with the gene delivery results in the hepatocyte microreactor cultures. The data
presented in Figure 4.11 were converted to cDNA copies per cell with the conversion factor
determined in Section 3.5 and then divided with the data presented in Figure 4.5 (Ad genomic
copies per cell - data set 2 corresponding to DNA extraction at t=48h). The results are shown in
Figure 4.12. All data points represent the ratio of the mean values (ml/m 2). The error bars
represent the standard deviation of the quotient (s) calculated from the standard deviations (sl
and s2) and the mean values (ml and m2) of the two quantities with the following formula:
m2 1 (10)
Ideally, EGFP expression efficiency relative to intracellular Ad genomic levels should be
independent of the experimental conditions (duration of infection, initial Ad concentration), given
that the transgene expression is driven by a constitutive promoter (CMV). In other words, one
would expect the mRNA levels to increase with the number of intracellular transgene copies.
Figure 4.12 indicates that for the majority of experimental conditions, the EGFP expression
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Figure 4.11. EGFP mRNA levels normalized against total RNA. The data were obtained as
described in Figure 4.10 and were analyzed with the Standard Curve Method. The
standards were prepared from serial dilutions of Ad genomic DNA. The number of EGFP
cDNA copies present in each sample (corresponding to 1 ng input total RNA) were
determined from the standard curve with interpolation. This graph shows the normalized
EGFP expression levels plotted against time of infection. All data points represent the
mean values of three samples and the error bars correspond to the standard deviation of
the mean.
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Figure 4.12. EGFP expression efficiency relative to Ad vector uptake. The data presented in
Figure 4.11 were converted to cDNA copies per cell and were normalized against the Ad
vector uptake data (Ad genomic copies/cell) presented in Figure 4.5 (data set 2: DNA
extracted at t=48h). All data points represent the ratio of the mean values and the error bars
correspond to the standard deviation of the quotient.
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relative to Ad uptake levels lay within a narrow range of values with an average of 1.2x1010
mRNA copies per Ad genomic copy and a standard deviation of 5x10 9. Three data points
(corresponding to short infection times) display higher average values as well as large standard
deviations. This is due to the relatively high average expression levels measured for these data
points (in comparison to the Ad uptake levels) as well as the high degree of variability among
the triplicate samples. It seems unlikely that this deviation has any biological significance. It
could be argued that high levels of intracellular Ad copies (resulting from longer Ad exposure at
high concentrations) might be toxic to the hepatocyte cultures or trigger gene silencing
mechanisms, leading to lower levels of mRNA transcription. However, if that was the case then
other data points should also have higher expression levels (e.g. 24h infection at Cd/10 and 8h
infection at Co/2). Additionally, the fluorescence microscopy data does not support that
hypothesis. In conclusion, within the limits of experimental error, the results suggest no
significant trend in EGFP mRNA expression levels relative to Ad vector uptake.
The sample variability exhibited in the RT-PCR experiment compared to the Ad vector
uptake results (also obtained with PCR) is most likely caused by the inherent variability of the
reverse transcription step, as explained in the introduction of section 3.6. The RT was carried
out using random hexamers as primers for cDNA synthesis, in order to create both EGFP
mRNA and 18S rRNA templates. However, ribosomal RNA is present at much higher levels
than the target mRNA in total RNA preparations. This could affect the sensitivity and accuracy
of quantification due to disproportionate priming of the 2 templates, especially at the low levels
of expression corresponding to the lowest Ad concentration.
The sensitivity and accuracy of the EGFP expression quantification could be improved
by modifying the RT-PCR assay to use EGFP-specific primers for cDNA synthesis. In that case
it would not be possible to normalize EGFP levels against an endogenous gene such as 18S
and apply the Comparative CT Method. However, combined with total RNA measurements and
the Standard Curve analysis method (or the Simplified Comparative CT method), this alternative
approach could provide more sensitive mRNA quantification.
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APPENDIX 4.1
Mathematical Model for Ad Mass Transfer to Monolayer (2D) Hepatocyte Cultures:
Derivation of Ad Conservation Equation and Boundary Conditions.
The control volume of the system is defined as the Ad-containing liquid film above the cell
monolayer. The boundaries of the control volume correspond to the cell monolayer at x=0O and
the liquid-air interface at x=L. Any edge effects at the walls of the culture well are considered
negligible. Additionally the cell monolayer is assumed to be flat and uniformly distributed on the
surface of the culture well. Therefore this system can be mathematically described as one-
dimensional diffusion and sedimentation with a heterogeneous reaction at the x=0O boundary.
r-------------------------------
-· control volume t
t------------------------------
ex
Vs = -usex
in, = -e
L
0
interface
unit vector
sedimentation velocity
unit vector normal to interfacial surface
The basic form of the conservation equation for Ad particles at any interior point of the control
volume is (Deen, 1998, Table 2.1):
ac
= - + J)
N is the total flux, Cvs is the convective flux (sedimentation) and J the diffusive flux of Ad.
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phase A
phase B
interface
B Eii
By substituting for:
V = -u,e x
J = -D C
a
V ex ax
the Ad conservation equation can be written as:
The basic form of the conservation equation for Ad particles at an interface is (Deen, 1998,
Table 2.1):
-CV, - - C ,= R
where v, is the interfacial velocity, nj is the unit vector normal to the interfacial surface pointing
from phase A toward phase B, and R is the rate of formation.
For the interface at x=O there is no flux in phase B, vj=0 (stationary interface) and R=-kuC.
Therefore the above-mentioned equation can be written as:
- N nl, = -kC
ac
u,C + D- = kuCax
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Similarly, for the interface at x=L there is no flux in phase A, vj=O and R=O. Then:
Ni-i, =0
ac
uC + D = 0
ax
Therefore the complete system of equations (including the initial condition) that describe the
mass transfer of Ad in the monolayer cell culture system is written as:
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ac aC a2C
= - +D
at sax ax2
u,C + D -= kC at x = O
ax
u,C + D = 0 at x = L
ax
C = Co at t = 0
APPENDIX 4.2
Mathematical Model for Ad Mass Transfer to Monolayer (2D) Hepatocyte Cultures:
Analytical Solution.
The mathematical model equations describing the processes of diffusion, sedimentation and
uptake of Ad particles in the hepatocyte culture system are as follows:
aC ~C C 2C
=u - + D
at ax ax 2
C(x,O)= Co
u,C(0,t)+D (0 t)
ax
C(W, t) = Co
Substituting for O=C/Co:
E aoe a2e= u -- +D
at ax ax2
O(x,0) = 1
u,0(O, t)+ Dae
ax
(0, t) = ku,(O, t)
e(o0, t) = 1
Applying the Laplace transform:
e(x, s) = L{e(x, t)} = e-stO(x, t)dt
0
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= kuC(O,t)
the transformed mathematical model can be written as:
/1d2 -E
D dx2
1d e-dx -11
-S S =0dx S
deD (0, s) = (k, - u, ) O(0, s)dx
O(=, s)=S
The general solution of the above differential equation is:
1S = CeXlx + C2eX2XS
where A1 and A2 are the roots of the characteristic equation:
DW2 + u8, - s = 0
-u, + u, 2 +4Ds
2D
- u - Us2 + 4Ds
~, =2 2D
>0
<0
and c, and c2 are constants to be determined from the boundary conditions. From the second
boundary condition (x-4o) and since A>O, c, has to be equal to zero. Then from the first
boundary condition:
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k, -Us
c2
2 s u 2 2k - u
S+ ;s +4D 2,[
Therefore the solution of the Laplace transformed model can be written as follows:
ku -u r
11O(x, s)= e
s s u 2 2k - u s
s+U_ +
4D 2-1
which can be simplified with the following substitutions:
k u -us
a=-
u2b-
4D'
X
C=
d= 2k u - u
2,VD
The inverse Laplace transform of the above is G(x,t). This operation cannot be easily performed
directly with Laplace transform tables or with programs such as Matlab or Mathematica. In order
to find the solution, the following Laplace-transform theorems were used:
s - shift theorem L-{F(s + b)}=e-bt f(t) where f(t)=L-{F(s)}
multiplication by 1 theorem
S
L-' (s)}= Jg(T)dT
0
where g(t) = L-'{G(s)}
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s s ae+d
Therefore, if
-cJs+b
F(s + b)= s+b+d
G(s) = a e-I -F(s +b)
- * F(s)= ec
then
1O(s) SG(s)S inverse Laplacetransform
where
g(t) = a -e-c. -L-'{F(s + b)}
= a. e -C - e - bt . fW
and f(t) can be determined as the inverse Laplace transform of F(s) with Matlab's Symbolic
Math Toolbox:
1f (t)=Tlt
C
2
-e 4t - d ecd+d2t . erfc 2-V(2
where erfc is the complementary error function. Note that f(t) and g(t) are also a function of x
since c is a function of x.
The last step to obtain the concentration profile G(x,t) is the integration of g(t) with respect to the
time t (see equation 1). The function g(t) can be written as:
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g(t) = a -e-c" bl,(t)- d -ecd 2(t)
where 1 -bt C2
01(t)= e 4t
2 (t)= e(d2-b erfc( 2d + d/
Then (from Matlab's Symbolic Math Toolbox):
0~, dt = 1 ec - erf + - -1 +e- erfO 221 +1
The solution to the integral of 02 cannot be found with programs like Matlab, Mathematica or
integration properties and it is possible that an analytical solution does not exist. This presents
an obstacle for the derivation of the concentration profile C(x,t) and consequently the equation
for the number of Ad particles taken up by the hepatocyte monolayers, NAd(t) (equation 5 in
Chapter 4):
t t
NAd(t) = nAku C(0,t)dt = nAkuCo f (0, t)dt (2)
0 0
This equation is needed to fit the uptake rate constant ku to the experimental data NAd(t). As is
obvious, the expression for the concentration at the cell monolayer, e(0,t) would be enough for
the data analysis.
0(0, t) = 1- fg(xI,r)dx
t0 -x=0
a T dT
= 1 -• erf ( )+ ad J2, (x,)d (3)
t0 - x=0
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In order to evaluate the behavior of the integral of 02 at x=O the following theorem can be used
(Bender and Orszag, 1978):
b
To determine the leading behavior of integral I(x) = f(x,t)dt as x-O
If f(x,t)-f(0,t) for x-O uniformly for a • t sb, that is if limf(x,t) -1
Xo f(O,t) uniformly in t
b b
f (x, t)dt = f (0,t)dt
a a
Then: for x-;O
provided that the right side of this relation is finite and non zero.
Therefore r2(X, d f.,l) e. (0o, )d
0 x=O 0
provided that
lim 2 (X, t )
urn o 2(0, t)
A(x, t)= (xt erfc-)  + di)
2,(O,t) erfc(dit)
uniformly in t
x 2k u - u,C=where d=
where JD' 2-JD
To determine if the limit of A(x,t) when x-O is equal to 1, a 3-dimensional plot was created
using Matlab. Whereas parameters D and us are known (see Chapter 4), the value of the uptake
rate constant ku is not. Therefore, graphs of A versus x and t were created for values of ku
ranging from 5x10 -8 to 5x10 s- cm/s. Similar behavior was observed in all cases. Figure 1 shows
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two graphs for ku=5x10-6 cm/s. Graph A shows the behavior of function A for the full range of
axes x and t. To examine what happens near t=O, A is plotted with t ranging from 0 to 10-10 s
and x from 0 to 10-8 cm (graph B). In conclusion, the function A is bound by 1 at x=0 and the
above mentioned theorem can be used. Then:
I 2 (0, z)dr = Je(d2-b .erfc(dci)dz
0 0
= [e (d2-býerfc(d\I- d 1 -(+ er i)
bd2 -b d -b
(derived using integration by parts, the expression for the derivative of the complementary error
d 2 -fz2
function erfc(z)= - e -Z  and Matlab's Symbolic Math Toolbox).dz
Then, 0(0,t) is determined with equation (3) and can be integrated to give the expression for
NAd(t) (equation 2):
F
S t2LI
+2
+ 1- -e 4D
FC -
D 2k - ku(k-u,) t
2 kuI k -US) e
2 ku(k -Usr us ku
.erfc
-erf s •+-2-ý-
2k• 
-US /t-1
24D
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NA nACNAd(t)= nAC s t0 2 +D
graph A
o
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o
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Figure 1. Surface plot of the function A(x,t) for ku= 5x10 -6 cm/s to determine the
behavior of A as x -- 0; graph A: full range of axes x [0-0.2cm] and t [0-86400s]; graph
B: axes range: x [0-10-8cm], t [0-10-10s].
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APPENDIX 4.3
Mathematical Model for Ad Mass Transfer to Monolayer (2D) Hepatocyte Cultures without
Sedimentation: Analytical Solution.
The mathematical model equations when the process of sedimentation is assumed negligible
are reduced to the following:
ac a2c
= D
at ax2
C(x,O) = Co
D ac (, t) = kC(O, t)
ax
C(oo, t) = Co
Following the same procedure as in Appendix 4.2, the Laplace-transformed model can be
written as:
d2
dx 2
deD (0,s)
dx
0(0, s)=-
The solution of the differential equation is:
(x, s)=
s s
s 19O =0
D s
= k, 6(0, s)
ku
+ ku
4;+4-
e
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In this case, the inverse Laplace transform can be determined directly with Matlab's Symbolic
Math Toolbox and therefore the concentration profile can be derived as:
X ((x+kut) XC(x,t) = C0 erf +eD erfc +ku
2, 2r-
The equation for the uptake of Ad particles can then be derived from:
t
NAd(t) = nAk u fC(O, t)dt
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NAd(t)= nACO 2 + k rexp k erfc ku -1
APPENDIX 4.4
Mathematical Model for Ad Mass Transfer to Monolayer (2D) Hepatocyte Cultures with
Diffusion and Fast-Reaction Boundary Condition: Analytical Solution.
The mathematical model equations when the process of sedimentation is assumed negligible
and the reaction rate is fast enough to assume that the Ad concentration at the surface of the
cell monolayer approaches zero, are reduced to the following:
aC D 2 c
=D
at ax 2
C(x,O) = Co
C(O, t) = o
C(oo, t) = Co
Following the same procedure as in Appendix 4.2, the Laplace-transformed model can be
written as:
d 2
dx2  D s)
(0o, s)= 0
1(O , s)= 1
s
The solution of the differential equation is:
1 1O(x,s) e
s s
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The inverse Laplace transform can be determined directly with Matlab's Symbolic Math Toolbox
and therefore the concentration profile can be derived as:
The equation for the uptake of Ad particles can then be derived from:
t
NAd (t)= nAku jC(O, t)dt
0
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C(x, t) = COerf(r- J(02
NAd = 2nAC 0 R0 rL
CHAPTER 5
Quantitative Analysis of Ad Gene Delivery in
Hepatocyte Microreactor Cultures
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5.1 Introduction
This chapter presents the quantitative analysis of adenoviral vector gene delivery to
hepatocytes cultured in the microreactor system. Like Chapter 4 it is divided into two parts. The
first part addresses the extracellular mass transfer and cellular uptake of the AdEGFP vector. A
simplified mathematical model is developed to describe these processes based on qualitative
observations and quantitative results obtained with two-photon laser scanning fluorescence
microscopy, as well as on quantitative real-time PCR data. The lower and upper boundaries for
the Ad uptake rate constant k3D are then determined by fitting to experimental results using the
model.
The second part examines the events following the Ad internalization, namely the
transgene (EGFP) expression (DNA transcription and mRNA translation). Protein levels are
quantified with fluorescence emission intensity measurements using a custom-made
miniaturized spectrometer and mRNA levels are measured with quantitative real-time RT-PCR.
Finally, gene delivery efficiency is also quantified in terms of the percentage of Ad-infected cells
via the detection of EGFP expression with two-photon microscopy.
5.2 Extracellular Mass Transfer and Celllular Uptake of AdEGFP
Vector
Ad gene delivery in hepatocyte monolayer cultures is a process that can be adequately
described with a one-dimensional mathematical model comprising Ad diffusion and cellular
uptake, as demonstrated in Chapter 4; moreover, the expression of the transgene (EGFP) can
be easily detected with fluorescence microscopy. The liver microreactor however is a complex
three-dimensional culture system with continuous medium flow. The adenoviral vector is
introduced in the medium reservoir at specific concentrations and circulates continuously in the
system for a defined amount of time. During the Ad infection the Ad particles flow into the
microreactor chamber and through the silicon scaffold channels, where they interact with the
hepatocyte tissue and are internalized by the cells. Figure 5.1 shows a schematic of this
process.
A rigorous mathematical model for the mass transfer of the Ad vector would have to
assume a specific tissue geometry representative of the average microreactor channel (for
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Figure 5.1. Schematic of hepatocyte tissue structures and adenoviral vector mass transfer
processes inside the microreactor channels.
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example a cylindrical fluid flow conduit in the center of the channel) and comprise the following
processes: convective transport of Ad in the z direction (Peclet number in the order of 103),
diffusion to the tissue in the r direction, diffusion and reaction (cellular uptake) inside the tissue.
The model combined with experimental data for the Ad uptake (real-time PCR) as a function of
initial Ad concentration would be applied to estimate the Ad uptake rate constant, k3D. It is
obvious that this is a complex mathematical problem. For example the rate of diffusion of the Ad
particles in the tissue depends on how compact the structure of the tissue is and whether there
are smaller fluid flow conduits running through it. The extraction of intact tissue units from the
scaffold for sectioning and histology to examine the tissue morphology is very impractical and
the material of the scaffold itself (silicon) cannot be sectioned. The alternative approach is via
the in situ detection of EGFP expression and spatial distribution of EGFP-expressing cells with a
fluorescence microscopy technique.
5.2.1 Tissue morphology and spatial distribution of Ad-infected hepatocytes in
microreactor cultures.
Conventional fluorescence microscopy cannot be applied to three-dimensional samples.
Figure 5.2a shows a fluorescence micrograph of an entire microreactor (40 channels) infected
with Ad at an initial concentration of 3.2x10 7i.p./ml for 24h. The image was taken at -70h after
the beginning of infection (when EGFP expression reaches maximum levels; see section 5.3.1)
with a FITC filter set and a 5X dry objective lens focusing at the top of the silicon scaffold.
Obviously there are hepatocytes expressing EGFP; however there is no 3D resolution and no
possibility to probe deep inside the tissue.
This issue was addressed with the application of two-photon laser scanning
fluorescence microscopy, a technique that allows non-invasive, in situ imaging of tissues with
three-dimensional resolution. The theoretical background and the experimental details of this
method are described in detail in Chapter 3 (section 3.8). Preliminary experiments
demonstrated the ability to detect EGFP inside the tissue and provided qualitative information
about the spatial distribution of expressing cells (section 3.8.2, Figures 3.8.2-3.8.3). EGFP was
detected throughout the channel cross section and the 60 to 100m-deep sections that were
imaged. Moreover, gene expression changes with time could also be followed by imaging the
same microreactor channels at different times.
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Figure 5.2. Morphology of hepatocyte tissue in microreactor channels. (a) Fluorescence
micrograph of entire microreactor infected with AdEGFP for 24h at a concentration of3.2x10 7i.p./ml. (b) Two-photon micrographs of microreactor channels stained with Hoechst33342. The red arrows point to cells that are 50-100lpm deeper inside the channel thanthose marked by white arrows. The yellow stars mark the position of smaller fluid flowconduits in the tissue.
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To obtain quantitative information about the spatial distribution of Ad-infected cells, a
protocol was developed which included nuclear counterstaining with Hoechst 33342 and
Ethidium Homodimer 1, to detect the number of live and dead cells respectively and distinguish
between EGFP expressing and non-expressing cells. These experiments were performed with a
different two-photon imaging system for enhanced resolution. The data were processed with the
MetaMorph software and the different categories of cells (live, dead, EGFP-expressing) were
counted. Section 3.8.3 contains a detailed description of the experimental procedures as well as
the data analysis, and Figures 3.8.5 and 3.8.6 demonstrate examples of the results.
The observation of 3D-reconstructed models of several microreactor channels (from two-
photon imaging data) provided information about the morphology of the tissue. Some examples
are presented in Figure 5.2b. This figure shows top view images of 3D-reconstructed models for
six microreactor channels. The hepatocytes were incubated with Hoechst to stain the nuclei. A
prevalent feature is the formation of a central fluid flow conduit; it is not cylindrical however, but
has a shape that rather resembles a conical section with the apex pointing away from the top of
the cell scaffold and towards the filter. This cannot be visualized in these 2D images, but certain
features are marked. The red arrows point to cells that are 60-100 m deeper inside the channel
than the cells marked with white arrows. Secondary medium flow conduits were also observed
in some cases, usually in channels containing higher numbers of cells. These are marked in
Figure 5.2b with yellow stars.
The spatial distribution of EGFP-expressing cells and dead cells was quantified as a
function of the channel depth, in order to detect a potential gradient in the Ad concentration in
the z-direction. Microreactors were infected with Ad at a concentration of 4x1 06pfu/ml (based on
the infectious titer measured by the Ad vector supplier) for 24h; the cells were stained with
Hoechst and ethidium homodimer and imaged -70h after the beginning of infection. Two-photon
imaging data from two microreactors and six channels (3 per microreactor) were used. Each
channel was imaged at a depth of 100gm and was divided into two sections, A (0-50gm) and B
(50-100gm). The percentage of EGFP-expressing cells and dead cells was calculated in each
section by counting the number of blue, green and red cells. The results are shown in Table 5.1.
The mean values of all 6 channels were calculated and are shown in the table as well as the
standard deviations. There is no significant difference between the mean values for the %
EGFP-expressing cells (i.e. the gene delivery efficiency levels) in the two sections; the same
applies to the mean values for the % dead cells (i.e. cell toxicity levels). Comparison between
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the two means in each case was performed by Student's t-test for two samples with unequal
variances. Statistical significance was determined at the <0.05 level.
Table 5.1: Spatial distribution of EGFP-expressing and dead cells in microreactor channels as a
function of channel depth.
% EGFP-expressing cells % dead cells
hanlpt h  1-50pm 50-100pm 1-50pm 50-1Opm
1 50.0 21.4 29.2 7.8
2 40.3 60.6 10.2 21.7
3 27.3 30.0 26.4 13.2
4 29.1 37.0 8.6 6.9
5 29.6 32.2 12.4 10.6
6 24.5 32.9 6.0 16.4
mean 33.5 35.7 15.5 12.8
standard deviation 9.7 13.3 9.8 5.6
Based on these results it can be assumed that the Ad concentration does not vary significantly
as a function of depth z inside the microreactor channels.
The observation of combined 3-color images (Hoechst-EGFP-Ethidium Homodimer) did
not provide conclusive information on whether all the cells in the tissue are accessible to the Ad
particles. At depths greater than 100pm and positions away from the main fluid flow conduit the
detection of EGFP-expression and Hoechst staining becomes increasingly difficult, possibly due
to limitations of the imaging technique (loss of emission intensity because of light scattering). To
circumvent this problem, a simplified approach was followed in order to develop a mathematical
model for the estimation of the Ad uptake rate constant, k3D. Two limiting cases were examined.
The first one assumes that all the cells in each microreactor channel are exposed to the same
Ad concentration; in this case a lower limit for k3D iS estimated. The second case assumes that
only the cells at the tissue-medium interface have access to the Ad vector (i.e. the tissue is
compact); in this case the upper limit for k3D is determined.
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5.2.2 Mathematical Model Description.
The total number of Ad particles taken up by the hepatocytes in the microreactor culture
during the time of Ad infection, NAd, is derived as the integral with time of the Ad flux at the
tissue surface:
NAd = A -(flux),, surface dt (1)
0
where A is the total surface area (cm2) that is exposed to the Ad and T=24h is the duration of
infection. The flux at the tissue surface is equal to the Ad uptake rate:
(flUX)cellsurface= k3DC (2)
where k3D is the uptake rate constant (cm/s) and C the Ad concentration in the medium
(infectious Ad particles/cm3). The Ad concentration in the medium is assumed constant
throughout the depth (z-dimension) and cross section (r-dimension) of each channel and is the
same inside all channels of the microreactor. Therefore C is a function of time t only.
The Ad concentration is expected to decrease with time as a result of the Ad uptake by
the cells. A simple calculation was performed to estimate the effect of Ad uptake based on the
experimental results presented in Figure 5.4a. If the initial Ad concentration is 6.4x10 7 i.p./ml,
the total number of infectious Ad particles in the circulating medium at the beginning of the
infection (t=0) is 1.28x109 (the total medium volume is 20ml). Assuming an uptake of 600 Ad
particles per cell by the end of the infection (a value that corresponds approximately to the
maximum uptake levels observed, Figure 5.4a) and an average of 40,000 cells in the
microreactor, the total number of Ad particles removed from the medium due to uptake by the
tissue will be 2.4x107. This corresponds to a decrease of less than 2% in the Ad concentration.
Consequently, the effect of the Ad uptake on the Ad concentration in the circulating medium is
not significant and can be neglected.
Before solving the mathematical model with the assumption that the concentration
remains constant with time (C(t)=Co), other factors were taken into consideration. Adenoviral
vectors are relatively stable at 370C and therefore any loss of infectivity during the 24h infection
was considered negligible. Another possibility is the adsorption of the Ad vector on the
microreactor system surfaces. As described in Chapter 2, the microreactor system consists of
several components, including the chamber, the medium reservoir, an extensive network of
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tubing and the crossflow filter. The materials of these components were originally selected for
low cell toxicity and low levels of protein adsorption. To determine whether there was significant
adsorption of Ad particles, the Ad concentration in the circulating medium was monitored with
time during the Ad infection of microreactor cultures.
Adsorption of Ad particles on microreactor system surfaces: Microreactor cultures were
infected with Ad at three concentrations (Co, Co/2 and Co/10, where Co=6.4x107 i.p./ml) for 24h.
Samples were collected from the medium reservoir at different times during the Ad infection (t =
0, 1, 3, 5, 8, 20 and 24h). The number of Ad particles in each sample was determined by
measuring the number of Ad genomic copies with quantitative real-time TaqMan PCR. This
method quantifies the total (infectious and non-infectious) Ad particle concentration. The ratio of
genomic titer over infectious titer is -1.06 and therefore CO,genomic= 6.8x1 07p./ml as determined in
Chapter 4.
Figure 5.3 shows a graph of the total number of Ad particles in the medium plotted as a
function of time for the three different initial concentration values. The data points represent the
mean values of 4 or 5 microreactor samples from two experiments (different rat liver perfusions)
and the error bars correspond to the standard deviation of the mean. The results indicate a
marked decrease in the concentration of Ad particles with time. Within 24h, the concentration
decreased on average by 55%, 30% and 65% for initial Ad concentrations of Co, Co/2 and Co/10
respectively (Co=6.4x1 07i.p./ml).
To reflect this change in concentration with time in the mathematical model, the
adsorption of Ad particles on microreactor system surfaces is assumed to follow first order
kinetics. Then the mass balance for Ad in the medium takes the form of the following differential
equation:
dC
= -kAC
at
where kA is the adsorption rate constant. The solution of this equation, subject to the initial
condition:
C= C att=O
is derived as:
C = C0e -k At (3)
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Figure 5.3. Adsorption of Ad vector on microreactor system surfaces during Ad
infection of hepatocytes. Microreactor cultures were infected with Ad at three
concentrations (Co, Co/2 and Co/10, where Co=6.4x10 7 i.p./ml) for 24h. The circulating
medium was sampled at different times during the infection and the number of Ad
particles (infectious and non infectious) was quantified with real-time TaqMan PCR. The
adsorption rate constant kA was fitted to the data separately for each initial Ad
concentration using Equation (3). This graph shows the total number of Ad particles in
the medium plotted against time after the beginning of the Ad infection. All data points
represent the mean values of two experiments (different rat liver perfusions) each
performed in duplicate or triplicate + the standard deviation of the mean. The solid lines
represent the exponential least squares regression with Excel.
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The adsorption rate constant kA was fitted to the experimental data shown in Figure 5.3
separately for each initial Ad concentration using Equation (3). The solid lines in the graph
represent the exponential least squares regression with Excel. The fitted kA values are also
shown in Figure 5.3. The mean of these three values was calculated and used in the
mathematical model for Ad uptake:
kA = 0.0324 h- '
After combining equations (1), (2) and (3), the number of Ad particles taken up by the
microreactor culture after time t, is given by the following equation:
1- e-kAt
NAd = Ak 3DCO kAkA
For the above value of kA and t=24h:
NAd = 17Ak 3DCO (4)
Therefore the Ad uptake rate constant k3D can be determined by fitting to the
experimental data presented in Figure 5.3 with equation (4). A is the total surface area which is
exposed to the Ad vector. As described earlier in this section, two limiting cases were examined:
(A) all cells in the microreactor are equally exposed to the Ad containing medium, (B) only the
cells at the tissue-medium interface have access to the Ad particles. The first case provides the
lower limit for the Ad uptake constant, k3D,L, whereas the second one provides the upper limit,
k3D,U.
(A) Lower limit for the Ad uptake constant in microreactor cultures, k3D,L: In this case all
hepatocytes in each microreactor channel are assumed to be equally exposed to the Ad vector.
Then the surface area A is given by the following equation:
A = nx Acell
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n is the total number of cells in the microreactor and Acell is the surface area of each cell.
Assuming that each hepatocyte is a cube with length of 25pm, then Acell=3,750pm2. Equation (4)
then becomes:
NAd = 17 Acel k3D,L CO
n
(5)
The uptake rate constant k3D,L can be determined by plotting NAd/n
internalized by the hepatocytes after a 24h infection, normalized to cell
the initial Ad concentration Co, and fitting a straight line through the
intercept = 0). k3D,L can then be calculated from the value of the slope.
(number of Ad particles
number) as a function of
experimental data (with
(B) Upper limit for the Ad uptake constant in microreactor cultures, k3D,U: In this case the
assumption is that only the hepatocytes at the tissue-medium interface are exposed to the Ad
vector. As discussed earlier in this chapter, the tissue geometry inside each microreactor
channel can be approximated to be such that a cylindrical medium flow conduit is formed in the
center of the channel as shown in the schematic below:
tissue area
In that case the area A in equation (4) is
channels:
the area of the cylinder multiplied by the number of
A = 40 x (2iRL)
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where L=230gm is the depth of the channel and R is the radius of the cylinder. Edge effects at
the top and bottom side of the tissue are assumed negligible. R depends on the thickness of the
tissue area and therefore on the number of cells inside the channel and is calculated as:
R = (channel volume) -(tissue volume)Nn
The channel has a square cross section 300gjm wide, therefore (channel volume)=2.07x1l0 7 m3.
The tissue volume is the product of the number of cells in the channel and the cell volume.
Assuming that each hepatocyte is a cube with length of 25[tm, then (cell volume)=15,625gm3.
The average number of cells per channel can be calculated by dividing the total number of cells,
n, with the number of channels in the microreactor (40). Equation (4) becomes:
NA = 17k3D,UC O  (6)A
The uptake rate constant k3D,U can be determined by plotting NAdA (number of Ad particles
taken up by the hepatocytes after a 24h infection, normalized to total surface area) as a function
of the initial Ad concentration Co, and fitting a straight line through the experimental data (with
intercept = 0). k3D,u can then be calculated from the value of the slope.
5.2.3 Experimental Results and Analysis.
The Ad vector uptake in microreactor cultures was quantified with real-tme PCR.
Microreactor cultures were infected with Ad at three concentrations (Co, C0/2 and Co/10, where
Co=6.4x10 7 i.p./ml) for 24h. The cells were harvested -70h after Ad infection for DNA extraction.
Total DNA content was measured with the Rediplate 96 PicoGreen DNA Quantification Assay.
The number of Ad genome copies was quantified with real-time TaqMan PCR. Figure 5.4a
shows a graph of the number of Ad copies normalized to cell number and plotted against the
initial Ad concentration. All data points represent the mean values of two experiments (different
rat liver perfusions) performed in duplicate or triplicate ± the standard deviation of the mean.
The Ad uptake increased linearly as a function of concentration. The normalized Ad uptake data
171
fnn(a)
@r1
0
0
:-
c.
z
2
a=5
n=4
UUU -
500 -
400 -
300 -
200
100 -
0
O.E+00 1.E+07
1
20000
2. E+07 3.E+07 4.E+-07 5.E+07
Ad concentration (i.p.Iml)
III I
30000 40000 50000
6.E+07 7.E+07
C,,1/2
c=,.,!1
60000
number of cells in microreactor, n
Figure 5.4. Quantification of Ad vector uptake in hepatocyte microreactor cultures with real-
time PCR. Microreactor cultures were infected with Ad at three concentrations (Co, Co/2 and
CO/10, where Co=6.4x107 i.p./ml) for 24h. The cells were harvested -70h after Ad infection for
DNA extraction. Total DNA content was measured with the Rediplate 96 PicoGreen DNA
Quantification Kit. The number of Ad genome copies was quantified with real-time TaqMan
PCR. (a) This graph shows the number of Ad copies normalized to cell number and plotted
against Ad concentration. All data points represent the mean values of two experiments
(different rat liver perfusions) performed in duplicate or triplicate ± the standard deviation of
the mean. (b) This graph shows the number of Ad copies normalized to cell number and
plotted against the total cell number, n. Each data point corresponds to one of the
microreactor samples shown in graph (a).
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(Ad copies/cell) for the individual microreactor samples were also plotted (on a logarithmic
scale) against the total cell number (Figure 5.4b). Each data point corresponds to a different
microreactor sample. By examining each group of data corresponding to a different initial Ad
concentration separately, it appears that, overall, the distribution of data is random and does not
follow any particular trend. For example, if the Ad uptake rate constant k3D was equal to the
lower limit (all cells exposed to Ad), the normalized Ad uptake would be expected to increase
with cell number. This is observed in the low Ad concentration group, but not in the other 2
groups. If k3D was equal to the upper limit (only cells at tissue-medium interface exposed to Ad),
the Ad uptake would be expected to decrease with increasing cell number. Higher cell number
in the microreactor channels means smaller surface area, A, exposed to the Ad vector. Such a
trend is not obvious in any data group either. Therefore, the actual value of k3D probably
corresponds to an intermediate state, where the hepatocytes at the tissue-medium interface are
exposed to higher Ad concentration levels than the cells deeper in the tissue.
Estimation of lower limit for the Ad uptake constant, k3D,L: Figure 5.5a shows a plot of NAd/n
as a function of the initial concentration Co. Equation (5) was used to fit k3D,L to the experimental
data described above. All data points represent the mean values of 4 or 5 microreactor samples
from two experiments (different rat liver perfusions) and the error bars correspond to the
standard deviation of the mean. The solid line corresponds to the linear least squares
regression performed in Excel. The rate constant value calculated from the slope is:
k3 D,L = 0.0076cm/s
Estimation of upper limit for the Ad uptake constant, k3D,U: Figure 5.5b shows a plot of
NAdA as a function of the initial concentration Co. Equation (6) was used to fit k3D,U to the
experimental data described above. The average cell number per microreactor in these
experiments was n=40,000. This corresponds to a cylinder radius R=85gm and a total surface
area A=0.05cm 2.All data points represent the mean values of 4 or 5 microreactor samples from
two experiments (different rat liver perfusions) and the error bars correspond to the standard
deviation of the mean. The solid line corresponds to the linear least squares regression
performed in Excel. The rate constant calculated from the slope is:
k 3D,U= 0.204 cm / s
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Figure 5.5. Mathematical model correlation to the experimental results for Ad vector uptake
in hepatocyte microreactor cultures. (a) Lower boundary for the Ad uptake rate constant k3D,L.
Equation (5) was used to fit k3D,L to the experimental data described in Figure 5.4. The graph
shows the number of Ad copies (NAd) normalized to cell number (n) and plotted against the
Ad concentration Co. (b) Upper boundary for the Ad uptake rate constant k3D,U. Equation (6)
was used to fit k3D,U to the experimental data. The graph shows the number of Ad copies
(NAd) normalized to the tissue area exposed to the Ad vector (A) and plotted against the Ad
concentration Co. All data points represent the mean values of two experiments (different rat
liver perfusions) performed in duplicate or triplicate + the standard deviation of the mean. The
solid lines represent the mathematical model correlation performed with linear least squares
regression in Excel.
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A similar uptake rate constant value is obtained if a different value of A is calculated for each
microreactor.
In conclusion, although the exact value of the Ad uptake rate constant in hepatocyte
microreactor cultures, k3D, could not be estimated, a simplified mathematical model was
developed based on qualitative and quantitative experimental data to determine its lower and
upper boundaries:
0.0076 cm/s < k3D < 0.204 cm/s
k3D lies within a range of approximately one order of magnitude. The efficiency of Ad uptake in
the microreactor cultures appears significantly higher than in the hepatocyte monolayer cultures,
since k3D is at least three orders of magnitude higher than k2D (estimated as -~10 5 cm/s).
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5.3 Transgene (EGFP) Expression
As described in Section 4.3, the levels of expression of the transgene (egfp) transferred
into the target cells by the vector (Ad) are what ultimately determines the efficiency of gene
delivery. In the experiments presented in this section gene expression was quantified as a
function of the initial Ad concentration in the medium. EGFP expression was detected and
monitored with time with a miniaturized spectrometer system especially designed for the
microreactor cultures, and quantified in terms of fluorescence intensity levels. As in the case of
the hepatocyte monolayer cultures, quantitative real-time RT-PCR was applied to measure the
EGFP mRNA levels. Additionally, EGFP protein was detected with a fluorescence microscopy
technique, in particular two-photon scanning fluorescence microscopy, and gene delivery
efficiency was quantified in terms of the percentage of EGFP-expressing cells. These
measurements were made approximately 70 hours after the Ad infection, when EGFP
expression reaches maximum levels in the microreactor cultures.
5.3.1 Quantification of EGFP expression with the Miniaturized Spectrometer System
The design and principle of operation of the spectrometer system have been described
in detail in Chapter 3 (section 3.7). Briefly, the EGFP protein produced in the hepatocytes
cultured inside the silicon scaffold channels is excited by a light beam passing through the
microreactor. The emission spectrum is detected by a fiber optic spectrometer and recorded at
different time points after the beginning of Ad infection. The spectral data are processed with
special software. The spectrum intensity at 509nm is used as a measure of EGFP expression
levels to plot the time course of expression. As shown in Chapter 3, in microreactor cultures
EGFP expression reaches maximum levels around 50-70h after the beginning of Ad infection
and then gradually declines.
In the experiments described earlier in this chapter (section 5.2) EGFP expression was
monitored with the spectrometer until t-70h when the hepatocytes were harvested for DNA
extraction. Total DNA content for each microreactor was measured with the Rediplate 96
PicoGreen DNA Quantification Assay and converted to cell number. The spectrometer data
were normalized against cell number. Figure 5.6 shows a graph of the normalized EGFP
emission intensity at t-70h (counts/cell) plotted as a function of Ad concentration (i.p./ml). All
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Figure 5.6. Quantification of EGFP expression levels in microreactor cultures with the
spectrometer system. Microreactor cultures were infected with Ad at three concentrations
(Co, Co/2 and Co/10, where Co=6.4x10 7 i.p./ml) for 24h. The change in EGFP expression with
time was monitored by measuring fluorescence emission with the spectrometer. The cells
were harvested after the last measurement (-70h) for DNA extraction. Total DNA content
was measured with the Rediplate 96 PicoGreen DNA Quantification Assay and converted to
cell number. This graph shows fluorescence emission intensity at -70h after Ad infection
normalized to cell number and plotted against Ad concentration. All data points represent the
mean values of 4-5 microreactor samples from two experiments (different rat liver perfusions)
+ the standard deviation of the mean.
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Figure 5.7. Comparison of the dependence of EGFP expression and Ad vector uptake on Ad
concentration. This graph shows the normalized EGFP fluorescence intensity data at t-70h
(Figure 5.6) and the normalized Ad copy number data (Figure 5.4a) quantified with the
spectrometer and PCR respectively, and plotted against the Ad concentration. All data points
represent the mean values of 4-5 samples ± the standard deviation of the mean.
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data points represent the mean values of 4-5 microreactor samples from two experiments
(different rat liver perfusions) and the error bars correspond to the standard deviation of the
mean. The graph indicates that protein expression increased linearly with Ad concentration.
Figure 5.7 shows a comparison of these results to the Ad uptake data obtained with real-
time PCR for the same microreactor samples (Section 5.2, Figure 5.4a). The two sets of data
are plotted on two differently scaled y-axes in order to compare their relative dependence on Ad
concentration. The graph indicates that the increase in Ad vector uptake with Ad concentration
correlates with the increase in EGFP expression.
5.3.2 Quantification of EGFP mRNA Levels with Real-Time TaqMan RT-PCR.
The same procedures for Ad infection in microreactor cultures as described earlier were
followed in this experiment as well. Hepatocyte cultures were infected with AdEGFP at three
different concentrations (Co, CO/ 2 and C/1 0, where Co = 6.4x107 i.p./ml) for 24 hours. Duplicate
samples were prepared for each condition. The change in EGFP expression with time was
followed with spectrophotometer measurements. The cells were harvested in Trizol Reagent for
RNA extraction at approximately t=70h (time point of maximum EGFP expression attained).
RNA was isolated and purified, and the total RNA content of each sample was measured. The
same amount of RNA (200 ng) was used for all reverse transcription reactions. The quantity of
cDNA sample amplified in each PCR reaction corresponded to 1 ng input total RNA. For each
sample the target gene (EGFP), as well as an endogenous reference gene (18S rRNA) were
amplified with quantitative real-time TaqMan PCR. The results were analyzed with the
Comparative CT Method, which calculates the EGFP mRNA levels normalized to 18S and
relative to a calibrator. Additionally, the data were analyzed with the Standard Curve method to
determine the number of EGFP cDNA copies present in each sample; in that case EGFP
expression was normalized to the amount of total RNA. All experimental procedures and data
analysis methods are described in detail in Chapter 3 (sections 3.5 and 3.6).
Control microreactor cultures that were not infected with Ad showed no PCR
amplification. The minus RT controls for the Ad-infected samples (in which the reverse
transcriptase is omitted from the RT reaction) tested negative as well.
Similar results were obtained with both data analysis methods. Figure 5.8 shows the
EGFP mRNA levels normalized against total RNA calculated with the Standard Curve Method.
EGFP expression (cDNA copies per ng total RNA) is plotted against initial Ad concentration.
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Each data point represents the mean value of two samples. The error bars correspond to the
difference from the mean. The results show a clear trend of increasing levels of EGFP
expression with increasing Ad concentration. This is in agreement with the trend observed in the
Ad vector uptake measurements (Figure 5.4a).
The ratio of mRNA levels divided by the intracellular Ad levels was calculated as a
measure of transgene expression efficiency relative to Ad uptake, a quantity that will be a basis
for comparison with the gene delivery results in the hepatocyte monolayer cultures (presented in
Chapter 4). The data presented in Figure 5.8 were converted to cDNA copies per cell with the
conversion factor determined in Section 3.5 and then divided with the respective Ad uptake data
presented in Figure 5.4a (Ad genomic copies per cell). The results are shown in Figure 5.9. All
data points represent the ratio of the mean values. The error bars represent the standard
deviation of the quotient calculated with Equation 10 of Chapter 4. The microreactor culture
results for EGFP expression, Ad uptake and their ratio for the three Ad vector concentrations
used in this experiment are also summarized in Table 5.2:
Table 5.2: EGFP expression efficiency relative to Ad vector uptake in microreactor cultures.
Initial Adconcentration EGFP expression Ad uptake EGFP expression/I (nia.p/m) (cDNA copies/cell) (Ad copies/cell) Ad uptake(i.pm) n=2 n=5 (cDNA/Ad copies)
6.4x10 7  (6.08 + 0.52) x10 11  330.3 ± 231.6 (1.84 + 1.30) x10 9
3.2x10 7  (5.23 ± 0.03) x1011 120.5 +104.9 (4.34 ± 3.77) x10 9
6.4x10 6  (7.2 ± 0.4) x1010 18.8 ± 14.3* (3.82 + 2.92) x10 9
*n=4
The microreactor cultures that were infected with the highest concentration of Ad,
display lower levels of relative EGFP expression, although the experimental error introduced by
the variability in Ad uptake data is rather large and the difference does not appear significant.
The average value of EGFP expression relative to Ad uptake for the microreactor cultures is
3.3x1 09 mRNA copies per Ad genomic copy with a standard deviation of 1.3x1 09.
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Figure 5.8. Quantification of EGFP mRNA levels after AdEGFP infection in hepatocyte
microreactor cultures with real-time RT-PCR. Microreactor cultures were infected with Ad at
three concentrations (Co, Co/2 and Co/10, where Co=6.4x10 7 i.p./ml) for 24h. Duplicate
samples were prepared for each condition. The cells were harvested 70h after Ad infection
for RNA extraction. Total RNA content was measured with the Rediplate 96 RiboGreen RNA
Quantification Kit. 200ng RNA were used for cDNA synthesis by reverse transcription. The
EGFP cDNA was quantified with real-time TaqMan PCR (1ng input total RNA per reaction).
The data were analyzed with the Standard Curve Method. Standards were prepared from
serial dilutions of Ad genomic DNA. The number of EGFP cDNA copies present in each
sample (corresponding to 1 ng input total RNA) were determined from the standard curve
with interpolation. This graph shows the EGFP expression levels normalized to total RNA
plotted against Ad concentration. All data points represent the mean values of two samples _
the error.
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Figure 5.9. EGFP expression efficiency relative to Ad vector uptake in microreactor cultures.
The data presented in Figure 5.8 were converted to cDNA copies per cell and were
normalized against the Ad vector uptake data (Ad genomic copies/cell) presented in Figure
5.4a. All data points represent the ratio of the mean values and the error bars correspond to
the standard deviation of the quotient.
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Comparison with spectrometer data (mRNA levels vs protein levels)
EGFP expression in the microreactor cultures that were subjected to RT-PCR, was also
monitored with the spectrometer from the beginning of Ad infection (t=0) until t-70h, when the
cells were harvested for RNA extraction. At that time EGFP expression had reached maximum
levels. Figure 5.10 shows the fluorescence emission intensity normalized against cell number
(determined from the total RNA measurements and the conversion factor calculated in section
3.5) plotted as a function of time after Ad infection. All data points represent the mean values of
two microreactor samples. The error bars correspond to the difference from the mean. The
spectrometer results at t-70h (normalized fluorescence intensity) are compared with the RT-
PCR results (normalized mRNA levels) in Figure 5.11. The two sets of data are plotted against
Ad concentration on two differently scaled y-axes, in order to compare the relative increase of
expression with Ad concentration. The graph indicates that the two measurements are in
agreement and that the dependence of EGFP mRNA levels (transcription) on the Ad
concentration correlates with that of EGFP protein levels (translation).
5.3.3 Quantification of AdEGFP Gene Delivery Efficiency and Cell Viability with 2-photon
microscopy
The application of two-photon microscopy for the detection of EGFP expression in
microreactor cultures was demonstrated earlier in this chapter (section 5.2). Two-photon
imaging data were used to extract information about the tissue morphology as well as the Ad
infection inside the microreactor channels (quantitative analysis of the spatial distribution of
EGFP-expressing hepatocytes), in order to develop a mathematical model and estimate the Ad
uptake rate constant. In the experiment presented in this section, two-photon imaging was
applied to quantify Ad gene delivery efficiency and cell viability as a function of the initial Ad
concentration in the circulating medium. Gene delivery efficiency was measured as the
percentage of EGFP-expressing cells and cell viability as the percentage of live cells.
Microreactor cultures were infected with AdEGFP for 24h at three different
concentrations 4x105, 2x106 and 4xl06pfu/ml. (Note: these values are based on the infectious
titer of the Ad preparation as measured by the vector supplier.); control samples were not
infected with Ad. Duplicate samples were prepared for each condition. The cells were stained
with Ethidium Homodimer 1 and Hoechst 33342 approximately 70h after the beginning of the Ad
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Figure 5.10. Quantification of EGFP expression levels with spectrometer measurements for
the microreactor cultures presented in Figures 5.8 and 5.9. The change in EGFP expression
with time was monitored by measuring fluorescence emission with the miniaturized
spectrometer. The cells were harvested after the last measurement (-70h) for RNA
extraction. Total RNA content was measured with the Rediplate 96 RiboGreen RNA
Quantification Kit and converted to cell number. This graph shows the fluorescence emission
levels normalized to cell number and plotted against time t after Ad infection. All data points
represent the mean values of two samples ± the error.
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Figure 5.11. Comparison of EGFP expression measurements with the spectrometer and RT-
PCR methods. This graph shows the normalized EGFP fluorescence emission data at t-70h
(black diamonds, left y-axis) and the normalized EGFP mRNA expression data (red squares,
right y-axis) quantified with the spectrometer and RT-PCR respectively, and plotted against
the Ad concentration. All data points represent the mean values of two samples ± the error.
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infection and imaged with a two-photon laser scanning fluorescence microscope. During
imaging the microreactors were connected to a portable environmental control system to
maintain the temperature and pH at physiological levels. Images were acquired from three
different channels in each microreactor. The two-photon imaging data were processed and
analyzed with the MetaMorph software. To quantify the percentage of EGFP-expressing cells
and live cells in each imaged channel, the total number of live cells was determined by counting
the Hoechst-stained nuclei, the number of dead cells by counting the Ethidium Homodimer-
stained nuclei and Ad infected cells by counting the number of green fluorescent cells. All
experimental procedures and data analysis methods are described in detail in Section 3.8.3.
The two-photon experiments were performed with a different batch of adenoviral vector,
therefore the real infectious titer was not known. As explained in Chapter 4 (section 4.1.3) the
actual infectious titer can be different (higher) from the one measured with the plaque forming
assay by the vector supplier. To determine the actual infectious Ad concentration in the medium
circulation, the Ad vector uptake was also measured in these microreactors. After imaging, the
hepatocytes were harvested for DNA extraction. The total DNA content of each sample was
measured with the RediPlate 96 PicoGreen DNA Quantification Assay and the number of Ad
genomic copies was quantified with real-time TaqMan PCR. The normalized Ad uptake (Ad
genomic copies per cell) was calculated for each microreactor and the mean values of the
duplicate samples are shown in Table 5.3. The real Ad concentration was then estimated from
the graph in Figure 5.5a with interpolation. The uptake levels for the lowest Ad concentration
(which are within the linear range) correspond to -2x10 7i.p/ml; this value is significantly higher
than the vector supplier's measurement but still lower than the genomic titer (2.56x10 7p/ml).
Table 5.3: Infectious Ad concentration determined from Ad vector uptake data.
initial Ad concentration Ad uptake initial Ad concentration
according to supplier's (Ad copies/cell) calculated from Figure 5.6
titer (pfu/ml) n=2 with interpolation (i.p./ml)
4x105  103.4 + 43.4 2x10 7
2x10 6  672.6 ± 367.7 1x10 8
4x10 6 849.5 + 11.6 2x10 8
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Figure 5.12 shows the Ad gene delivery efficiency (% EGFP-expressing cells) and
cytotoxicity (% dead cells) in microreactors, quantified with two-photon microscopy and plotted
as a function of the initial Ad concentration in the medium. In graph A the 2-photon data are
plotted together with the normalized Ad uptake results obtained with real-time PCR. The two
sets of data are plotted in differently scaled y-axes to compare the relative change with Ad
concentration. The percentage of EGFP-expressing cells increased linearly as did the number
of internalized Ad copies per cell. However, for an increase in concentration of one order of
magnitude, Ad uptake increased twice as much as the number of EGFP-expressing cells. This
difference indicates that as the Ad concentration increases, the number of Ad infected cells with
detectable levels of transgene expression increases as well as the number of internalized Ad
particles in each infected cell. Cell viability was not affected by the Ad infection and remained at
levels similar to the control cultures for the range of Ad concentration values studied (Graph B).
These results show the ability to quantify gene delivery efficiency in the three-
dimensional microreactor cultures with two-photon microscopy. However, they cannot be
compared with the respective results in monolayer hepatocyte cultures (Section 4.2.1) because
they are obtained with different imaging methods and instruments. In both cases the
quantification of the number of EGFP-positive cells depends on the threshold above which
fluorescence emission can be detected, which is determined by the optics configuration and the
detection system of each instrument. Additionally, in the microreactor there is loss of emission
intensity with increasing sample depth, which affects the outcome of these measurements.
Therefore, comparative analysis can only be performed when studying the efficiency of different
gene delivery vectors.
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Figure 5.12. Quantification of Ad gene delivery efficiency and cell viability in liver
microreactor cultures with two-photon microscopy. The cultures were incubated with
AdEGFP at three concentrations (Co, Co/2 and Co/10, where Co=2x10 8i.p./ml ) for 24hr.
Duplicate samples were prepared for each condition. Approximately 70h after the beginning
of Ad infection the cells were counterstained with Hoechst 33342 and Ethidium Homodimer-1
for imaging. Images were acquired from 3 different channels in each miroreactor. The
number of live cells was determined by the count of Hoechst-stained nuclei, the number of
dead cells by the count of Ethidium-stained nuclei and the number of EGFP-expressing cells
by the count of green fluorescent cells. Graph A shows the % EGFP-expressing cells (as
well as the normalized Ad vector uptake) plotted against the initial Ad concentration. Graph
B shows the % dead cells plotted against the initial Ad concentration. All data points
represent the mean values of two microreactors ± the difference from the mean.
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CHAPTER 6
Conclusions and Future Directions
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6.1 Summary of Results - Conclusions
In vitro systems currently used for gene delivery experiments often fail to reliably predict
in vivo responses to gene delivery vectors, a phenomenon that to large extent could be the
result of the inability to recreate key features of the in vivo environment.
The main objective of this thesis was to compare the gene delivery efficiency of an
adenoviral vector (Ad5-CMV-EGFP) in standard 2D hepatocyte culture and in the Tissue-
Engineered Liver Microreactor. The latter is a culture system designed to facilitate the
morphogenesis of three-dimensional tissue-like structures from isolated liver cells under
continuous perfusion and maintain cell viability and hepatic functionality for long-term culture
periods. Quantitative assays were developed based on Real-Time PCR and RT-PCR to
measure the levels of Ad vector uptake and transgene expression. Additionally, the Ad mass
transport was mathematically modeled in both systems to estimate the Ad uptake constant as a
basis for comparison of delivery efficiency. This parameter was found to be significantly higher
in the microreactor system (about three orders of magnitude), suggesting a more efficient
mechanism of Ad internalization.
Research studies in the past few years have shown that Ad uses different mechnisms to
infect hepatocytes in vitro and in vivo. In vitro, Ad binds to the cells via the CAR receptor and is
internalized via interactions with integrins. In vivo however Ad utilizes a different pathway.
Evidence suggests that interactions with HSPG (heparan sulfate proteoglycans) enable liver
transduction (Smith et al., 2003, Alemany and Curiel, 2001; Martin et al., 2003; Smith et al.,
2002). Recent work has found that in vivo CAR is localized at the junctions between
hepatocytes (lateral surface) and is not accessible to hepatic blood flow. Therefore the
difference in Ad uptake efficiency we observed between the two in vitro systems could be the
result of these different mechanisms of Ad uptake. However, there is no information at this point
to indicate whether the Ad-HSPG interaction is more efficient than the Ad-CAR interaction.
Gene expression was measured in terms of transgene mRNA levels. The ratio of gene
expression relative to Ad uptake was estimated as the basis for comparison of vector
transcription efficiency. No significant difference was found between the 2 systems (ratios within
the same order of magnitude) although experimental errors were relatively high probably due to
the nature of the reverse transcription process. A more sensitive and accurate RT-PCR protocol
is required to detect possible differences (or trends as a function of initial Ad concentration
and/or duration of infection). These experiments provide some evidence that a more
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physiological culture system can provide different information (potentially more relevant to the in
vivo situation) compared to standard in vitro culture.
6.2 The Liver Microreactor as an In Vitro Assay for Gene Delivery
The Tissue-Engineered Liver Microreactor is a promising platform for developing an
alternative in vitro assay for gene delivery. It enables the formation of 3D perfused hepatic
structures that resemble those of in vivo liver tissue and exhibit enhanced and sustained
functional responses. Additionally its design allows the application of microscopy and
spectroscopy for repeated in situ observation. Based on this characteristic, two assays were
developed in this thesis for detection and quantification of gene delivery. The custom-designed
spectrometer assay provides a means for non-invasively tracking the time course and levels of
reporter gene expression by measuring fluorescence emitted by the cells cultured in the
microreactor channels. This technique provides a convenient platform for comparative analysis
of different vectors. The two-photon fluorescence scanning microscopy assay can be applied for
detailed imaging of the hepatic tissue structures with 3-dimensional resolution. Combined with
an environmental control system that maintains the temperature and pH at physiological levels
this assay can be performed non-invasively to track the changes in transgene (EGFP)
expression with time.
An important advantage of this system in comparison to standard hepatocyte culture is
the maintenance of cell viability (for at least 3 weeks). Whereas monolayer hepatocyte culture
deteriorates within a few days, long-term experiments can be performed in the microreactor.
This aspect is of particular interest in cases where transgene expression following vector
delivery is delayed (e.g. in the case of adeno-associated viral vectors).
The long-term maintenance of liver specific functions (such as the expression of
hepatocyte-specific transcription factors) could be important in studying gene delivery vectors
targeted to the liver via hepatocyte-specific promoters or receptors.
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6.3 Future Directions
The difference observed in the efficiency of Ad gene delivery between the two in vitro
systems poses an interesting question. Is there a mechanism of Ad internalization different than
the CAR interaction involved in the case of the liver microreactor system? A potential approach
to this question would be to determine the distribution of CAR in the tissue structures in the
microreactor channels and whether it mimics that of in vivo tissue. Additionally, gene delivery
experiments using an Ad vector with CAR ablation mutations could provide an answer. If
hepatocyte transduction is not eliminated then another mechanism is involved.
The set of assays developed in this thesis provide a convenient platform for gene
delivery studies comparing the efficiency of various vectors. Moreover, the advances in 2-
photon imaging technology will facilitate the application of this technique and enable the
development of more efficient protocols.
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